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Abstract 
Urban emissions of antibiotics into the environment have the potential to ad-
versely affect terrestrial and aquatic organisms. Developed standardized test meth-
ods allow the quantification of the resulting ecotoxicological risk, which strongly 
relies on a comprehensive situation analysis by predicting or measuring a repre-
sentative antibiotic concentration of interest. Predicting the input loads of antibi-
otics to wastewater treatment plants using secondary input data (e.g. prescriptions) 
is a reasonable method if no analytical data is available. The absence of such data 
poses the question of an aquired reasonable sample quantity to capture local sea-
sonal differences in prescriptions as well as flow conditions within the catchment 
area. Both, the theoretical and measurement based determination of environmen-
tal concentrations have been scarcely verified in practice. Hence, high resolution 
prescription data in combination with an extensive monitoring campaign at the 
wastewater treatment plant Dresden-Kaditz (WWTP) were used as a basis to eval-
uate the reliability of predicting and measuring urban antibiotic emissions. 
As expected, the recovery of antibiotic input loads strongly varies among sub-
stances. The group of macrolides as well as sulfamethoxazole and trimethoprim 
were almost fully recovered whereas nearly all substances of the beta-lactam family 
exhibit high elimination rates during the wastewater transport in the sewer system. 
Yet other antibiotics (e.g. fluoroquinolones) show distinct fluctuations through 
the year, which was not obvious from relatively constant prescriptions. The latter 
substances are an example that available data are not per se sufficient to predict the 
actual release into the environment which, in certain cases, emphasizes the neces-
sity of adequate measuring campaings. The extensive data pool of this study was 
hence used to calculate the necessary number of samples to determine a repre-
sentative annual mean load to the WWTP. Based on the applied approach, a min-
imum number of 20 to 40 samples per year is proposed to reasonably estimate a 
representative annual input load of antibiotics and other micropollutants. Regard-
ing the WWTP, the mass flow analysis revealed that macrolides, clindamy-
cin/clindamycin-sulfoxide and trimethoprim were mainly released with the efflu-
ent, while penicillins, cephalosporins as well as sulfamethoxazole were partly de-
graded in the studied WWTP. Levofloxacin and ciprofloxacin are the only antibi-
otics under investigation with a significant mass fraction bound to primary, excess 
and digested sludge. In this context, the sludge concentrations are considered to 
be highly inconsistent which leads to questionable results. It remains unclear 
whether the inconsistencies are due to insufficiencies in sampling and/or analytical 
determination or if the fluctuations can be considered reasonable for digesters. 
Subsequently, verified antibiotic loads were evaluated regarding their ecotoxico-
logical effects in the aquatic environment. Two approaches were applied (1) to 
address the ecological impact on individual trophic levels algae, daphnia and fish, 
and (2) to assess the possible synergistic potential of antibiotic combinations. 
Ciprofloxacin, levofloxacin and the group of cephalosporins showed to signifi-
cantly affect the aquatic environment. They either have the highest impact on (one 
of) the lowest trophic level(s) or disproportionately increase the ecotoxicological 
risk due to their synergistic characteristics. In this regard, the deficiencies regarding 
the input prediction of these antibiotics is of particular concern. The underestima-
tion of such critical mass flow conditions weakens the approach of assessing en-
vironmental risks on the basis of secondary data like prescriptions. Hence, efforts 
must be made to further develop the projection model by improving the quality 
of secondary data, identifying additional emitters and understanding possible re-
tention and degradation dynamics of antibiotics within the sewer system. 
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Zusammenfassung 
In der Humanmedizin eingesetzte Antibiotika werden im menschlichen Körper 
nicht vollständig metabolisiert und gelangen über die Ausscheidungen in das kom-
munale Abwasser. In der Kläranlage erfolgt nur eine unvollständige Elimination 
dieser Stoffe, so dass der Kläranlagenablauf einen Hot Spot für Antibiotikaemis-
sionen in die Umwelt darstellt. Das induzierte ökotoxikologische Risiko kann an-
hand standardisierter Testverfahren und allgemein anerkannter Bewertung-
sansätze für Einzelsubstanzen abgeschätzt werden. Erfolgt jedoch die Betrach-
tung von Antibiotikagemischen, wie es für den gereinigten Ablauf einer Kläranlage 
sinnvoll ist, sind aufgrund zumeist unspezifischer Wirkmechanismen und dem 
Mangel an repräsentativen Daten eine Reihe von Vereinfachungen und An-
nahmen zu treffen. Es besteht in der Folge die Gefahr einer Unterschätzung des 
durch Substanzgemische hervorgerufenen ökotoxikologischen Risikos. Eine 
vielversprechende Möglichkeit den Entscheidungsprozess über mögliche Vermei-
dungs- und Eliminationsmaßnahmen zu unterstützen besteht in der Priorisierung 
von Antibiotika entsprechend ihres Effektpotentials. Hierbei sind Substanzen zu 
identifizieren, die den größten Einfluss auf die Nahrungskette im Gewässer bzw. 
das höchste (negative) Synergiepotential mit anderen Substanzen aufweisen. Die 
Verringerung dieser Substanzen führt zu einer hohen ökologischen Effektivität 
und Effizienz der eingesetzten Mittel. 
Wie im Fall des klassischen Bewertungsansatzes, ist auch für den Priorisier-
ungsansatz eine umfängliche und zuverlässige Situationsanalyse die 
Grundvoraussetzung für verwertbare Ergebnisse. Die Situationsanalyse beruht 
auf der analytischen Bestimmung bzw. der Abschätzung von emittierten Antibi-
otikafrachten zur Berechnung von repräsentativen Umweltkonzentrationen. Ana-
lytisch ermittelte Umweltkonzentrationen vieler Antibiotika weisen aufgrund 
saisonaler Verschreibungsmuster eine hohe zeitliche und räumliche Variabilität 
auf. Die für eine adäquate Erfassung der Situation notwendigen Messkampagnen 
sind kostenintensiv, wobei die tatsächlich notwendige Häufigkeit der Probenahme 
von zumeist nicht hinreichend bekannten substanzspezifischen Informationen, 
wie der chemischen Stabilität im Rohabwasser und der saisonal beeinflussten Ap-
plikation, abhängt. Alternativ können Antibiotikaeinträge in die Kanalisation an-
hand von Verschreibungsdaten abgeschätzt und mit Hilfe von Stoffflussanalysen 
(SFA) zur ökotoxikologischen Bewertung herangezogen werden. Eine vom Um-
fang befriedigende, direkte Gegenüberstellung von prognostizierten und analyt-
isch ermittelten Frachten ist bisher jedoch nicht erfolgt, so dass die Verifizierung 
dieses Ansatzes noch aussteht. Für den Fall einer bestehenden Verschreibung-
spflicht für Antibiotika besitzen Verschreibungsdaten eine vergleichsweise hohe 
zeitliche und räumliche Informationsgüte. In Verbindung mit einer an diese 
Datenqualität angepassten Messkampagne, ergibt sich die Möglichkeit einer de-
taillierten SFA mit substanzspezifischer Bewertung der Eignung des Prognoseans-
atzes.  
 
Die am Beispiel der Stadt Dresden durchgeführte Bewertung des Prognoseansa-
tzes fußt auf einer 15-monatigen Messkampagne und den für das Einzugsgebiet 
der Zentralkläranlage Dresden-Kaditz verfügbaren Verschreibungsdaten der 
AOK PLUS. Erwartungsgemäß ergibt der Abgleich von erwarteten und analytisch 
ermittelten Frachten eine starke Variation der für den Zulauf der Kläranlage er-
mittelten Wiederfindungsdaten verschiedener Substanzen. Die analytisch ermittel-
ten Frachten von Sulfamethoxazol, Trimethoprim sowie der Gruppe der Mak-
rolid-Antibiotika entsprechen nahezu den prognostizierten Mengen. Die Beta-
Laktam-Antibiotika unterliegen bereits während des Abwassertransports einer 
umfänglichen, zumeist biologisch bedingten, Elimination, was zu hohen Unterbe-
funden im Zulauf der Kläranlage führt. Andere Substanzen hingegen (z.B. 
Fluorchinolone) weisen messtechnisch eine signifikante Jahresdynamik auf, die 
aufgrund der weitgehend konstanten Verschreibung in dieser Ausprägung nicht 
zu erwarten ist. Die Auswertung zuletzt genannter Substanzen zeigt deutlich, dass 
die Nutzung von Verschreibungsdaten nicht per se ausreicht, um die Emission 
von Antibiotika (und anderer Pharmazeutika) sowie die sich daraus ergebenden 
Umweltkonzentrationen mit ausreichender Sicherheit prognostizieren zu können. 
Für eine nachgelagerte ökotoxikologische Bewertung ist in diesen Fällen die 
Durchführung von Messungen unumgänglich. Zur effizienten Planung derartiger 
Kampagnen wurde der umfassende Datenpool dieser Studie hinsichtlich der er-
forderlichen Probenanzahl zur Bestimmung einer repräsentativen mittleren 
Jahresfracht ausgewertet. Es ergibt sich ein Minimum von 20 bis 40 homogen über 
das Jahr verteilten Proben, um die jährlich in die Kläranlage eingetragene Fracht 
an Antibiotika bzw. anderer Mikroschadstoffe mit ausreichender Sicherheit ab-
schätzen zu können.  
Im Rahmen der SFA in der Kläranlage Dresden-Kaditz wird deutlich, dass Mak-
rolide, Clindamycin und dessen Humanmetabolit Clindamycin-Sulfoxid sowie Tri-
methoprim in der nahezu keiner Elimination unterliegen, wohingegen Penizilline, 
Cefalosporine und auch Sulfamethoxazol teilweise bis vollständig abgebaut 
werden. Mit Levofloxacin und Ciprofloxacin handelt es sich um die einzigen un-
tersuchten Antibiotika, welche zu einem signifikanten Massenanteil an Primär-, 
Überschuss- und Faulschlamm gebunden vorgefunden werden. Aufgrund der ho-
hen Relevanz dieses Eliminationspfades für die zuvor genannten Antibiotika be-
darf die Beobachtung von z. T. widersprüchlichen Schwankungen einer kritischen 
Betrachtung der Ergebnisse. Es ist nicht abschließend geklärt, ob die beobachteten 
Fluktuationen auf eine unzureichende Qualität der Probenahme und/oder der An-
alytik zurückzuführen sind oder sich die Schwankungen in einem für Faulbehälter 
tolerierbaren Bereich befinden.  
Im Anschluss an die verifizierten Antibiotikaemissionen erfolgte die Priorisierung 
der betrachteten Antibiotika nach ihrem ökotoxikologischen Effektpotential. 
Zum einen wurde der ökologische Einfluss auf verschiedene, die Nahrungskette 
bildende trophische Ebenen (Alge, Daphnie, Fisch) untersucht. In Anlehnung an 
die humanmedizinische Kombinationstherapie erfolgte im zweiten Ansatz die 
 
 
 
 
Beurteilung der Antibiotika hinsichtlich ihres möglichen Potentials zur 
Verstärkung von negativen Effekten durch das gleichzeitige Auftreten mit anderen 
Substanzen. Für Ciprofloxacin, Levofloxacin und die Gruppen der Makrolide und 
Cefalosporine konnten signifikante Beeinträchtigungen der aquatischen Umwelt 
nachgewiesen werden. Diese Stoffe und Stoffgruppen führten im Rahmen der un-
tersuchten Substanzen entweder zur höchsten Schadwirkung gegenüber der nie-
drigsten trophischen Ebene oder besitzen das höchste Synergiepotential in Kom-
bination mit anderen Substanzen.  
Die Auswertung der SFA bestätigt die grundsätzliche Eignung der 
Verschreibungsdaten sowie des entwickelten Prognosemodells zur Vorhersage 
von Antibiotikaemissionen im urbanen Raum. Die Stoffflussanalyse stellt somit 
ein strategisches, im Vergleich zur Messung kostengünstiges Instrument zur Iden-
tifikation von Hot Spots der Antibiotikaemission dar und erleichtert die Entschei-
dungsfindung für monetär aufwendige Reduktionsmaßnahmen am Ort der Ent-
stehung oder in der Kläranlage (z.B. 4. Reinigungsstufe). Die Vorgehensweise zur 
Priorisierung von Substanzen hinsichtlich ihres ökotoxikologischen Effektpoten-
tials eignet sich sehr gut, Antibiotika mit dem höchsten Schadpotential zu identi-
fizieren. Die Verschneidung der Kenntnis dieser Substanzen mit den Ergebnissen 
der SFA macht deutlich, dass mit Ausnahme der Makrolide, alle ökotoxikologisch 
priorisierten Antibiotika eine mangelhafte Prognosefähigkeit aufweisen. Die un-
vollständige Abbildung kritischer Stoffströme, wie z.B. Frachtspitzen, führt insbe-
sondere im Fall der ökotoxikologisch priorisierten Substanzen zu einer Minderung 
der Aussagekraft des auf Verschreibungsdaten beruhenden Prognoseansatzes. An 
diesem Punkt ist in zukünftigen Betrachtungen anzusetzen, um die Qualität von 
Verschreibungsdaten zu verbessern, potentiell nicht erfasste Emittenten in die 
Betrachtungen einzubeziehen, sowie die Dynamik der Rückhalte- und Elimina-
tionsprozesse in der Kanalisation adäquat beschreiben zu können. Die ergänzende 
Betrachtung weiterer Anlagentechnologien (z.B. Festbettreaktoren) kann zur 
Bestätigung der am Beispiel der Kläranlage Dresden-Kaditz gewonnenen 
Ergebnisse beitragen bzw. Unterschiede bei der Elimination von Antibiotika das 
Potential, die Problematik der Antibiotika und anderer Mikroschadstoffe bereits 
während der Planung von Abwasseranlagen berücksichtigen zu können. 
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Introduction 
SCOPE 
Many infectious diseases are treated or prevented by using antibiotics, which are 
an important group of pharmaceuticals in today’s human and veterinary medicine. 
Although there is no real alternative to substitute their specific effect regarding 
bacterial infections, the extensive use of antibiotics must be related to two major 
concerns. First, they are known to promote the emergence of resistances and stu-
dies suggest an increase of resistance-related deaths in Europe from 23’000 in 2015 
to 400’000 in 2050, if no action is taken (Meyer 2015). Hence, the increasingly 
compromised ability to treat infectious diseases is considered to be the strongest 
concern of human future (BIO 2013). Reasons for the vast spread of resistances 
can be found in poor hygiene and prescribing practice, self-medication in coun-
tries with freely available antibiotics, non-compliance as well as a lack of uniform 
European, not to mention international, regulations (WHO 2015b). According to 
current knowledge, increasing consumption of antibiotics proportionally affects 
the probability of clinical resistances (ECDC/EFSA/EMA 2015, Rodriguez-Mo-
zaz et al. 2015). As a consequence, the World Health Organization (WHO) has 
brought the draft “global action plan on antimicrobial resistance” into being to 
prospectively ensure the successful treatment and prevention of infectious di-
seases (WHO 2015a). The German implementation was accordingly executed in 
form of the German antimicrobial resistance strategy DART 2020 
(BMG/BMEL/BMBF 2015) which underlines the urgency of this topic.  
On the other hand, urban emissions of antibiotics into the environment have the 
potential to adversely affect terrestrial and aquatic organisms (Kümmerer 2009). 
In contrast to the environmental hazard caused by resistances, for which no ade-
quate assessment approach presently exists (Berendonk et al. 2015), standardized 
test methods have been developed recently to quantify the ecotoxicological risk 
resulting from antibiotics (EU 2003). Their adequate application strongly relies on 
a comprehensive situation analysis by predicting or measuring a representative an-
tibiotic concentration of interest (Predicted or Measured Environmental Concen-
tration – PEC or MEC) as well as the estimation of a specific antibiotic concen-
tration below which the exposition is not expected to cause adverse effects (Pre-
dicted No-Effect Concentration – PNEC). PNEC values are determined on the 
basis of toxicological endpoints covering a variety of sensitive species to protect 
community function (EU 2003). In many cases only a limited number of toxicity 
studies are available, since the market introduction of most antibiotics was during 
the 20th century, years before the “Guideline on the environmental risk as-
sessment of medicinal products for human use” was put into action (EMA 2006). 
The resulting limited scientific validity of data sets is accounted for by using em-
pirically derived assessment factors, which depend on the number and relevance 
of tested organisms as well as acute or chronic test durations (EU 2003). In this 
context, the concept of “concentration addition” (also termed “dose addition”) 
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allows the transformation of multiple toxicity values of single antibiotics into an 
overall mixture toxicity called risk or hazard index RIadd or Hadd, respectively 
(EPA 2000). Even though this concept is based on the idea of similar modes of 
action (Berenbaum 1985), it also leads to reasonable predictions, irrespective of 
the specific pharmacological action of substances present in the mixture (Alten-
burger et al. 1996).  
Regarding the situation analysis, measured environmental concentrations are va-
rying in time and space (Ternes and Joss 2007), limiting the significance of local 
samplings for entire water bodies, not to mention catchment areas. A reasonable 
sample quantity is acquired to capture local seasonal differences in prescriptions 
(Mühlbauer 2014) as well as flow conditions, which leads to time and budgetary 
constraints. The mass flow analysis (MFA) within a defined system represents a 
promising tool as a basis for risk control regarding antibiotics, if coupled with 
quality criteria like PNEC values (Chevre et al. 2013, Chevre et al. 2011). The 
knowledge on the combination of mass flow and quality criteria allows the identi-
fication of critical flow conditions in order to take appropriate action. The estima-
tion of antibiotic loads entering the system can be carried out using secondary data 
like sales (Bendz et al. 2005), productions (Choi et al. 2008) and prescriptions (Go-
bel et al. 2005). Data quality strongly depends on its primary purpose of generation 
and regional input predictions are often limited by insufficient temporal and spatial 
resolution of data. These limitations were shown to be crucial regarding antibiotic 
prescriptions (GERMAP 2012, Li and Zhang 2011, Mühlbauer 2014), but rarely 
discussed or questioned in past environmental risk assessment (ERA) studies 
(Coutu et al. 2012).  
After medical application, antibiotics are partly eliminated in the human body, the 
sewer system, the wastewater treatment plant (WWTP) as well as the aquatic en-
vironment. Human excretion values are based on pharmacological studies, but 
have been rarely validated in practice (Ghosh et al. 2009). Degradation and sorp-
tion are the main processes influencing antibiotic loads during the wastewater 
transport, which strongly affects the mass flow of antibiotics and corresponding 
recovery of expected loads at the WWTP input. A direct comparison between 
predicted and measured antibiotic input loads has been scarcely performed in 
practice (Bendz et al. 2005, Ghosh et al. 2009, Gobel et al. 2005). Resulting reco-
very values are partly disproportionate and likely to be linked to a very limited 
number of samples. So far, it can be stated that the pending verification of the 
approach’s applicability and the associated suitability of load estimation as a pre-
diction tool must be questioned. In this context, the question on the necessary 
sample quantity to reasonably determine characteristic input loads of WWTP 
arises.  
The majority of WWTP are designed to purposefully eliminate organic com-
pounds as well as, depending on WWTP size and legislation, the nutrients nitrogen 
and phosphorus. In most countries the comprehensive introduction of an advan-
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ced treatment step to eliminate micropollutants in WWTP, i.e. oxidation and ad-
sorption processes, is not required under national legislation. Hence, the conven-
tional treatment process applying nitrogen and phosphorus removal is state of the 
art and representative for the current situation regarding antibiotic removal in 
WWTP. The results of previous studies regarding the removal efficiency of va-
rious antibiotics ranged from complete elimination to significant production (Luo 
et al. 2014), whereby differences can be partly related to changing conditions ori-
ginating from WWTP operation as well as flow and load variations. In this context, 
the term “operational parameters” will be understood to include typical WWTP 
parameters, which are not subject to any control (e.g. temperature). In particular, 
operation parameters like solid retention time SRT (Suarez et al. 2012, Vieno et al. 
2007), hydraulic retention time HRT (Guerra et al. 2014, MacLeod and Wong 
2010) as well as plant design (Guerra et al. 2014, Larcher and Yargeau 2012, Suarez 
et al. 2010) and seasons (Gracia-Lor et al. 2012, Guerra et al. 2014, Kwon and 
Rodriguez 2014, Zhang et al. 2015) were shown to possibly influence the removal 
process. Moreover, the re-transformation of metabolites to their parent subs-
tances was discussed (Goebel et al. 2007), which also affects the actual calculation 
of removal rates. Apart from this aspects, in many cases negative removal values 
are considered to be the result of an insufficient sampling method (Majewsky et 
al. 2011) and longer sampling campaigns are required to achieve reliable results 
(Gobel et al. 2005). 
GOALS AND STRUCTURE 
The main objective of this work comprises the realization and verification of MFA 
for fate characterization of antibiotics in an urban wastewater system, in combi-
nation with risk assessment approaches to identify the most toxic and unpredic-
table representatives. The timeliness of emerging contaminants in urban wastewa-
ter systems has led to numerous publications aiming for answers regarding fate 
and ecological impact of antibiotics. The majority of conclusions is based on very 
few samples, without considering specific inflow and catchment characteristics of 
the respective WWTP. These essential restrictions led in particular to the ambition 
of critically evaluating results concerning their reliability and significance (data 
quantity and quality).  
The catchment area of the WWTP Dresden-Kaditz and the receiving stream Elbe 
constitute the study area of the present work. A total of 14 antibiotics as well as 
one human metabolite, which were chosen on the basis of their amount of con-
sumption, are investigated.  
The thesis is composed of four articles covering the following three compartments 
and according objectives: 
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Table 1: Structure and objectives. 
Objective Reference 
C
om
pa
rt
m
en
t 
1.
C
at
ch
m
en
t a
nd
se
w
er
 sy
st
em Prediction and 
verification of  
input loads 
Marx, C., Mühlbauer, V., Schubert, S., Oertel, 
R., Ahnert, M., Krebs, P., Kuehn, V. (2015). 
Representative input load of antibiotics to 
WWTPs: Predictive accuracy and deter-
mination of a required sampling quantity 
Water Research 76, pp. 19-32. 
2.
W
as
te
w
at
er
tre
at
m
en
t p
la
nt
Mass flow  
analysis WWTP 
Marx, C., Günther, N., Schubert, S., Oertel, 
R., Ahnert, M., Krebs, P., Kuehn, V. (2015). 
Mass flow of antibiotics in a wastewater 
treatment plant focusing on removal vari-
ations due to operational parameters 
Science of The Total Environment 538, pp. 779-788 
3.
E
nv
iro
nm
en
t
Prioritization of 
risk-driving  
antibiotics 
Marx C., Mühlbauer V., Krebs P., Kuehn V. 
(2015). Species-related risk assessment of 
antibiotics using the probability distribu-
tion of long-term toxicity data as 
weighting function: a case study 
Stochastic Environmental Research and Risk 
Assessment 29, pp. 2073-2085 
Marx, C., Mühlbauer, V., Krebs, P., Kuehn, V. 
(2015). Environmental risk assessment of 
antibiotics including synergistic and an-
tagonistic combination effects 
Science of The Total Environment 524-525, 
pp. 269–279 
Each article provides a detailed characterization of boundary conditions and pos-
sible sources for uncertainties and errors. Combining the results of all investigated 
compartments leads to an integrative evaluation of antibiotic’s impact on the en-
vironment and further provides evidence on the suitability of secondary data to 
perform environmental risk assessment. The subsequent identification of high-
impact substances constitutes the basis for sophisticated risk management strate-
gies resulting in high ecological effectiveness. 
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APPROACH AND METHODS 
1. Compartment: Catchment and sewer system
The prediction model for the input of antibiotics into the sewer system is based
on prescriptions provided by the statutory health insurance company AOK PLUS
and several hospital pharmacies. The model considers the projection of available
prescription data to the entire population of the catchment area as well as the
prediction of actual and future prescriptions, based on prescribed amounts from
past years. Outpatient data are available on a weekly basis but do not provide in-
formation on the treatment initiation, the application period or the patient’s com-
pliance. In connection with low resolution inpatient prescription data, the evalua-
tion on a monthly basis is regarded as more expedient for a comparison between
predicted and measured input loads to the WWTP. The available outpatient pres-
criptions represent about 41 % of Dresden’s total population, whereby an identical
prescription practice was assumed for patients insured under the remaining statu-
tory health insurance schemes (about 49 %). This assumption is also justified re-
garding privately insured patients (about 10 %) due to their corresponding nation-
wide share in antibiotic preparations (Wild 2015). Subsequent to the projection,
the prediction approach is based on the evaluation of past prescription data and
consists of two steps. First, the estimation of the annual drug consumption based
on their development of the last few years, and second, the determination of a
characteristic seasonal trend to calculate respective monthly drug loads. In con-
nection with the antibiotic-specific excretion rate, the input load into the sewer
system of the catchment area can be estimated.
Hereafter, estimated input loads were compared with analytically determined input 
loads at the WWTP. The WWTP monitoring was carried out for 15 months, taking 
daily 24h-composite samples. Intermediate degradation processes during the resi-
dence time in the sewers were taken into consideration carrying out laboratory 
experiments. Discharge losses from combined sewer overflows were estimated to 
about 10 % of the annual load (Marx and Kuehn 2015) but not quantitatively 
considered due to their irregular, event-based occurrence. To address the signifi-
cance and reliability of the findings, both the predicted and measured values were 
evaluated with respect to uncertainties deriving from the prediction model and 
analytics. 
2. Compartment: Mass flow analysis WWTP
In contrast to the monthly evaluation of input loads, the detection of possible
operational influences on the removal of antibiotics calls for a substantiated ap-
proach. In- and output loads considerably fluctuate within the period of one
month, which does not permit their comparison with moderately changing para-
meters like solid retention time and temperature. Hence, the removal from the
liquid phase was determined from cumulative in- and output loads within time
series of gapless in- and effluent data sets. Operational parameters under investi-
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gation were averaged correspondingly for each time series to detect possible de-
pendencies. Additionally, antibiotics were analytically determined in primary, ex-
cess and digested sludge to estimate the removal of antibiotics by adsorption as 
well as to assess their fate during the anaerobic sludge treatment. The applied ana-
lytical method was specifically developed to determine antibiotic concentrations 
from matrices with high solids content. 
The mass flow analysis was established normalizing antibiotic loads from the ef-
fluent and the digested sludge to the diurnal input load. The difference between 
100 % and both output streams hereby indicates a degradation or production of 
the respective compound, depending on a positive or negative outcome, respecti-
vely. In this context, degradation is understood as the loss of the antibiotic’s ori-
ginal molecule structure by biotic or abiotic processes. So-formed transformation 
products can have similar properties, compared to their parent substances, but are 
not further taken into consideration regarding the actual mass flow analysis. 
3. Compartment: Prioritization of risk-driving antibiotics 
The study focuses on risk assessment of antibiotics in the liquid phase. It was 
carried out on the basis of prescription data applying excretion and elimination 
values, which have been validated by the results of the first two studied com-
partments. The dilution of the WWTP effluent entering the receiving stream Elbe 
is usually estimated assuming complete mixing. Nevertheless, limited mixing pro-
cesses are the reason for expanded effluent plumes in the receiving streams (Jirka 
et al. 2004) whose antibiotic concentrations are likely to remain higher than the 
complete mixing calculation suggests. In order to cover the two concepts, the 
ERA was carried out for both, complete mixing and undiluted effluent plume. In 
addition, the scope of this study focuses on single antibiotics (no transformation 
products), neither considering elimination processes in surface water bodies like 
sorption, hydrolysis and photolysis nor the existing preload from upstream settle-
ments.  
The determination of specific PNEC values was primarily carried out according 
to EU guidelines (EU 2003), based on an intense literature review covering long-
term toxicity data of all available tested species. The lowest available toxicity 
thresholds for considered standard organisms (algae, daphnia, fish) was merged 
with the species sensitivity distribution of all available species to express the risk 
probability towards each species level. The most hazardous antibiotics to the lo-
west species level additionally weaken higher-tier organisms, in terms of food 
supply, and can be considered as potential environmental risk-driving substances. 
Synergistic and antagonistic effects were assessed applying the interaction-based 
hazard index (EPA 2000) which is based on binary interaction experiments. The 
subsequently performed sensitivity analysis provides evidence on the relevance of 
available studies as well as tested concentration ranges. 
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Representative input load of antibiotics to WWTPs:  
Predictive accuracy and determination of a required sam-
pling quantity  
Marx, C., Mühlbauer, V., Schubert, S., Oertel, R., Ahnert, M., Krebs, P.,  
Kuehn, V. 
ABSTRACT 
Predicting the input loads of antibiotics to wastewater treatment plants 
(WWTP) using certain input data (e.g. prescriptions) is a reasonable method 
if no analytical data is available. Besides the spatiotemporal uncertainties of 
the projection itself, only a few studies exist to confirm the suitability of re-
quired excretion data from literature. Prescription data with a comparatively 
high resolution and a sampling campaign covering 15 months were used to 
answer the question of applicability of the prediction approach. As a result, 
macrolides, sulfamethoxazole and trimethoprim were almost fully recovered 
close to 100 % of the expected input loads. Nearly all substances of the beta-
lactam family exhibit high elimination rates during the wastewater transport 
in the sewer system with a low recovery rate at the WWTP. The measured 
input loads of cefuroxime, ciprofloxacin and levofloxacin fluctuated greatly 
through the year which was not obvious from relatively constant prescribed 
amounts. The latter substances are an example that available data are not per 
se sufficient to monitor the actual release into the environment. Furthermore, 
the extensive data pool of this study was used to calculate the necessary num-
ber of samples to determine a representative annual mean load to the 
WWTP. For antibiotics with low seasonality and low input scattering a mini-
mum of about 10 samples is required. In the case of antibiotics exhibiting 
fluctuating input loads 20 to 30 evenly distributed samples are necessary for 
a representative input determination. As a high level estimate, a minimum 
number of 20 to 40 samples per year is proposed to reasonably estimate a 
representative annual input load of antibiotics and other micropollutants. 
KEYWORDS 
Antibiotics, recovery rate, prescription data, sample quantity, wastewater 
treatment plant 
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INTRODUCTION 
Input loads of antibiotics into the sewer system and the environment are often 
estimated using information on nationwide productions, sales or prescribed 
amounts (Bendz et al. 2005, Choi et al. 2008, Gobel et al. 2005). If applying this 
approximation method, it has to be taken into account that the catchments of 
wastewater treatment plants (WWTP) can vary significantly in amounts of actually 
administered antibiotics due to socio-economic reasons. Li and Zhang carried out 
an evaluation of prescription data of antibiotics from different districts in Hong 
Kong and stated that a breakdown of district- or nation-wide prescriptions to 
single catchments is not acceptable to sufficiently estimate input loads (Li and 
Zhang 2011). In addition to local variations regarding drug administration further 
uncertainties arise through the necessary use of substance-specific excretion rates. 
Those pharmacokinetic information are based on only a few pharmacological stu-
dies and have been rarely validated in practice (Ghosh et al. 2009). One of the few 
studies comparing predicted and measured influent was carried out for trimetho-
prim at the Kälby WWTP in Sweden (Bendz et al. 2005). As a result the theoretical 
load was almost 5 times higher than the measured value. Reasons for the discre-
pancy were not provided. At a Swiss WWTP about 50 % and 75 % of predicted 
sulfamethoxazole and trimethoprim loads were determined, respectively, taking a 
sum of 8 samples in 2002 (March) and 2003 (February, November) (Gobel et al. 
2005). Investigated macrolides azithromycin, clarithromycin and roxithromycin 
were fully recovered by the measurement. Those investigations provide important 
information on the reliability of applied extrapolation methods for load determi-
nation but also raise the question of an appropriate sample quantity in this field of 
investigations. For example, grab samples and short-term composite samples (2h, 
4h etc.) were shown to be not suitable for input load characterization due to high 
fluctuations within one day (Coutu et al. 2013, Li and Zhang 2011). In this context, 
most of the previous investigations with the aim of determining antibiotic input 
loads used a comparatively low number of input samples. Zhou et al. used each 2 
hr time-integrated samples in two consecutive days to perform a mass balance 
analysis of two WWTP in South China during May and November 2010 (Zhou et 
al. 2013). Plosz et al. (2010) and Gao et al. (2012) used 6 h-, 8 h- and 24 h-com-
posite samples (three of each type) to investigate input load dynamics and evaluate 
the contributing processes for pharmaceutical removal, respectively (Gao et al. 
2012, Plosz et al. 2010). Four 24 h- composite samples were used to investigate 
the elimination pathways of antibiotic loads in a Chinese WWTP (Li et al. 2013). 
A total of eight 24 h-composite (flow proportional) samples were taken to deter-
mine the mean input load to the WWTP Kloten-Opfikon, near Zurich, Swit-
zerland (Gobel et al. 2005). By far the highest number of 24 h-mixed composite 
samples was taken to examine temporal dynamics of antibiotics in the WWTP 
Lausanne, Switzerland. A total of 84 samples were evenly distributed over the year 
to capture the seasonality of antibiotics (Coutu et al. 2013). 
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The current state of knowledge poses two main questions regarding the determi-
nation of the representative input load of antibiotics to WWTP:  
1) Is the extrapolation of suitable input data (production, sales or prescriptions)
in combination with the excretion rate sufficiently accurate to estimate the
input loads to WWTPs?
2) What is the appropriate number of samples to determine the characteristic
input loads of WWTP, in case alternative input data are not available?
In order to provide answers to the above questions an intensive monitoring pro-
gram was carried out at the WWTP Dresden-Kaditz taking daily samples over a 
period of 15 months. The determined input loads were compared to predicted 
values based on in- and outpatient prescription data for the catchment area of the 
WWTP. This comprehensive information give insights into load fluctuations of 
antibiotics at WWTP inflows and establish a solid basis to evaluate excretion rates 
from literature. Proceeding from the pool of high resolution data a substance 
specific estimation on the minimal number of samples which satisfactorily des-
cribes the annual mean load was carried out. 
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MATERIALS AND METHODS 
Ambulant and clinical prescription data 
A total of 14 antibiotics were investigated covering the following classes: macro-
lides (azithromycin, clarithromycin, roxithromycin), tetracyclines (doxycycline), 
cephalosporins (cefuroxime, cefotaxime), sulfonamides (sulfamethoxazole + tri-
methoprim), lincosamide (clindamycin), penicillins (penicillin V, piperacillin, 
amoxicillin) and fluoroquinolones (ciprofloxacin, levofloxacin).  
The projection model is based on in- and outpatient prescription data. Outpatient 
prescription data were provided by the AOK PLUS, the largest statutory health 
insurance company in the district of Saxony, Germany. About 41 % of the popu-
lation in Dresden is insured by the AOK PLUS while the remaining part is being 
held by other statutory and private health insurance companies. Ambulant data 
are available weekly for 2005 – 2012. Inpatient prescriptions were available for 
three major hospitals covering about 65 % of hospital beds in the catchment area 
of the WWTP Dresden-Kaditz. Hospital prescription data are available for 2011 
and 2012 on a quarterly or monthly basis, depending on the institution. The pro-
jection factor of stationary prescriptions to the entire catchment area was calcu-
lated to 100%/65% = 1.54. Comparing the amounts of in- and outpatient pres-
cribed amounts it can be stated that most antibiotics are predominantly prescribed 
in the ambulant sector. The projected amounts of all hospitals constitute less than 
30 % of the total prescriptions (= sum of in- and outpatient loads) in the cat-
chment area (see Figure 1). Levofloxacin (40 %), cefuroxime (80 %), piperacillin 
(100 %) and cefotaxime (100 %) are exceptional cases and hospitals are considered 
to be the main contributors to the overall administration, regarding those subs-
tances. 
In most cases hospital antibiotics are constantly applied throughout the year. The 
standard deviations of mentioned high-impact substances are less than 17 % and 
justify the assumption of an even (constant) administration in hospitals. The pres-
cription characteristic of remaining antibiotics with higher standard deviations SD 
(roxithromycin: 77 %, amoxicillin: 61 %, clarithromycin: 49 %, doxycycline: 42 %, 
azithromycin: 38 %, ciprofloxacin: 27 %, clindamycin: 25 %) will also be assumed 
to be evenly distributed over the year since no repeating seasonal pattern is evident 
and their impact on the total input to the catchment area is negligible.  
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Figure 1: Proportion of antibiotics administered in the three major hospitals in Dresden in 2011 and 
2012, referred to the total catchment’s input 
Ambulant macrolide prescriptions follow a distinct seasonality throughout the 
year. During the months of January and February prescriptions are more than 
double compared to the summer season (May to August). Sulfamethoxazole, tri-
methoprim, penicillin V and levofloxacin show a seasonal influence. Nonetheless, 
in relation to annual average the differences between summer (80 %) and winter 
(120 %) are not as profound as for macrolides. In the ambulant sector clindamy-
cin, doxycycline and ciprofloxacin are evenly administered throughout the year. In 
the case of cefuroxime the seasonality developed during the period under review. 
During the years 2005 and 2006 no seasonality was observed. In subsequent years, 
differences between winter and summer started to increase. In relation to the an-
nual mean, 115 % and 80 % of cefuroxime were prescribed in winter and summer 
2012, respectively, which amounts a gain of about 50 %. This significant develop-
ment is interesting but carries no weight considering the vast amount of plainly 
prescribed cefuroxime in hospitals.  
Projection and prognosis model of influent loads 
The WWTP Dresden-Kaditz treats the wastewater of five cities (Dresden, Freital, 
Heidenau, Pirna and eastern Radebeul) and some bordering municipalities. The 
current loading is about 650000 PE, of which around 80 % are living in Dresden. 
The WWTP has a design capacity of 740000 PE. The catchment area has a size of 
about 9 400 km² with no known industries producing or applying significant 
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amounts of antibiotics (e.g. industrial husbandry). The sewer system consists of 
about 800 km of combined sewers, around 450 km of separate sewerage system 
and 350 km for stormwater runoff. Due to the significant amount of combined 
sewers (nearly 50 %) the loss of antibiotic loads in case of a stormwater induced 
discharge of mixed wastewater (wastewater + stormwater) must be kept in mind. 
These events are usually of very short duration and do not influence the prediction 
at normal conditions, i.e. dry weather. 
It is assumed that AOK-insured people constitute a representative portion of the 
entire catchment area of the WWTP. Concluding, an extrapolation using the insu-
rance ratio of 41 % is regarded to be justified. The share of privately insured people 
(about 10 %) will not be considered independently, due to a lack of information 
regarding a specific prescription practice. An equal prescription behavior will be 
assumed for patients of private and statutory health insurance companies.  The 
variety of hospital prescriptions depends on the number and type of clinical sta-
tions and can vary significantly between institutions. A detailed differentiation bet-
ween the available hospitals, based on existing stations and corresponding anti-
biotic usage was not possible from the available data set. Hence, the extrapolation 
of clinical prescriptions to the catchment area was carried out using the 65 % co-
verage of hospital beds. The following equation 1 sums up the assumptions made 
to calculate the total antibiotic input to the catchment area of Dresden Kaditz. 
PAB,a,AOK and PAB,a,hospital represent the ambulant (AOK) and hospital prescriptions, 
respectively. 
%65%41
,,,,
,,
hospitalaABAOKaAB
aprojAB
PP
I  (Equation 1) 
(for a = 2005 .. 2012) 
y
II
II a,proj,AB1ya,proj,ABa,proj,AB1a,pred,AB

  (Equation 2) 
(for a = 2004+y .. 2012 and y = 2, 3, 4) 
The monitoring program at the WWTP Dresden-Kaditz was predominantly car-
ried out in 2013. While corresponding prescription data are not available for this 
year, it is necessary to extend the projected input of antibiotics to predict the pres-
criptions for 2013. The prediction of absolute monthly input loads of 2013 was 
carried out following a two-stage procedure. First, the prediction of monthly 
changes can be reasonably assumed on the basis of a relative seasonality within 
the year. As outlined in 2.1, the seasonal characteristics of most antibiotics, except 
cefuroxime, annually repeat with nearly identical pattern. This characteristic 
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becomes even more apparent normalizing each month to the corresponding an-
nual mean. Hence, the normalized seasonal pattern of 2005 – 2012 is averaged 
(see Figure 2B) and will be referred to as ‘relative seasonality’. The corresponding 
monthly standard deviation will be subsequently used for quantifying the uncer-
tainty (see equation 3) of applying a recurring seasonality (see 3.1). The average 
uncertainty of seasonality of each antibiotic was calculated using equation 4 (see 
Figure 3). As the second step, neglecting the monthly variations, the prognosis of 
the annual quantity of administered antibiotics is carried out using the mean con-
sumption change of the previous 2, 3 and 4 years. The procedure originates from 
the Euler’s forward method and was adopted according to equation 2. The three 
approaches using the trend prediction according to the prior 2, 3 and 4 years were 
tested for their degree of uncertainty, in order to determine the one with the lowest 
derivation between predicted and actual annual quantity. For this purpose, Euler’s 
forward method was applied on the entire dataset using y = 2, 3 and 4. In general, 
the maximal derivations using either one of the prognosis approaches were nearly 
similar (supplementary material Figure S2, annex 1). At least the trend prognosis 
of the annual consumption change using the previous 3 years showed slightly bet-
ter results (especially for sulfamethoxazole and trimethoprim) and was ultimately 
used for the prediction of administered antibiotics in 2013 (see Figure 2A and 
equation 2 applying y=3). As a result, the specific mean input load of 2013 can be 
predicted considering the region-specific consumption development. The uncer-
tainty of each antibiotic will be expressed using the maximal deviation from the 
application of equation 2 (y=3) for the years 2008 – 2012 using equation 5. The 
results are summarized in supplementary material Figure S2 (annex 1). Finally, 
combining the information of the mean annual input load and the relative seaso-
nality gives a solid forecast for absolute monthly input loads for 2013. 






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a,real,AB
m,a,real,AB
m,season,AB I
I
U (Equation 3) 
for m = Jan .. Dec, and a = 2005 .. 2012 
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Figure 2-A: annual prescription loads of roxithromycin from 2005 – 2012 (hatched bars) and the prog-
nosis for 2013 (grey bar); 2-B: mean relative seasonality of roxithromycin for the time period between 
2005 – 2012 (standard deviation represented by error bars) 
Excretion rate of antibiotics 
A crucial link between drug prescription and its recovery at the inflow of a WWTP 
is the human excretion rate of the parent drug and its behavior within the sewer 
system. A lack of reliable data must be stated since the accurate excretion rate of 
a new drug plays a minor role in permission requirements for a commercial launch. 
Hence, pharmaceutical companies do not share the interest of providing profound 
information on human elimination pathways and their individual products in de-
tail. Bibliographical references contain information on total excretion including 
metabolites, oral or parenteral administration as well as excretion rates specifically 
referring to urine, faeces or a combination of both. Due to this variety in data type 
and range an intensive literature search was carried out in order to minimize un-
certainty and back up applied data. A summary of excretion rates is given in 
Table 1. 
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Table 1: Excretion rate of antibiotics under investigation 
Antibiotic Excretion rate (EAB) 
Cefuroxime 42.8 – 57.0 % (ODDB 2014) 
Clarithromycin 60.0 – 78.11  % (Abbott 2006. Hirsch et al. 1999) 
Azithromycin 67.42  % (Sandoz 2009) 
Roxithromycin 47.83  – 60.0 % (Hirsch et al. 1999. Sanofi-Aventis 2009) 
Clindamycin 10 – 35 % (Pharma 2012b. Still et al. 2006) 
Amoxicillin 60 – 85 % (Aktories et al. 2009. Martindale 1993) 
Penicillin V 29 - 43 % (Pharma 2012c) 
Ciprofloxacin 40.0 – 69.7 % (Kümmerer et al. 2000. Pharma 2012a) 
Levofloxacin 74.9 – 85.9 % (Wagenlehner et al. 2006) 
Sulfamethoxazole 15 – 254 %  (Hirsch et al. 1999. Martindale 1993) 
Doxycycline 22 – 70 % (Hirsch et al. 1999, Pharma 2008) 
Trimethoprim 40 – 60 % (HSDB 2014, Martindale 1993) 
Piperacillin 60 – 95 % (Aktories et al. 2009, Fresenius 2012b) 
Cefotaxime 40 – 60 % (Fresenius 2012a) 
The reliability of excretion data cannot be assessed from the information provided 
in literature. Hence, the uncertainty regarding the determined range of excretion 
values will be calculated using equation 6, expressing the relative deviation of the 
range limits to the range’s mean. 
min,ABmax,AB
min,ABmax,AB
excretion,AB EE
EE
U


 (Equation 6) 
Monitoring program and analytical methods 
The monitoring at the influent of the WWTP Dresden-Kaditz was carried out 
from October 2012 until December 2013. All 14 antibiotics were analyzed daily in 
flow proportional 24h-composite samples. Samples taken were stored at 4°C using 
brown glass flasks for a maximum time period of 7 days until transport and ana-
lysis in the lab. In June 2013 the inflow measurement was interrupted due to flood 
water in the receiving stream, River Elbe. The inflow of the WWTP was maxed 
out and measuring equipment was put out of service as a precautionary measure. 
Since the 24h-sampler was operational most of that time, the inflow hydrograph 
could be restored using the incoming ammonia concentration (see supplementary 
material Figure S1, annex 1). 
1 Using equation S1 (annex 1) with fA,AB = 59.9 % and fM,AB = 36.6 % 
2 Using equation S1 (annex 1) with fA,AB = 37 % and fM,AB = 88 % 
3 Elimination of 37.8 % through feces + 10 % through urine 
4 Using equation S1 (annex 1) with fA,AB = 100 % and fM,AB = 75 – 85 % 
Representative input load of antibiotics to WWTPs 
22 
In the laboratory, composite wastewater samples were immediately prepared for 
the antibiotic analyses and a method developed by Rossmann et al. (2014) was 
used to quantify the selected antibiotics and determine their stability in diverse 
wastewater during a maximum storage of 7 days (Rossmann et al. 2014). Briefly, a 
50-mL aliquot of homogeneous wastewater was mixed with 0.8 mg/mL EDTA- 
Na2 (Ethylenediaminetetraacetic acid disodium salt dehydrate, ACS reagents;
Sigma, St. Louis, MO, USA) and filtered through a glass fibre filter (< 0.9 µm;
WICOM, Heppenheim, Germany). With formic acid (LC-MS grade; Sigma, St.
Louis, MO, USA) the sample was adjusted to a pH of 3.5 (± 0.2). Then, 2.5 mL
of prepared wastewater were extracted by Solid Phase Extraction (SPE) onto a 30
mg Oasis HLB Vac Cartidge  (Waters, Milford, MA, USA) using the Gilson Auto-
matic Sample Processor ASPEC XL (Middleton, WI, USA). The extracts were
analyzed by a LC-MS/MS system. The chromatographic separation was per-
formed with a Synergi 4µ HydroRP 80A, 150 x 2.0 mm (Phenomenex, Aschaffen-
burg, Germany) column with a Security Guard  C18, 4 mm x 2 mm i. D. (Pheno-
menex, Aschaffenburg, Germany) and secondly, with a 100 mm x 3 mm Nu-
cleoshell HILIC 2.7 µm column (Machery-Nagel, Düren, Germany) for the anti-
biotics amoxicillin, ciprofloxacin, doxycycline and levofloxacin. For the detection,
an API 4000 tandem mass spectrometer (ABSciex, Framingham MA, USA) was
equipped with an electrospray interface (ESI) in the multiple reaction monitoring
mode (MRM).
The maximal analytical errors resulting from spiking diluted urine with 100, 1000 
and 5000 ng/l are 14.6 % (amoxicillin), 13.5 % (levofloxacin, 12.0 (cefuroxime, 
penicillin V), 11.5 % (piperacillin), 10.6 % (ciprofloxacin), 9.8 % (roxithromycin), 
9.7 % (cefotaxime), 9.6 % (sulfamethoxazole), 9.3 % (clarithromycin, doxycycline), 
7.3 % (azithromycin, trimethoprim) and 5.9 % (clindamycin). The influent matrix 
showed to be very different compared to diluted urine and quantification was rea-
lized using standard addition of 1000 ng/l and 5000 ng/l (only cefuroxime, amoxi-
cillin and doxycycline), respectively (Rossmann et al. 2014).  
Laboratory investigation on the stability in raw wastewater 
Laboratory experiments were conducted in order to determine antibiotic behavior 
in raw wastewater which, along with excretion, is a second crucial link between 
drug prescription and its recovery at the inflow of WWTPs. The sewer system is 
a very heterogeneous system and oxygen conditions along the flow path are diffi-
cult to describe. In order to assess different elimination characteristics the experi-
ments were conducted at both, anaerobic (oxygen < 0.1 mg/l) and aerobic (oxy-
gen > 2.0 mg/l) conditions. The experiments were carried out in the dark at 10 
and 20 °C. The temperatures were kept constant using a water bath. Aerobic and 
anaerobic conditions were established by introducing air or nitrogen, respectively. 
2 ml of the stock solution containing 1 µg/ml of each antibiotic were added to 2 
L glass flasks in order to raise the antibiotic concentration by 1000 ng/l. The mean 
residence time of wastewater in the sewer systems until it reaches the WWTP can 
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be estimated to about 12 h. Accordingly, in order to describe the stability of anti-
biotics within this time horizon samples were taken before the addition of 
1000 ng/l as well as after 15 min and 12 h. Values determined for 10 and 20 °C 
were averaged to address the different temperature conditions throughout the 
year. The recovery rate was determined using equation 7. The corresponding error 
was calculated according to linear error propagation using equation 8. 
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With t being the concentration after 15 min (initial recovery) and 12 h. 
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RESULTS AND DISCUSSION 
Uncertainties of predicted input loads 
The recovery rate of projected antibiotic inputs involves a set of uncertainties 
which are depicted as three levels of grey in Figure 3 and Figure 5 and will be 
presented in the following. The regarded uncertainties were added and related to 
the mean monthly input load to depict the entire range of values predicted by this 
approach. The internal band (darkest grey) represents the variation of excretion 
values found in literature Table 1 and was calculated using equation 6. On average, 
absolute numbers of excretion data deviate between 10 and 20 %. In case of 
doxycycline and piperacillin the variation exhibits the largest spread of all antibio-
tics, whereas only one literature value was available for azithromycin. Based on 
the relative uncertainty of the mean excretion, clindamycin and doxycycline exhi-
bit the largest deviation of about 50 % (see Figure 3). 
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Figure 3: Composition of uncertainty regarding the predicted input loads based on prescription data 
(deviation due to seasonality was averaged over the year) 
The mid band of grey (see Figure 3 and Figure 5) represents the uncertainty of the 
relative seasonality (fluctuations) from 2005 – 2012 and was calculated using equa-
tions 3 and 4, respectively. The standard deviation percentage (SD) of each month 
is a measure of how reliable the application of an averaged seasonal trend is. The 
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highest mean SD between 11 – 13 % were determined for all macrolides (see Fi-
gure 4). Macrolides have the most pronounced seasonality and exhibit peak values 
between January and March. Irrespective of the seasonality itself, the peak values 
cannot be specifically related to certain (illness-) events and seem to occur ran-
domly, which makes a solid forecast difficult. Without taking macrolides into ac-
count, the average uncertainty due to seasonal fluctuations of antibiotics amounts 
to about 6 %. 
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The external band (lightest grey in Figure 3 and Figure 5) addresses the maximum 
uncertainty of the applied annual trend prediction. Therefore, the trend was cal-
culated for 2008 to 2012 and compared with the corresponding actual prescrip-
tion. The maximum relative discrepancy of the five years was calculated according 
to equation 5 and is considered to be well suited to act as indicator of the progno-
sis’s reliability (see 3-year trend prediction in supplementary material Figure S2, 
annex 1). Except for doxycycline, all substances under investigation have a maxi-
mum trend uncertainty of 10 to 20 %. Doxycycline shows a continuously decrea-
sing prescription from 2005 – 2008 and 2010 – 2012. In 2009 the prescription 
increased above the value of 2005 which is the reason for the vast uncertainty of 
52 %. 
Figure 3 summarizes the addressed deviations of expected input loads to the 
WWTP. Except for clindamycin and doxycycline, total deviations of all substances 
vary between 30 and 50 %. The strongly diverging excretion values of clindamycin 
and doxycycline, as well as the above presented trend uncertainty of the latter, lead 
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to a comparatively high overall uncertainty of 62 % and 113 %, respectively. The 
percentages are referred to the mean predicted input load derived from the pro-
jection and forecast model. 
Seasonal recovery rate of antibiotics 
Figure 5 illustrates the predicted (grey-leveled band) and measured (box plots) in-
put loads of antibiotics. The black solid line characterizes the mean WWTP-in-
flow. In the following, the discussion of recovery rates for each antibiotic is divi-
ded into sub-sections, regarding the mode of antibiotic application, measured in-
put characteristic and characteristic properties of antibiotics under investigation.  
Sulfamethoxazole and trimethoprim  
As sulfamethoxazole and trimethoprim are nearly exclusively administered toge-
ther, mono-preparation of trimethoprim can be neglected. Measured data of tri-
methoprim widely correspond with the lower limit of the predicted input range. 
An average recovery of 76 % was yielded whereas about 67 % of all data points 
can be found within the forecasted area (see Figure 5B). The seasonal characteris-
tic of trimethoprim exhibits a more distinctive variation (2.5-fold increase in Ja-
nuary and February) than supposed from prescription data. This variation of mea-
sured input loads was also observed at the Vidy WWTP (220 000 inhabitants and 
several hospitals), in Lausanne, Switzerland, where the gain was in the range of a 
3-fold increase (Coutu et al. 2013). Comparing the two studies, similar specific
input loads of 21.6 – 64.8 µg/(PE*d) (Coutu et al. 2013) and
30.8 – 76.9 µg/(PE*d) (present study) were determined. The lower PE-loads in
Switzerland were expected since antibiotic consumption in Switzerland is about
30 % lower than in Germany (Filippini et al. 2006). The range of measured input
loads in five Swedish WWTP of 29 – 450 µg/(E*d) is too large to be compared
with results from this study (Lindberg et al. 2005).
Measured sulfamethoxazole data fit well into the predicted input band from 
December 2012 to October 2013 (see Figure 5A). At the end of 2012 and 2013 
significantly higher values were detected which cannot be explained by the predic-
tion model. The unexpected increase could neither be verified using the sul-
famethoxazole/trimethoprim-ratio which should be constant in raw wastewater 
throughout the year. Göbel et al. also used the information of the substance ratio 
in human medicine for verification purposes of the analytical measurements, ne-
glecting differing excretion ratios of both substances (Gobel et al. 2005). Without 
taking the specific ratio of the excreted parent substance into account, the results 
of this estimation are misleading and the verification must be questioned. Consi-
dering the prescription and excretion data a theoretical ratio in the range of 1.25 
to 3.13 is expected to be found in wastewater (administration ratio S/T = 5/1; 
excretion sulfamethoxazole (S): (0,15 – 0,25) x 5; excretion trimethoprim (T): 
(0,40 – 0,60) x 1; expected wastewater ratio: 0,75/0,6 – 1,25/0,40 = 1,25 – 3,13). 
This ratio was not observed during months with elevated sulfamethoxazole loads, 
which puts those measurements into question. No plausible explanation could be 
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found for such high sulfamethoxazole loads and corresponding data were ex-
cluded from further data analysis. Neglecting implausible data, a mean recovery of 
85 % was yielded and 85 % of all data points are to be found within the predicted 
input range. Determined influent loads of 58.0 – 190.3 µg/(E*d) agree well with 
results from Sweden (46 – 210 µg/(E*d)) (Lindberg et al. 2005) and Australia 
(72 – 100 µg/(E*d)) (Watkinson et al. 2007). 
Azithromycin, clarithromycin and roxithromycin 
All three macrolides have a strong seasonal prescription characteristic which cor-
relates with the monitoring data at the WWTP inflow. Clarithromycin and roxi-
thromycin are to be found at the lower limit of the expected range and partly 
below it (see Figure 5D and E, respectively). It can be noticed, that, based on 
prescription data, the measured winter peak is shifted back by one month for all 
three macrolides. In case of clarithromycin and roxithromycin this is partly explai-
ned by the duration of administration of about 10 – 14 days, which prolongs the 
period of time between prescription and excretion. Azithromycin is usually admi-
nistered for 3 – 5 days which is not sufficient to describe this discrepancy (see 
Figure 5C). Nevertheless, azithromycin correlates well with the predicted input 
load but shows significantly higher variation within one month, compared to cla-
rithromycin and roxithromycin. The higher scatter might lead to a distortion of 
the actual input load which coincidently results in a backwards shifted peak of the 
monitoring data.  
It can be noticed that all macrolides exhibit a load peak during the stormwater 
event in June 2013. Due to the protonation of the basic dimethylamino group 
macrolides are mainly positively charged at neutral pH (Gobel et al. 2005) which 
may lead to an adsorption to the negatively charged wastewater particles via cation 
exchange. The stormwater-induced load peak might be an indication of the remo-
bilization of sewer sediment and/or adsorbed substances, respectively. A load 
peak was also observed for trimethoprim which has low to moderate adsorption 
capability (Straub 2013). In contrast, sulfamethoxazole is negatively charged at 
neutral pH and adsorption to particle matter might be insignificant (Tambosi et 
al. 2010) which, based on the absent load peak in June 2013, supports the assump-
tion. The stormwater event in June 2013 was the only time a significant increase 
of input loads could be put into relation to an elevated rainwater-induced WWTP 
inflow, respectively. Regarding the load peak it must be also kept in mind that load 
losses through the discharge of mixed water (combined sewer system) are quite 
likely which diminishes the measured load at the WWTP. Hence, the load increase 
at the WWTP constitutes only the net amount of antibiotics which were remobi-
lized in the sewer systems. 
The mean recovery rates of azithromycin, clarithromycin and roxithromycin were 
determined as 110%, 58 % and 76 %, respectively, whereas 30 %, 43 % and 53 % 
of available data are to be found within the predicted input band. The macrolides 
covered in the present study were also quantified in the input of 2 Swiss WWTP 
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(Gobel et al. 2005). Except for azithromycin the recovery values remain below the 
expectations referring to results from Gobel et al. (each around 100 %) which 
might be due to further interferences like the sampling method and/or the analy-
tical error (see 3.3). Regardless of the recovery rate, the daily input load of azithro-
mycin from study (25.8 – 155.3 µg/(E*d)) is comparable to results from other 
investigations: 45 – 101 µg/(E*d) (Gobel et al. 2005); 118.9 – 207.3 µg/(E*d)) 
(Ghosh et al. 2009). More than 800 µg/(E*d) of clarithromycin were determined 
Japanese WWTPs which is vastly exceeding the load of this 
(45.9 – 260.0 µg/(E*d)) and other studies (59 – 160 µg/(E*d) (Gobel et al. 2005); 
22.9 – 210.4 µg/(E*d) (McArdell et al. 2003)). The Input loads of roxithromycin 
amount between 8.4 and 49.9 µg/(E*d) which is comparable to other investiga-
tions: 5.0 – 19.3 µg/(E*d) (McArdell et al. 2003); 4.7 – 31.0 µg/(E*d) (Li and 
Zhang 2011); 20.8 – 71.3 µg/(E*d) (Ghosh et al. 2009). 
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Figure 5: Predicted (band of three levels of grey) and measured input loads of antibiotics  
(area of boxplots represents the range of 25 % to 75 % percentile, whiskers illustrate 10 to 90 % per-
centiles of all data, outliers are depicted as dots); the monthly mean of the daily WWTP inflow is illus-
trated as solid line 
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Figure 5 (continued): Predicted (band of three levels of grey) and measured input loads of antibiotics  
(area of boxplots represents the range of 25 % to 75 % percentile, whiskers illustrate 10 to 90 % per-
centiles of all data, outliers are depicted as dots); the monthly mean of the daily WWTP inflow is illus-
trated as solid line 
Cefuroxime, ciprofloxacin, levofloxacin, doxycycline 
Cefuroxime, ciprofloxacin, doxycycline and levofloxacin are examples of an un-
systematic connection between constant prescriptions and unexpected high fluc-
tuation in measured loads. Interestingly, the increase of ciprofloxacin and cefu-
roxime corresponds to the seasonality of macrolides from December to February 
(see Figure 5F and G) unlike prescriptions would suggest. Levofloxacin belongs 
to the same antibiotic group of fluoroquinolones like ciprofloxacin but has a pro-
longed peak from February to June (see Figure 5H). This is surprising since similar 
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medical application (same antibiotic group) suggests similar input characteristics 
at the WWTP input. On the other hand, nearly during the entire year doxycycline 
meets predicted input loads but shows a 4 to 5-fold increase during the stormwater 
event in June 2013 (see Figure 5I). A possible explanation is the fact that tetracy-
clines have complexing properties (Pamreddy et al. 2013) which suggest a delay 
during the wastewater transport in sewer systems at dry weather. Stormwater 
might subsequently lead to remobilization of sewer sediment and/or re-dissolu-
tion of doxycycline from the sewer particles, respectively, which in turn leads to 
higher input loads at the WWTP. Nevertheless, based on total predicted input 
loads doxycycline is heavily underestimated, unlike the other antibiotics of this 
group. Hence, it was questioned, if a load peak in the range of approximately 3 
additional input months is acceptable, in terms of adsorption capacity of sus-
pended solids (SS) in raw wastewater. As a result, additional measurements com-
paring the inlet and outlet of the preliminary settling tank (n = 31, separation ef-
ficiency of SS: 60 %) did not show significant load removal (p = 0.1654) during 
the settling process, suggesting only a minor adsorption to SS. Hence, it seems 
implausible that the additional 22 t SS (+ 40 %) entering the WWTP during the 
stormwater event contributed to the load peak of doxycycline. During the flood 
event, the infiltration of ground- and river water holds a share in the prolonged 
inflow increase. There are no data available to determine whether a significant 
concentrations in the infiltration water could have contributed to the load peak at 
the WWTP or if only dilution took place. According to the plants efficiency regar-
ding doxycycline removal of about 76 % (n = 300, median = 100 % removal, own 
data) no significant doxycycline emissions into the environment are expected and 
concentrations in river- or groundwater are assumed to be comparatively low. 
Hence, it is rather unlikely that the input load of the WWTP was influenced by 
natural water bodies. Furthermore, it is difficult to determine how an erroneous 
analytical method could have affected the load calculation. Assuming a reliable 
analysis method, re-dissolution of doxycycline from sewer particles is favored in 
this context but needs further investigations to be supported. 
The strongly fluctuating input values of ciprofloxacin and levofloxacin (Ofloxacin 
and levofloxacin are racemats and analytically considered as one substance) were 
also observed in a WWTP in Switzerland. In the present study, ciprofloxacin loads 
elevate from about 50 g/d up to more 200 g/d which corresponds well with the 
4 – 5-fold increase determined in Switzerland (Coutu et al. 2013). The results for 
the input loads of ciprofloxacin (59.9 – 273.6 µg/(E*d)) show to be similar to 
other investigations: 27.5 – 171.7 µg/(E*d) (Ghosh et al. 2009); 259 µg/(E*d) 
(Castiglioni et al. 2006); 49.6 – 104.3 µg/(E*d) (Karthikeyan and Meyer 2006); 
200 – 300 µg/(E*d) (Li and Zhang 2011).  Levofloxacin’s input load increases 
from 50 g/d to about 250 g/d and is comparable to the 5-fold increase at Vidy 
WWTP (Coutu et al. 2013). The determined specific values for levofloxacin of this 
study (47.7 – 364.6 µg/(E*d)) are in the range of comparable investigations: 
189.5 – 395.3 µg/(E*d) (Ghosh et al. 2009); 360 µg/(E*d) (Castiglioni et al. 2006). 
Cefuroxime and doxycycline exhibited specific input loads of 
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183.3 – 273.6 µg/(E*d) and 39.2 – 174.1 µg/(E*d), respectively. A second increase 
at the end of the year, as it was observed in the Swiss WWTP, could not be repro-
duced in the present study. The mean recovery rates of 53 %, 41 %, 155 % and 
49 % were determined for cefuroxime, ciprofloxacin, doxycycline and levo-
floxacin, respectively, whereas 18 %, 18 %, 86 % and 15 % of the measured data 
are to be found within the predicted input band. 
Amoxicillin, clindamycin, cefotaxime, piperacillin and penicillin V 
The antibiotics amoxicillin, clindamycin, cefotaxime, piperacillin and penicillin V 
are significantly overestimated by input projection and exhibit unsatisfying reco-
very results. Except for clindamycin, all antibiotics of this sub-section belong to 
the beta-lactam family (Figure 5K – N) and are prone to biodegradation processes 
in raw wastewater. As for pre-degradation in raw wastewater (see 3.3), out of 4 
investigated beta-lactams three decreased to a significant degree within 12 h. Due 
to analytical problems no data were obtained for penicillin V. However, given the 
fact that penicillin is well known for its instability in biological systems (Watkinson 
et al. 2009) the lack of data can be omitted in this case. In summary, low recovery 
results were expected and verified for beta-lactams and were within the applied 
projection model. Mean recovery values during the monitoring program were de-
termined to 3 % (penicillin V), 8% (amoxicillin), 9 % (piperacillin) and 22 % (ce-
fotaxime). Cefotaxime was the only substance with 3 (1 %) measuring values wi-
thin the predicted area, the remaining beta-lactams did not hit the target area. The 
corresponding measured input loads amount to 9.4 – 222.6 µg/(E*d) (amoxicil-
lin), 2.9 – 66.0 µg/(E*d) (cefotaxime), 9.0 – 445.5 µg/(E*d) (piperacillin) and 
1.3 – 35.5 µg/(E*d) (penicillin V). Due to the expected inconsistency of the mea-
sured values (e.g. biodegradation) a comparison to other investigations is not pro-
mising to be carried out. 
In case of clindamycin (see Figure 5J), the uncertainties of the projection model, 
or rather the excretion rate, lead to a comparatively large range of expected input 
loads. Oddly enough, incoming quantities are still below the projected values 
(mean: 7%) and only 16 % of determined loads (5.1 – 36.3 µg/(E*d)) are within 
predicted area. At Vidy WWTP per capita values of 2.2 – 4.4 µg/(PE*d) (Coutu 
et al. 2013) are significantly lower compared to the present study 
(7.7 – 30.7 µg/(PE*d) ). Furthermore, during the stormwater event in June 2013 
increased input loads were determined. For the time being, due to the lack of in-
formation regarding the fate of clindamycin, the elevated values during stormwater 
must be attributable to both remobilization and degradation processes as a conse-
quence of a reduced retention time in the sewer system (see next paragraph).  
Recovery and degradation in raw wastewater 
In the laboratory experiments on the stability in raw wastewater (see 2.5) it was 
found, that expected values (raw sample + 1000 ng/l) of many antibiotics were 
not completely recovered 15 min after their addition to wastewater. This was unex-
pected since both dissolved and adsorbed antibiotics were equally included in the 
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analytical method. In order to further address the initial loss, the ratio of measured 
value and expected value has been termed “initial recovery”. It raises the question 
as to whether the difference between expected value and initial recovery was due 
to a spontaneous decay subsequent to entering the wastewater matrix or due to an 
insufficient sampling procedure and analytical method. Even the use of deuterated 
antibiotics like trimethoprim d9 and ciprofloxacin d6 resulted in an initial “disap-
pearance” of 20 and 40 – 60 %, respectively. Furthermore, sampling as well as 
transport, storage time and conditions prior to analytical extraction might be a 
source of inconsistent results in investigations on the antibiotic stability in raw 
wastewater. A final explanation could not be found on the basis of the present 
data set. Nevertheless, even if the analytical methodology failed to include certain 
fractions of antibiotics, an integrative view of WWTP results and pre-degradation 
data is key to evaluating the recovery of prescription data, since both were deter-
mined using the same methodology. Determined mean recovery rates derived 
from the WWTP were compared with the range of recovered antibiotics after ad-
dition (initial recovery) and 12 h sewer residence time, respectively, referring to 
the expected value (see Figure 6). The two latter values were illustrated using bands 
with two levels of grey, referring to anaerobic (dark) and aerobic (light) results. 
The corresponding errors are depicted as dark and light grey with lower opacity. 
Figure 6: Recovery of antibiotics in raw wastewater on a laboratory scale at anaerobic and aerobic con-
ditions compared with the mean WWTP input (standard deviation is illustrated by error bars) 
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Clarithromycin, clindamycin, trimethoprim, ciprofloxacin and levofloxacin show 
similar elimination characteristics under aerobic and anaerobic conditions. Azi-
thromycin, roxithromycin, sulfamethoxazole and doxycycline are eliminated to a 
lesser extent under reducing conditions, while cefotaxime behaves vice versa. Ce-
furoxime, amoxicillin and piperacillin could not be evaluated under anaerobic con-
ditions due to analytical problems. Neglecting the initial recovery and taking the 
band width as indicator of degradability azithromycin, clarithromycin, roxithro-
mycin (only under aerobic conditions), trimethoprim, ciprofloxacin (only under 
anaerobic conditions), levofloxacin and doxycycline are stable in raw wastewater 
exhibiting less than 20 % reduction within 12 h. All beta-lactams, clindamycin, 
roxithromycin (only under anaerobic conditions), sulfamethoxazole and cipro-
floxacin (only under aerobic conditions) were reduced by more than 20 %.  
It is noted that the majority of data points from the WWTP recovery are within 
or close to both, anaerobic and aerobic recovery ranges (see Figure 6). To some 
extent cefuroxime can be found below the expected recovery in wastewater under 
aerobic conditions. Apart from analytical errors the discrepancy could be due to a 
misleading projection approach. Among all outpatient antibiotics under investiga-
tion cefuroxime exhibited the highest prescription gain between 2005 and 2012 of 
which about 80 % is attributed to hospitals (see Figure 1). This might be an indi-
cation that projecting hospital prescription using the number of hospital beds in 
the catchment is not sufficient to accurately determine the input to the WWTP. A 
detailed differentiation between medical stations and corresponding prescriptions 
may be expedient rather than blurring the data by putting total hospital prescrip-
tion into relation to institution’s bed capacity.  
Strangely, roxithromycin recovery at the WWTP is closer to the results of aerobic 
wastewater conditions while recovery values of azithromycin and cefotaxime seem 
only to fit if wastewater was mainly anaerobic. The oxygen introduced into 
wastewater during its passage through the sewer system is assumed to be low, 
compared to oxygen consumption. Hence, anaerobic conditions are supposed to 
be predominating, although not solely.  
Except for doxycycline, the projection and prediction model of input loads can be 
considered to be verified by the pre-degradation experiments in raw wastewater. 
The recovery rates determined from the monitoring data are within or close to the 
values of the laboratory results which provide information on the overall recovery 
and pre-degradation of antibiotics during the residence time of wastewater in the 
sewer system. Furthermore, the verification of the projection model also supports 
the use of the excretion data from medical literature to predict environmental con-
centrations using production, sales and prescription data.  
Significance of determined input loads depending on sample quantity 
Previous studies already demonstrated the insignificance of grab samples, in terms 
of load characterization of WWTPs (Loganathan et al. 2009), due to major input 
fluctuations within one day (Coutu et al. 2013, Li and Zhang 2011). Hence, the 
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use of composite samples using auto-samplers is the favoured alternative. In this 
context, the solid data pool of this study will be used to estimate a necessary num-
ber of samples to approximate a representative annual input load of antibiotics. It 
is assumed that the average load of this study is representative for the actual input 
load to the WWTP Dresden-Kaditz, excluding the data during the time period of 
the flood event (01.06. – 19.06.2013). Sample values were randomly drawn from 
the entire data set of each and every antibiotic using a uniform distribution without 
replacement. The number of drawings was varied between one and the maximum 
amount of available monitoring values (see supplementary material Table S1, an-
nex 1). Each drawing range (1 sample, 2 samples, 3 samples etc.) was repeated 500 
times. All repetitions within the drawing ranges were averaged to determine the 
corresponding mean of the theoretical sampling campaign. Preliminary calcula-
tions carried out to assess the impact of repetitions showed that 500 replicates 
were sufficient to minimize the deviation of necessary sample numbers to a value 
below 10 % (see supplementary material Figure S3). From supplementary material 
Figure S4 it can be seen that higher sample quantities result in lower deviations 
from the annual mean, in terms of uncertainty. Hence, uncertainty was related to 
an appropriate number of samples for 95 % of all repetitions with 2.5 % and 
97.5 % being the lower and upper quantiles. As a result, outliers were excluded 
and the practicability of results was increased. Figure 7 summarizes the rela-
tionship between deviation and sample quantity for all antibiotics. For comparison 
reasons the results were normalized to one year (365 days) due to different quan-
tities of monitoring values (see supplementary material Table S1, annex 1). 
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Deviation from the representative annual mean input load
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Figure 7: Number of necessary samples per year depending on the theoretical deviation (uncertainty) 
of the representative annual mean input load 
All antibiotics were evaluated for a deviation (or uncertainty) of 20 %, which is 
supposed to be close to reasonable considering the significant expense of any re-
sulting scope of investigations. In the following, the given number of samples are 
considered to be evenly distributed throughout the year. Trimethoprim and sul-
famethoxazole, the latter excluding implausible months (see 3.2), have been shown 
to be the most reliable measurements. Fluctuations of measured input loads have 
in general been small which results in an appropriate measurement quantity of 10 
samples per year. In contrast, 160 samples must be taken to reliably determine the 
characteristic input load of penicillin and amoxicillin. The former has a lower de-
tection frequency than most antibiotics which makes an increase of sampling in-
cidence necessary. The seasonality of the macrolides azithromycin, clarithromycin 
and roxithromycin is comparable with the fluctuations measured for clindamycin, 
cefuroxime and ciprofloxacin, in terms of uncertainty. A number of 
30 - 40 samples per year are necessary to determine the characteristic input load 
of those antibiotics. Doxycycline and levofloxacin as well as the inpatient antibio-
tics piperacillin and cefotaxime exhibit slightly higher fluctuations of input loads 
and 55 - 80 samples are required to calculate the mean annual input load, accepting 
an uncertainty of 20 %.  
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Table 2: Uncertainty of measured input loads of antibiotics applying the relationship between sample 
quantity and uncertainty determined in this study 
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Ciprofloxacin 65% - 55% - 10% 
Trimethoprim 35% - - 20% 5% 
Sulfamethoxazole 40% - 35% 25% - 
Doxycycline - > 100 % - - - 
Levofloxacin - - 80% - 15% 
Roxithromycin - - 60% 40% - 
Azithromycin - - 60% 45% - 
Clarithromycin - - 60% 40% - 
Clindamycin - - 70% 50% 15% 
The influencing factors for the uncertainty, and therefore the number of necessary 
samples, are manifold. These factors are potentially attributed to the length and 
structure of the sewer system, catchment size, location and operation of the auto-
sampler (representative sample from completely mixed inflow), sample storage 
(temperature, duration) and the applied analytical method. Among those, the sto-
rage of samples and the analytical method are mainly the only factors that can be 
classified and used for comparison purposes between studies. Hence, it is propo-
sed that the link between load characterization of antibiotics (and other anthropo-
genic substances related with wastewater) and the appropriate number of samples 
can be generalized. Accordingly, monitoring of 20 to 40 samples, evenly distri-
buted throughout the year, is recommended depending on whether the substance 
under investigation is seasonally influenced or not. In summary, the results clearly 
show that most monitoring programs rely on far too few samples. Similar findings 
at Vidy WWTP, Switzerland, result from an appropriate number of samples. The 
deviation of the characteristic loads is within the range of 5 % (trimethoprim) and 
15 % (clindamycin and levofloxacin) and covers relevant fluctuation throughout 
the year (Coutu et al. 2013).  
Table 2 summarizes the uncertainty of measured input loads from other studies 
applying the information provided in Figure 7. It can be concluded that the results 
of most studies carry a significant error of more than 50 % due to the small num-
ber of samples taken. This seriously diminishes the significance of the presented 
results. Hence, for future sampling campaigns regarding antibiotics and other 
pharmaceuticals a sufficient sample quantity should be provided to minimize the 
error and increase the scientific value of the investigation. 
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CONCLUSION 
For most antibiotics the applied projection and prediction model in combination 
with excretion ratios from literature could be verified by loads determined during 
the long-term monitoring at the WWTP. Additionally, laboratory experiments 
provided information on the pre-degradation in raw wastewater which further im-
proved the understanding of the occurring processes during the wastewater trans-
port. Some antibiotics like ciprofloxacin or levofloxacin behaved unexpected over 
the time period under investigation. According to the prescription data the com-
paratively low variations were not confirmed by the analytical data. It is unclear at 
which point the projection model is afflicted with errors. Hospital data might 
constitute an input path which cannot be sufficiently projected on the basis of 
previous time periods or the number of hospital beds. Further simplifications like 
an assumed equality of prescription between private and statutory insurants, the 
non-compliance in the use of prescription drugs (Grosso et al. 2012) or the use of 
antibiotics in veterinary medicine, respectively, might also contribute to the dis-
crepancy between expected and measured values. In case of doxycycline the mea-
sured values during the stormwater event play a crucial role regarding overall re-
covery. A quantitative assessment of the above-mentioned is not possible within 
the frame of the present results. 
On average, the analytical error of < 15 % is 2 – 3 times lower than the uncertainty 
of predicted input loads (see Figure 3). Hence, the analytical method is regarded 
to be sufficiently reliable for input measurements. On the basis of the extensive 
data pool of this study, calculations were carried out to evaluate the validity of 
monitoring programs based on the number of samples. Taking antibiotics with 
low seasonality and low input scattering like trimethoprim and sulfamethoxazole 
a minimum of about 10 samples is required to calculate a representative annual 
mean load. For antibiotics exhibiting fluctuating input loads, e.g. due to seasona-
lity, 30 to 40 evenly distributed samples are necessary for a representative input 
determination with a deviation of about 20 %. Hence, it is proposed that a mini-
mum number of 20 to 40 samples should certainly be taken to reasonably estimate 
a representative input load. The main findings of the study can be summarized as 
follows: 
- Estimation of antibiotic input loads on the basis of up-to-date prescription
data is provides results with an average uncertainty of 30 – 50 %
- The analytical error of current analytical methods using LC-MS/MS is suffi-
ciently low for the quantification of antibiotic input loads
- A minimum sample quantity of 20 – 40 samples is recommended for the reli-
able determination of antibiotic input loads.
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Mass flow of antibiotics in a wastewater treatment plant 
focusing on removal variations due to operational param-
eters 
Marx, C., Günther, N., Schubert, S., Oertel, R., Ahnert, M., Krebs, P., Kuehn, V. 
ABSTRACT 
Wastewater treatment plants (WWTPs) are not designed to purposefully eli-
minate antibiotics and therefore many previous investigations have been car-
ried out to assess their fate in biological wastewater treatment processes. In 
order to consolidate previous findings regarding influencing factors like the 
solid and hydraulic retention time an intensive monitoring was carried out in 
a municipal WWTP in Germany. Over a period of 12 months daily samples 
were taken from the in- and effluent as well as diverse sludge streams. The 
14 selected antibiotics and one metabolite cover the following classes: cepha-
losporins, diaminopyrimidines, fluoroquinolones, lincosamide, macrolides, 
penicillins, sulfonamides and tetracyclines.  
Out of the 15 investigated substances, the removal of only clindamycin and 
ciprofloxacin show significant correlations to SRT, temperature, HRT and 
nitrogen removal. The dependency of clindamycin’s removal could be related 
to the significant negative removal (i.e. production) of clindamycin in the 
treatment process and was corrected using the human metabolite clindamy-
cinsulfoxide. The average elimination was adjusted from -225 % to 3 % 
which suggests that clindamycin can be considered as an inert substance du-
ring the wastewater treatment process. Based on the presented data, the mass 
flow analysis revealed that macrolides, clindamycin/clindamycin-sulfoxide 
and trimethoprim were mainly released with the effluent, while penicillins, 
cephalosporins as well as sulfamethoxazole were partly degraded in the stu-
died WWTP. Furthermore, levofloxacin and ciprofloxacin are the only anti-
biotics under investigation with a significant mass fraction bound to primary, 
excess and digested sludge. Nevertheless, the sludge concentrations are 
highly inconsistent which leads to questionable results. It remains unclear 
whether the inconsistencies are due to insufficiencies in sampling and/or 
analytical determination or if the fluctuations can be considered reasonable 
for digesters. Hence, future investigations have to address antibiotic’s tem-
poral dynamics during the sludge treatment to decide whether or not the 
widely reported standard deviations of sludge concentrations reflect realistic 
fluctuations. 
KEYWORDS 
Wastewater treatment, sludge, antibiotics, elimination, removal, mass flow 
analysis 
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INTRODUCTION 
The elimination of antibiotics from municipal wastewater receives great scientific 
and political attention due to their associated potential risk to the environment 
and human health. Recently, macrolide antibiotics were added to the European 
watch list of substances for Union-wide monitoring (EU, 2015) which underlines 
the timeliness of antibiotic’s release from urban areas into the environment. 
Wastewater treatment plants (WWTPs) are originally designed to reduce organic 
compounds, nitrogen and phosphorus from municipal and industrial wastewaters. 
Hence, previous investigations focusing on the fate of introduced antibiotics in 
WWTPs resulted in a heterogeneous picture regarding the span of removal effi-
ciencies of certain substances (Luo et al., 2014), while significant systematic diffe-
rences in removal rates between various substances could be detected. The diffe-
rences between studies were partly associated to differing operational regimes of 
the WWTP like solid retention time (SRT) (Clara et al., 2005; Suarez et al., 2012; 
Vieno et al., 2007), hydraulic retention time (HRT) (Guerra et al., 2014; MacLeod 
and Wong, 2010) and the plant design itself, e.g. nitrification-denitrification and 
microbial community of the activated sludge system (Guerra et al., 2014; Larcher 
and Yargeau, 2012; Suarez et al., 2010). Other studies investigated the differences 
of removal efficiencies between seasons (Gracia-Lor et al., 2012; Guerra et al., 
2014; Kwon and Rodriguez, 2014; Zhang et al., 2015). Many of the above men-
tioned investigations also reported negative elimination rates, which are inter-
preted as a production of antibiotics during the biological treatment process. Des-
pite the fact that the re-transformation of metabolites to their parent substances 
has been previously proposed (Goebel et al., 2007) many of the negative values 
are likely to be the result of an insufficient sampling method (Majewsky et al., 
2011a) and longer sampling campaigns are required to achieve reliable results (Go-
bel et al., 2005).  
In addition to the aqueous phase, it is advantageous if mass flow studies also in-
volve sludge loads to fully understand the fate of antibiotics during wastewater 
treatment (Guerra et al., 2014; Kasprzyk-Hordern et al., 2009). A few studies are 
available providing information on concentrations of antibiotics in both the liquid 
and the solids phases. The reason why studies providing an integrative view on all 
removal pathways are scarce is presumably mainly due to the high efforts neces-
sary to carry out substance analyses with complex matrices like sludge 
(Jelic et al., 2011). Most investigations performing a mass flow analysis rely on a 
very limited number of liquid samples (4 (Yan et al., 2014a; Yan et al., 2014b; Zhou 
et al., 2013a); 6 (Gobel et al., 2005; Guerra et al., 2014; Zhang et al., 2013)) and of 
sludge samples (1 (Zhang et al., 2013); 2 (Zhou et al., 2013a); 3 (Zuccato et al., 
2010)) per WWTP. Despite the limited number of samples the studies mentioned 
above provide valuable initial information on antibiotic removal pathways. Ne-
vertheless, due to the expected influence of the plant design, operational parame-
ters etc. on the removal of antibiotics in combination with low sampling quantities, 
the significance of results from previous mass flow analyses needs to be improved. 
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An intensive sampling of one single WWTP can provide detailed information on 
the removal mechanism at different operational conditions. Due to diversity in 
plant design, operational regime and wastewater composition such results cannot 
be adequately gathered from monitoring campaigns targeting multiple plants.  
In this study, the WWTP Dresden-Kaditz was monitored over a period of 
12 months taking daily in- and effluent samples. Additional sludge samples from 
the in- and output of the digesters were taken to include the adsorbed fraction of 
antibiotics into the mass flow analysis. The high data quantity in connection with 
routine operational data was used as a basis to investigate the influence of WWTP 
operation on the removal efficiency of antibiotics. The subsequently performed 
mass flow analysis will be used as a tool to describe the fractioning of antibiotics 
after the wastewater and sludge treatment. 
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MATERIALS AND METHODS 
Catchment area and WWTP operation 
The WWTP Dresden-Kaditz treats the wastewater of five cities (Dresden, Freital, 
Heidenau, Pirna and eastern Radebeul) and some bordering municipalities in 
Saxony, Germany. The WWTP has a design capacity of 740,000 PE with a current 
communal loading according to Table 1. The catchment area has a size of about 
9400 km² with no known industries producing or applying significant amounts of 
antibiotics (e.g. intensive livestock husbandry). The sewer system consists of about 
800 km of combined sewers and around 800 km of separate systems, consisting 
of some 450 km of sewerage system and 350 km of stormwater sewers. The 
wastewater is being mechanically treated by four coarse screens of 65 mm, three 
fine screens of 15 mm, a grit chamber and primary clarifiers with a total volume 
of 4800 m³. The plant was designed for biological nitrogen removal and chemical 
precipitation of phosphorus with a total treatment tank volume of 112,000 m³ of 
which up to 60 % can be operated without aeration. The secondary circular settling 
tanks have a total surface area of 10,920 m³. The anaerobic digesters are operated 
at 37 °C, have a total volume of 21,000 m³, a current hydraulic retention time of 
about 19 days and a loading rate of about 2.9 to 3.2 kgCOD/(m³*d). The total 
suspended solid (TSS) reduction in the digester amounts to 37 % and around 
20,000 m³ of biogas is produced per day. The process diagram of the WWTP 
Dresden-Kaditz including all relevant wastewater and sludge flows is provided in 
Figure 1. 
Figure 1: Process diagram of the WWTP Dresden-Kaditz with sampling points of the wastewater and 
sludge streams 
Due to the legal framework regarding the elimination of total inorganic nitrogen, 
denitrification is carried out from May to October (see Table 1). Consequently, 
from November to April the WWTP is being operated at predominant aerobic 
conditions to keep nitrifiers within the system and to ensure the reliable start-up 
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of N-removal in April. During summer the focus of operation is on guaranteeing 
complete nitrification and denitrification. Accordingly, the TSS in the treatment 
tank is operated at about 3 g/L. During winter, insufficient settling characteristics 
of the activated sludge (higher sludge indices) require a lowering of the TSS in the 
activated sludge tank to meet the targeted sludge volume of about 400 mL/L. 
Thus, the failure probability of the secondary clarifiers is minimized.  
Considering the monitoring period of 12 months from January to December 2013, 
the three resulting operation periods which are characterized by the presence and 
absence of denitrification are further characterized in Table 1. The input loads and 
pH-values are comparable due to low industrial contribution from the catchment 
area. In June 2013 (time period II) a flood event decisively influenced the WWTP 
inflow which results in a comparatively high standard deviation (SD) of the hy-
draulic retention time (HRT). The inflow temperatures deviate between time pe-
riods according to seasonality and the NO3-N effluent concentration is reflec-
ting the operational regime regarding N-removal. 
Table 1: Characteristic information of the three time periods under investigation 
(mean ± standard deviation) 
Operation period 
Winter Summer Winter
01.01. - 
30.04.2013 
01.05. - 
31.10.2013 
01.11. - 
31.12.2013 
Input load COD [kg/d] 83329 ± 10417 81881 ± 21458 94651 ± 20067 
Input load TKN [kg/d] 9514 ± 571 8904 ± 1,444 10936 ± 2,372 
Input load total P [kg/d] 1320 ± 99 1402 ± 299 1648 ± 379 
Inflow temperature [°C] 11.9 ± 1.0 15.9 ± 2.0 14.3 ± 1.6 
Inflow pH [-] 7.8 ± 0.1 7.8 ± 0.2 7.8 ± 0.1 
HRT [d] 0.82 ± 0.22 0.65 ± 0.56 1.09 ± 0.21 
SRT [d] 13.1 ± 0.5 18.9 ± 1.2 18.5 ± 0.9 
Effluent NO3-N [mg/l] 20.1 ± 5.3 5.5 ± 1.7 16.5 ± 3.2 
Sample collection and analytical methods 
The monitoring campaign at the WWTP Dresden-Kaditz was carried out from 
January until December 2013. The 24h volume proportional composite samples 
from the in- and effluent (see Figure 1) were taken daily starting at 8:00 a.m using 
brown glass flasks. The automatic sampler (Endress+Hauser ASP Station 2000) 
takes a sample volume of 25 ml per 480 m³ inflow and is equipped with 12 and 
24 bottles for influent and effluent sampling, respectively. The total sample vo-
lume during dry weather is about 250 – 300 ml/h. Samples were stored at 4°C 
using brown glass flasks for a maximum time period of 7 days until transport and 
analysis in the lab. From a previous investigation using the same influent data set 
(Marx et al., 2015) it can be concluded, that refrigeration was sufficient to preserve 
the antibiotics during the storage time. In June 2013, the inflow measurement was 
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out of order due to the flood event caused by the river Elbe. The respective inflow 
hydrograph was reconstructed using the ammonia concentration. Details are des-
cribed in Marx et al. (2015).  
A total of 14 sludge samples were taken as grab samples during 2013 (summer) 
and 2014 (winter) to cover different seasons of the year. Primary sludge (PS), ex-
cess sludge (ES) and digested sludge (DS) were separately sampled using provided 
sampling taps and analyzed in order to assess the fate of antibiotics during the 
anaerobic sludge treatment. PS, ES, and DS were collected after the PS and ES 
thickeners and from the effluent of the digester (see Figure 1), respectively. A 
summary of the determined sludge concentrations is provided in 
Table 3. The analysis parameters and according regulations of in- and effluent and 
sludge samples are summarized in the supplementary material S1.  
A total of 14 antibiotics and one human metabolite were investigated covering the 
following classes: macrolides (AZI – azithromycin, CLA – clarithromycin, ROX 
– roxithromycin), lincosamide clindamycin (CLI) and its metabolite clindamycin-
sulfoxide (CLI-S)), tetracyclines (DOX – doxycycline), cephalosporins (CEF – ce-
furoxime, CEFO – cefotaxime), sulfonamides (SUL – sulfamethoxazole), diami-
nopyrimidines (TRI – trimethoprim), penicillins (PEN – penicillin V, PIP – pipe-
racillin, AMO – amoxicillin) and fluoroquinolones (CIP – ciprofloxacin, LEV –
levofloxacin). The in- and effluent samples were analyzed by SPE and LC-MS/MS
according to a method developed by Rossmann et al. (2014). Briefly, wastewater
samples were spiked with Na2EDTA, centrifuged and filtered through glass fibre
filters. Then, samples were adjusted to a pH of 3.5 using formic acid and spiked
with a standard addition of 1000 ng/L. For SPE, 30 mg Water Oasis HLB car-
tridges were used. For the following analysis by LC-MS/MS, a Synergi HydroRP
(Phenomenex, Aschaffenburg, Germany) and a Nucleoshell HILIC column (Ma-
chery-Nagel, Düren, Germany) were used for separation.
Sewage sludge samples were analyzed using ultrasonic associated extraction (USE) 
as additional extraction step before following the above mentioned SPE and LC-
MS/MS method (Rossmann et al., 2014). USE was applied as it was described in 
other studies for extraction of sewage sludge, agricultural soil or other biosolids 
(Ho et al., 2012; Martin et al., 2010). In detail, approximately 0.2 to 1.0 g of ho-
mogenized, dried sludge (25 °C, 4 d) was accurately weighed into 50 mL centrifuge 
tubes. For the spiking of sludge, working standard solutions of 1 and 10 µg/mL 
were weekly prepared and stored at 4°C. For USE, a mixture of Acetonitril, 0.1 M 
EDTA and McIlvaine buffer (pH 4.5) was used. 5 mL of the extraction buffer 
(ACN:EDTA-McIlvaine Buffer, 50:50) were added to the spiked sludge, vortex 
mixed for 30 s, placed into a ultrasonic bath for 5 min and then centrifuged at 
6000 rpm for 6 min. Supernatant was collected into a separate tube. The settled 
sludge was extracted by USE twice more and 0.5 mL of the combined supernatant 
was completely reduced by gently air stream and then diluted with 5 mL of purified 
water. Then, samples as well as the liquid fraction of the sludge were analyzed by 
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SPE onto a 60 mg HLB cartridges (Water Oasis, USA) followed by LC-MS/MS 
as described in Rossmann et al. (2014) under use the above mentioned columns 
for separation. The liquid fraction of the sludge was determined to correct the 
sludge concentrations. After the centrifugation step about 80 % of water remains 
in the sample before it is dried in the oven. Hence, the sludge concentration has 
to be reduced by the dissolved mass of antibiotics to calculate the actual sludge 
specific sludge loading. The liquid fraction of most antibiotics was determined to 
be below 15 % (see supplementary material S2). 
Determination of elimination rates from the liquid phase 
The varying HRT as well as internal mixing processes and devices in WWTP reac-
tors significantly increase the uncertainty of removal rates based on 24h mixed 
samples. Shifts between calculated in- and output loads lead to a high scatter of 
calculated removal efficiencies as being found in some studies (e.g. trimethoprim: 
-88 to 85 % (Verlicchi et al., 2012)). For large catchment areas and long sewer
residence times broadly prescribed pharmaceuticals exhibit a low load variance
between consecutive days and the concentration of inert substances with low sorp-
tion potential is almost exclusively influenced by the WWTP inflow, i.e. inversely
proportional to the daily inflow rate. Although the measured variance cannot per
se be attributed to the sampling strategy and inflow dynamics it still complicates
the estimation of a sufficiently reliable removal rate. Furthermore, it might mislead
subsequent investigations regarding influences on the removal rate of antibiotics
depending on plant operation alternatives. In order to minimize this uncertainty
the elimination rate of antibiotics was determined from the cumulative in- and
output loads within time series of gapless in- and effluent data sets. A minimum
of seven consecutive daily in- and output loads was chosen in order to cover every
day of the week at least once. A summary of all identified time series is given in
supplementary material S3 (annex 2). The actual elimination rate of each time se-
ries was determined using linear regression (see slopeAB,i in equation 1) and is
shown as the gradient of the approximated lines which are exemplarily shown in
Figure 2. The index “i” refers to the numbering of the time series. Four antibiotics
were chosen to demonstrate the variety of curve slopes from moderate elimination
(SUL and LEV) to inert behavior (TRI and ROX), where the measurements ac-
tually yielded slightly negative elimination.
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, 1 ,  [%] (Equation 1) 
Subsequently, corresponding operational parameters were averaged for each iden-
tified time series to investigate the dependency between elimination efficiency and 
operational parameters using the t-test on the < 0.05 significance level. The ope-
rational parameter under investigation were chosen on the basis of previous in-
vestigations. The temperature (Golovko et al., 2014; Suarez et al., 2012; Zhang et 
al., 2015) as well as HRT and SRT (Kwon and Rodriguez, 2014; Verlicchi et al., 
2012) are among the most discussed influencing parameters and will also be a 
subject of discussion in this study. Furthermore, nitrification and denitrification 
(Gobel et al., 2005; Suarez et al., 2010; Suarez et al., 2012) as well as iron concen-
tration (Polesel et al., 2015a) were shown to have an influence on the removal of 
certain antibiotics. The calculation of normalized mass flows is provided in supple-
mentary material S4 (annex 2).  
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RESULTS AND DISCUSSION 
Elimination from the liquid phase 
Figure 3 presents the mean removal efficiencies from the liquid phase (RAB,liquid) 
based on all identified time series for each antibiotic. As expected, CEFO (Gul-
kowska et al., 2008; Li and Zhang, 2011), CIP (Gao et al., 2012a; Singer et al., 
2014; Zhou et al., 2013a; Zuccato et al., 2010) and SUL (Li and Zhang, 2011; Sahar 
et al., 2011) are partly removed from the liquid phase while the macrolides AZI 
(Morasch et al., 2010; Yan et al., 2014b), CLA (Golovko et al., 2014; Morasch et 
al., 2010) and ROX (Li and Zhang, 2011; Yan et al., 2014a) as well as TRI (Go-
lovko et al., 2014) and CLI-S (no comparable studies) show low (< 20 %) or no 
removal. Apart from AZI the determined mean removal efficiency of all subs-
tances are consolidated by 6 to 10 gapless time series covering different seasons 
of the year. Hence, they can be considered to be highly representative for the 
treatment plant under investigation. The comparison of cumulative in- and output 
loads results in high coefficients of determination covering time series of up to  
44 days without missing values (see supplementary material S3, annex 2). On ave-
rage, each time series is consolidated with 21 days providing a high reliability of 
the determined values. CEFO, DOX and AMO were eliminated to values below 
the detection limit most of the time under investigation and were only sporadically 
released with the effluent. Due to the unsystematic behavior regarding their release 
from the WWTP those antibiotics will be discussed apart from the ubiquitous 
antibiotics presented in Figure 3. PEN was only occasionally detected in the in-
fluent and completely removed in the WWTP. Accordingly, no further evaluation 
will be carried out in this context.  
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Figure 3: Mean elimination and corresponding number of available time series (bars represent the 
mean and whisker the standard deviation of all time series) 
As stated above, operational parameters were shown to have an effect on the re-
moval efficiency of antibiotics. For example, higher temperatures enhance micro-
bial activity and possibly the biotransformation of certain substances. On the other 
hand, adsorption decreases with rising temperatures. SRT can be interpreted as a 
measure of microbial diversity of the activated sludge and a positive correlation to 
the removal efficiency is expectable. In general, the variation of determined remo-
val efficiencies of all studied antibiotics is rather low and thus no significant de-
pendencies to operational parameters are expected. The applied linear regression 
model confirmed this expectation for most antibiotics (see Table 2). Only CLI and 
CIP exhibit high correlation coefficients for some operational parameters at the 
5 % significance level. Hereby, CLI is of special interest due to its “production” 
during the treatment process, compared to the input load, which has been already 
reported elsewhere (Alexy et al., 2006; Morasch et al., 2010; Oertel et al., 2013). 
According to Marx et al. (2015), CLI is constantly prescribed over the year but 
shows strongly fluctuating input loads (SD = 80 %, n=312), which can also be 
observed for other easily degradable antibiotics like PEN (SD = 110 %, n = 71) 
and PIP (SD = 99 %, n = 297). In connection with the negative and inflow-de-
pendent elimination in the WWTP (see supplementary material S5) a pre-transfor-
mation of CLI to a so far unidentified transformation product (CLI-TP) is propo-
sed to occur during the transport in the sewer system. In this context, the term 
transformation is used since the negative elimination during the wastewater 
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treatment indicates a re-transformation of CLI-TP to the parent substance CLI. 
Furthermore, CLI-S seems to be a promising indicator to correct measured input 
loads of CLI. The metabolite is jointly excreted with CLI, exhibits a low variation 
of input loads (SD = 27 %, n = 210), which agrees with a constant prescription 
pattern, and showed to be inert during the wastewater treatment (Figure 3). CLI-
S does not seem to re-transform to CLI and is thus also considered inert in sewers. 
According to human pharmacokinetics, about 85 % of the taken drug is metabo-
lized by the liver (Holly and Stevens, 1997) of which 90 % are excreted as CLI-S 
(Wynalda et al., 2003). Hence, around 75 % of the taken CLI will be excreted as 
CLI-S. On the other hand, 10 to 35 % of CLI is supposed to be excreted un-
changed (Pharma, 2012; Still et al., 2006), which is partly contradictory in connec-
tion with the excretion of CLI-S. For consistency reasons the excretion of CLI is
therefore assumed to be between 10 and 25 % which results in an expected excre-
tion ratio of CLI-S/CLI between 3.0 and 7.5. Since no conclusive information are
available on the share of other human metabolites, e.g. N-dimethyl-clindamycin,
those substances will be considered negligible in this context.
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Figure 4-A: Dependency between measured CLI-S/CLI-ratio and WWTP inflow; 4-B: correlation of 
corrected CLI (CLI*) removal with SRT, temperature and N-removal (whisker represent the SD of 
corresponding time series) 
Due to the ideal tracer characteristics of CLI-S and the proposed pre-transforma-
tion of CLI the CLI-S/CLI ratio should be close to the theoretical excretion ratio 
at low sewer residence times or high WWTP inflows, of which both are of equi-
valent use. A study focusing on hospital wastewater determined a low removal 
efficiency but no production for clindamycin (Kovalova et al., 2012). These results 
support the above thesis since the residence time between excretion and WWTP 
inlet was very short and therefore, pre-transformation processes in the sewer are 
minimized and can be assumed to be close to zero. From Figure 4-A it can be seen 
that in the present study, above an inflow of 15.000 m³/h the measured 
CLI-S/CLI-ratio approaches a value of 3.3 ± 1.0 (n = 22), which meets the lower
limit of the theoretical excretion ratio of 3.0. This finding supports the assumption
of an in-sewer pre-transformation of CLI and furthermore provides evidence that
the analytical methods used for both substances are reliable. The calculated ratios
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from Figure 4-A were subsequently used to determine the theoretical amount of 
CLI-TP entering the WWTP (see equation 2). Proposing a complete re-transfor-
mation into CLI during the treatment process the input loads of CLIi and CLI-
TPi were summed up and compared to effluent loads CLIe (see equation 3). The
resulting removal efficiency (CLI*) of 3 % ± 17 % closes the gap between in- and
output load and points to the conclusion that CLI is not prone to elimination
processes during the wastewater treatment. Correlating the corrected removal ef-
ficiencies CLI* with operational parameters (n = 7) reveals that applying the pro-
posed re-transformation model leads to an insignificant dependency to WWTP
inflow (r = -0.17) and iron concentration (r = 0.23) but strengthens the correla-
tions to temperature (r = 0.98), SRT (r = 0.93) and N-removal (r = 0.85) (see
Figure 4-B). It should be noted that the variability of removal must be addressed
to both elimination of CLI and re-transformation of CLI-TP. No further diffe-
rentiation can be made on the basis of the available information.
.
	 	  [ng/L] (Equation 2) 
∗ 1 100% [%] (Equation 3) 
The apparent positive cross correlation between temperature and SRT (r = 0.93) 
is partly due to the change of operational regimes of the WWTP Dresden-Kaditz, 
switching from predominantly aerated conditions in winter to denitrification in 
summer. For the identification of factors influencing the removal of clindamycin, 
this operational change is rather hindering because no precise information can be 
provided whether SRT, temperature or denitrification is responsible for the varied 
removal efficiency. Furthermore, due to enforced denitrification along with higher 
SRT in the summer period the relationship between CLI removal and N-removal 
seems to be a spurious correlation rather than a causal relationship. As a summary 
it can be stated that temperature and/or SRT have an influence on the analytically 
determined removal rate of CLI, whereby a differentiation between both factors 
is not possible on the basis of the available data. Moreover, the lack of detailed 
information on the so far unidentified transformation product CLI-TP does not 
allow to differentiate whether the dependency to temperature and/or SRT actually 
refers to the re-transformation of CLI-TP or the removal of CLI itself.   
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Table 2: Correlation coefficients between removal efficiency of antibiotics and operational parameters 
of the WWTP Dresden-Kaditz (asterisks indicate correlations on the < 0.05 significance level) 
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AMO 0.00 0.00 0.00 0.00 0.00 0.00 
AZI 0.16 -0.66 -0.48 -0.80 -0.75 0.75 
CEFO -0.68 0.83 -0.07 0.95 0.04 0.99* 
CEF 0.00 0.03 -0.29 0.09 -0.08 0.50 
CIP -0.09 0.79* -0.30 0.77* -0.15 0.79* 
CLA 0.28 0.15 -0.03 0.17 0.16 0.41 
CLI 0.80* -0.85* 0.06 -0.77* -0.84* -0.45
CLI-S 0.28 0.40 0.15 0.67 -0.21 -0.46
DOX 0.00 0.00 0.00 0.00 0.00 0.00 
LEV -0.13 -0.15 -0.25 -0.24 0.48 0.07 
PEN 0.00 0.00 0.00 0.00 0.00 0.00 
PIP 0.39 0.39 0.05 0.56 -0.60 0.43 
ROX 0.69 0.02 0.64 0.19 0.18 -0.53
SUL -0.48 0.21 -0.17 0.08 -0.28 0.19 
TRI 0.55 -0.30 0.46 0.04 -0.26 -0.38
Similar to CLI, the removal of CIP is also significantly correlated to treatment 
temperature, SRT and N-removal (p < 0.05, see Figure 5) but is not influenced by 
the HRT. As in the case of CLI or CLI-TP, respectively, the temperature and SRT 
cannot be clearly evaluated independently from each other and removal must be 
considered to be influenced by either one or both parameters. In this context, in 
a study from Finland where 12 WWTP were investigated, no obvious dependency 
between SRT and CIP removal was found (Vieno et al., 2007). Similarly, CIP re-
moval was similar during winter (January to March, 60 % removal) and summer 
(June to September, 63 %) in a study of six Italian WWTP (Castiglioni et al., 2006). 
Comparing activated sludge processes with biological nitrogen removal and simple 
nitrification also exhibits similar removal capacities with 86 % (n = 7) and 79 % 
(n = 11) elimination of the total CIP input load, respectively (Vieno et al., 2007). 
In summary, it can be concluded that none of the presented findings regarding 
influential parameters are directly confirmed by other investigations. Accepting 
the results from Finland leads to the conclusion that temperature is the driving 
force for the observed removal fluctuations. On the other hand, the SRT becomes 
the main influencing factor if relying on the results from Italy. The inconsistency 
between the present findings and the studies from Finland and Italy might be ex-
plained by the applied approaches of considering one single WWTP (this study) 
and the integrative evaluation of multiple plants (Castiglioni et al., 2006; Vieno et 
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al., 2007). The diversity of plant configurations and catchment characteristics 
might blur the results and complicate comparability between results. Hence, 
further investigations are needed to understand the actual mechanism of the iden-
tified influences in order to control and take advantage of the remaining removal 
“gap” between 54 and 68 % (see Figure 5). 
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Figure 5: Correlation of CIP removal with SRT, temperature and N-removal (whisker represent the SD 
of corresponding time series) 
CIP is known to strongly adsorb to activated sludge, a process that is supposed to 
be highly pH-dependent (Kuemmerer, 2009). This suggests that pH should ac-
tually be responsible for the changing removal efficiencies. Nevertheless, accor-
ding to Table 2, the pH is of subordinate importance which becomes plausible 
taking into account a close-to-constant pH-value in the biological wastewater 
treatment process of Dresden-Kaditz (6.63 ± 0.06, n = 235). The maximum ad-
sorption to aerobic and anoxic sludge occurs between pH 6 and pH 8 with no 
significant intermediate variation (Zhou et al., 2013b), which indicates that pH 
does not significantly influence the removal efficiency of CIP during conventional 
wastewater treatment. The optimal operation pH for microorganisms in the bio-
logical treatment systems lies between 6.5 and 8.5 (Junkins et al., 1983; Metcalf 
and Eddy, 1972) which implies that pH will mostly be found within this range and 
is generally of minor importance regarding the variability of CIP removal in most 
WWTP applying the conventional activated sludge process. Nevertheless, the ne-
gligible pH-range in the present investigation does not allow a solid conclusion 
with statistical significance. Previous findings demonstrate an enhancement of 
CIP removal induced by the addition of iron salts (Polesel et al., 2015a). The study 
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was carried out with activated sludge of 3.0 gTSS/L applying an iron concentra-
tion of 20 mgFe3+/L (Polesel et al., 2015a) which is comparable to the conditions 
at the WWTP Dresden-Kaditz (2.88 - 3.05 gTSS/L, 4 -17 mgFe3+/L). Despite the 
similarity of boundary conditions the reported dependency between CIP removal 
and iron addition is not supported for the time period under investigation (see 
Table 2).  
The removal of LEV has been reported to be highly inconsistent and ranges from 
negative (Yan et al., 2014a; Zhang et al., 2015) to moderate (Li and Zhang, 2011; 
Zhang et al., 2013) up to an almost complete elimination (Singer et al., 2014). In 
this study the removal rate was determined to 55 ± 5 % and is consolidated by  
10 time series. Hereby, the adsorption to sludge seems to be the main removal 
route (see also 3.3), since biodegradation is considered to be of low significance 
(Kim et al., 2005). Other parameters like temperature (Castiglioni et al., 2006), SRT 
and denitrification (Vieno et al., 2007) were shown to have no influence on the 
removal of LEV, which can be supported by the results of this study (see Table 
2).  
AZI, CLA and ROX as well as TRI were found to be poorly removed during the 
treatment process with no significant dependencies on either one of the investi-
gated parameters. The results on SRT and temperature for ROX and TRI are sup-
ported by studies from Suarez et al (2012) who also reported a significant decrease 
of ROX removal due to denitrification (Suarez et al., 2010; Suarez et al., 2012). 
The latter has been investigated on a lab-scale, but cannot be confirmed from 
present data of a large-scale WWTP (see Table 2). In an extensive monitoring, 
CLA and TRI removal resulted to be seasonally influenced (Golovko et al., 2014), 
which is not supported by neither the present nor other studies (Castiglioni et al., 
2006; Suarez et al., 2012).  
In previous studies, the removal of SUL ranges from below 10 % (Zuccato et al., 
2010) up to 90 % (Gracia-Lor et al., 2012), where temperature, the microbial com-
munity of the activated sludge system, the sampling strategy as well as the SRT are 
considered to influence the overall efficiency of this process (Kwon and Rodri-
guez, 2014; Larcher and Yargeau, 2012; Suarez et al., 2012). Then again there is 
evidence that neither temperature, SRT, HRT nor plant configuration, in terms of 
denitrification, significantly contribute to the variance of SUL reduction (Goebel 
et al., 2007; Suarez et al., 2010) which is analogous to the results from the present 
study. This variety of differing results leads to the conclusion that the knowledge 
on the fate of this antibiotic remains rather incomplete. In this context, the possi-
bility of N4-acetyl-sulfamethoxazole being re-transformed to SUL, a hypothesis 
which is based on the reported re-transformation of N4- acetylsulfamethazine to 
its parent substance, was introduced by Gobel (2005), still remains unproved. On 
the other hand, the good correlation between predicted and measured WWTP 
input loads of SUL (Marx et al., 2015) in connection with the constant removal 
efficiency from 10 time series rather rejects this explanation of a re-transformable 
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metabolite being the reason for inconsistent removal rates. The monitoring of hu-
man metabolites in combination with their parent substances is an important part 
in mass flow analyses but it should be focused on sampling procedures and diffe-
rences in the microbial communities of the activated sludge in order to understand 
the reported variability of SUL removal (Larcher and Yargeau, 2012; Majewsky et 
al., 2011b). 
CEFO was detected on an irregular basis in the in- and effluent with a detection 
frequency of 71 and 14 %, respectively, and resulted in a generally high removal 
efficiency (100 % in 3 out of 4 time series with 13 to 15 values each, see supple-
mentary material S3). During the first quarter in 2013 one time series of 14 days 
exhibited low temperature and low SRT with an elimination of approximately 
42 %. It remains unclear why elimination was incomplete during that time because 
complete elimination could be observed in the fourth quarter with similar opera-
tion conditions. On the basis of this very limited evidence it must be concluded, 
that temperature and SRT do not significantly influence the removal of CEFO 
during wastewater treatment. 
DOX was detected in 70 and 25 % out of all in- and effluent samples, respectively. 
The data suggest complete removal (i.e. effluent concentration were below the 
detection limit) for 65 % of the samples. For the remaining 35 % effluent concen-
tration could be detected, but no pattern was found and release from WWTP 
seems rather incidentally. This observation is supported by results with variable 
removal efficiencies determined within other studies (Lindberg et al., 2005; Singer 
et al., 2014). AMO was detected in the effluent only once during the entire moni-
toring and is considered to be completely removed. Accordingly, seasonal diffe-
rences as observed by Castiglioni et al. (2006) cannot be confirmed. 
Adsorption to the sludge phase and degradation during the anaerobic 
treatment 
Apart from the WWTP effluent, the withdrawal of PS, ES and ultimately DS is 
the second major removal route for antibiotics from the water phase in WWTPs. 
Accordingly, considering sludge loads are inevitable to perform a reliable mass 
flow analysis. 
Table 3 presents the analytically determined concentrations of antibiotics in the 
main sludge streams of the WWTP Dresden-Kaditz. All macrolides show to have 
a minor adsorption potential which has been reported elsewhere (Jelic et al., 2012; 
Jelic et al., 2011; Peng et al., 2011; Zhang et al., 2013). It can be noted for macro-
lides that PS exhibits the highest adsorption capacity per gram TSS. The antibiotic 
CLI is poorly found in either type of sludge which is supported by results from 
Ohio with 10 to 20 µg/kg TSS (Spongberg and Witter, 2008). The low values of 
the metabolite CLI-S are similar to CLI but cannot be confirmed due to the lack 
of respective studies described in literature. TRI was reported with sludge concen-
trations between 8 and 140 µg/kg TSS (Gobel et al., 2005; Guerra et al., 2014; 
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Jelic et al., 2011) which is similar to the values of this study. The DOX concentra-
tions of ES and PS are about two times lower (ES = 313 µg/kg TSS; 
PS = 762 µg/kg TSS) than those found in investigations by Gao et al. (Gao et al., 
2012b).  
SUL concentration is somewhat higher in PS, whereas ES as well as DS exhibit an 
adsorption capability which is about 1/3 lower. In contrast to other antibiotics 
under investigation the determined values are well above most comparable studies 
which reported concentrations in the range between 27 and 88 µg/kg TSS 
(Gao et al., 2012b; Gobel et al., 2005). Merely the DS concentrations in two Spa-
nish WWTPs (112 and 178 µg/kg TSS (Nieto et al., 2010)) are comparable to 
results found in this study. As reported elsewhere, CIP and LEV are highly affine 
to either type of sludge (Gao et al., 2012a; Guerra et al., 2014; Martin et al., 2015; 
Peng et al., 2011) and maximum sludge concentrations were determined up to 
2256 and 1296 µg/kg TSS, respectively. The high affinity of fluoroquinolones to 
sludge is supposed to be triggered by electrostatic interactions resulting from po-
sitively charged locations of these substances (Stevens-Garmon et al., 2011). The 
antibiotics CEFO, CEF, PEN, PIP and AMO could not be detected in any sludge 
samples. 
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Table 3: Concentrations of antibiotics in primary (PS), excess (ES) and digested sludge (DS) in ng/g 
(mean ± SD; number of values in brackets, n.d. – not detected) 
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Amoxicillin AMO n.d. n.d. n.d.
Azithromycin AZI 111 ± 58 (9) 
43 ± 32 
(12) 
87 ± 46 
(14) 
Cefotaxime CEFO n.d. n.d. n.d.
Cefuroxime CEF n.d. n.d. n.d.
Ciprofloxacin CIP 1878 ± 965 (10) 
1451 ± 731 
(12) 
2145 ± 1425 
(12) 
Clarithromycin CLA 47 ± 24 (10) 
12 ± 5 
(11) 
9 ± 4  
(5) 
Clindamycin CLI 10 ± 4 (9) 
18 ± 6 
(12) 
18 ± 6 
(13) 
Clindamycin- 
Sulfoxid CLI-S
18 ± 7 
(8) 
12 ± 5 
(9) 
12 ± 7 
(11) 
Doxycycline DOX 220 ± 177 (10) 
90 ± 87 
(12) 
193 ± 202 
(14) 
Levofloxacine LEV 631 ± 297 (10) 
1142 ± 395 
(12) 
1296 ± 852 
(13) 
Penicillin V PEN n.d. n.d. n.d.
Piperacillin PIP n.d. n.d. n.d.
Roxithromycin ROX 14 ± 6 (9) 
4 ± 2  
(8) 
6 ± 3  
(5) 
Sulfamethoxazole SUL 292 ± 343 (7) 
213 ± 202 
(12) 
196 ± 146 
(5) 
Trimethoprim TRI 34 ± 14 (9) 
69 ± 54 
(10) 
66 ± 62 
(7) 
The mass flows from the input (PS + ES) to the output (DS) of the digester were 
determined to validate the calculated sludge loadings and to characterize the fate 
of antibiotics during the anaerobic treatment (see Table 3 and supplementary ma-
terial S6, annex 2). On average, most sludge-borne antibiotics decrease only mar-
ginally during the anaerobic sludge treatment, whereas CLA, CLI-S, ROX and CIP 
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are reduced by more than 50 % (see supplementary material S6, annex 2). Taking 
the corresponding SD of RAB,digester into account it must be concluded that the re-
liability of most results is not sufficiently high to draw firm conclusions. In case 
of AZI, CLI, TRI, DOX and LEV the standard deviation exceeds 40 % and makes 
a statement on the fate during the anaerobic treatment highly questionable. In 
contrast, a decrease of CLA, CLI-S, ROX, SUL and CIP during the anaerobic 
treatment is assumed to be very likely. The purpose of performing the mass flow 
analysis of the digester is not merely to determine precise elimination rates but to 
give an idea on the behavior of antibiotics in the anaerobic treatment and to draw 
attention to the instance of highly inconsistent sludge concentrations. The SD of 
sludge concentrations can be found in the range of 50 (e.g. CLA and ROX) and 
even >100 % (e.g. SUL and DOX) of the mean value. These deviations have al-
ready been reported elsewhere (Guerra et al., 2014; Martin et al., 2015; Peng et al., 
2011) without discussing it in further detail.  
Possible reasons for this inconsistency are manifold and can be theoretically ad-
dressed to input fluctuations, sorption and desorption processes, hydrolysis and 
degradation processes as well as sampling, sample storage/preparation and the 
analytical method. Input fluctuations directly affect the antibiotic concentration in 
primary sludge but have minor influence on excess and digested sludge. The high 
SRT in aeration and digestion tanks buffers load peaks and sludge concentration 
changes slowly over time. On the other hand, hydrolysis, degradation, sorption 
and desorption occur on a faster time scale, but are expected to be at a close-to-
constant rate in case the operation regime is not changed. Hence, the reason for 
the high deviations of sludge concentrations cannot be found on the basis of the 
available data or the understanding of WWTP operations. From the analytical 
point of view, the complex matrix composition of sludge (high TSS, impurities 
like high ammonia concentrations in DS) requires elaborate extraction and purifi-
cation methods. Still, the extensive sorption of analytes can lead to very low reco-
very rates (Heidler and Halden, 2008), which demonstrates the limitations of such 
methods. A promising approach to evaluate the reliability of sludge concentrations 
is to perform mass flow analyses across key units in the sludge streams, e.g. diges-
ters and dewatering units. Nonetheless, at the present there is a lack of such peer-
reviewed literature (including this one) providing a sufficient number of sludge 
samples with an adequate resolution to distinguish between real load fluctuations 
and an erroneous analytical determination. Hence, it is highly recommended that 
future studies dealing with sludge-borne antibiotics focus more closely on this type 
of data plausibilization. 
WWTP mass flow analysis  
The mass flow analysis combines all information on the removal routes of the 
investigated antibiotics and CLI-S. As demonstrated in Figure 6 most antibiotics 
have a low sorption to the digested sludge and either pass through the plant un-
hindered or are prone to degradation. The macrolides AZI, CLA and ROX are 
mostly inert with only a small fraction adsorbing to the sludge. The load of AZI 
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slightly increased by about 12 %, CLA was degraded by 11 % and ROX was fully 
recovered not showing any production nor degradation. Considering the re-trans-
formation model for CLI (CLI*, see 3.1) leads to the conclusion that the introdu-
ced (excreted) load is not affected by the urban sanitary system and completely 
discharged with the effluent. About 13 % of the total CLI* input adsorbed to the 
sludge. The human metabolite CLI-S and the antibiotic TRI behave similarly with 
high mass fractions found in the effluent and a low amount found in the sludge. 
The mass flow analyses of both substances result in a low overall production of 
about 6 and 12 % during the treatment process, respectively, which is in all pro-
bability due to the uncertainty of the mass flow analysis.  
PIP and SUL are absent in the sludge and the difference between in- and output 
load of about 40 and 60 %, respectively, can be attributed to degradation. It is not 
clear why degradation of SUL or PIP stopped at these points, an observation 
which can also be found in other studies (Golovko et al., 2014; Singer et al., 2014; 
Suarez et al., 2012). The cephalosporins CEF and CEFO were exclusively found 
in the effluent and the degradation was determined to 66 and 86 %, respectively.  
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Figure 6: Fate of antibiotics during wastewater treatment 
As already discussed, CIP and LEV have high sorption propensities and the sludge 
path is of major importance regarding their overall removal. The material flow 
analyses of CIP and LEV reveal a production of 79 % and 75 %, respectively. On 
average, 141 % of CIP’s input load is found in the sludge which is highly ques-
tionable and not in accordance with most of the data from other studies (Lindberg 
et al., 2006; Petrie et al., 2014; Zhou et al., 2013b). The average sludge fraction of 
LEV determined in this study (130 %) is also difficult to bring into context with 
other literature results ranging from 9.35 (Yan et al., 2014b) to 69 % (Zhou et al., 
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2013a). Nevertheless, similar “questionable” results have been reported from one 
Canadian WWTP with 245 % (LEV) and 480 % (CIP) of the median input load 
being found in the digested sludge (Guerra et al., 2014). A possible error source 
for the deviating results might be the determination of input loads which consti-
tutes the basis of the mass flow approach. A recent study estimated that 37 % of 
influent CIP was sorbed onto particulates  
(Polesel et al., 2015b) with a chance of not being completely desorbed during the 
sample preparation of the applied analytical method. Making use of this theoreti-
cally resulting correction factor of 0.63 reduces the CIP production, originating 
from the results of the mass flow analysis, from 79 to 12 %. This outcome seems 
to be within the realms of possibility but does not consider the moderate removal 
(≥ 33%) during the anaerobic sludge treatment (see supplementary material S6, 
annex 2). The solid fraction in the effluent was estimated by multiplying the mean 
TSS-content of 12.9 mgTSS/l (SD = 3.7 mgTSS/l, n = 333) with the mean CIP 
concentration determined for ES. As a result, 18.7 ngCIP/l is emitted with the 
effluent which constitutes a theoretical increase of about 11 %, compared to the 
mean effluent concentration of 164 ng/l (SD = 101 ng/l, n = 328). This result 
corresponds very well to previous observations (also 11 %) using a pilot scale ac-
tivated sludge process (Petrie et al., 2014). In case of LEV the load increase in the 
effluent amounts about 7 %, which is 2/3 lower than determined by Petrie et al. 
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CONCLUSIONS 
The significance of the determined removal efficacy of antibiotics and other mi-
cropollutants is strongly limited by uncertainties deriving from sampling and ana-
lytics. Apart from the complex water and sludge matrices, particularly the sampling 
of consecutive in- and effluent samples is very difficult to accomplish in mixed 
systems like WWTP. In this context, quantifying antibiotic mass loads is the only 
way to evaluate the analytically determined concentrations in the liquid and solid 
phase in order to increase the reliability of results.  
The use of gapless time series of at least 7 consecutive days is very well suited to 
provide reliable information on the removal of antibiotics from the liquid phase. 
The so-determined loads from the in- and output of the investigated WWTP are 
costly and time-consuming but minimize spurious influences like HRT as well as 
diurnal and other short-term load fluctuations. Furthermore, the comparison of 
different time series and their respective operating parameters is very promising 
to understand removal mechanisms and to identify options for operational inter-
vention. In the majority of present cases operational parameters do not signifi-
cantly influence the removal rate during the biological treatment process. Solely 
the elimination of CIP and CLI seems to depend on either SRT, temperature or a 
combination of them. Hereby it must be noted that the standard deviation of the 
removal rate of 18 % (CLI) and 5 % (CIP) are too low to draw conclusions.  
Except for CIP and LEV, the mass flows of antibiotics under investigation can be 
sufficiently described by sampling the liquid phase, since the adsorbed fraction is 
negligible compared to the corresponding influent load. On the other hand, only 
inadequate information is available on the actual fate of CIP and LEV. Based on 
the evaluation of gapless times series, the removal from the liquid phase is consi-
dered to be reliable. In contrast, the integration of corresponding sludge loads 
leads to highly uncertain results The above considerations regarding the possibility 
of an incomplete analytical coverage of particulate-bound antibiotics (see 3.3) only 
partially explain these discrepancies and illustrate the need for additional explana-
tory approaches. Regarding the sampling strategy of the present investigation, the 
sludge sampling was partly carried out in 2014 and does not correspond to the 
monitoring campaign in 2013. Although the prescription behavior, which directly 
affects input and sludge loads of the WWTP, is not expected to undergo excessive 
changes within this time frame, an insufficient sampling strategy has likewise to be 
considered as possible error source. At the present there is also a lack of studies 
regarding the short- and long-term variability of sludge loads during sludge 
treatment as it was presented in this study. Therefore, it remains unclear whether 
the inconsistent results are due to insufficiencies in sampling and/or analytical 
determination or if they can be considered to be reasonable fluctuations. The fo-
cus of future investigations should hence be laid on antibiotic’s temporal dynamics 
during the sludge treatment.  
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Species-related risk assessment of antibiotics using the 
probability distribution of long-term toxicity data as 
weighting function – a case study 
Marx C., Mühlbauer V., Krebs P., Kühn V. 
ABSTRACT 
Urban areas are among the main sources which release antibiotics into the 
environment. The fate of antibiotics during their passage through the hu-
man body, the sewer system and the waste water treatment processes can 
be estimated and used for ecological risk assessment. The present approach 
deals with the possibility of addressing the ecological impact on individual 
trophic levels using a probability function to attenuate the classical PNEC 
approach. The species sensitivity distribution (SSD) is based on available 
long-term toxicity data and was fitted using the Hill-equation. The species-
related toxicity threshold was merged with the slope characteristics 
gathered from SSD to express the risk probability of each species level. The 
results for algae and crustaceans show that azithromycin, clarithromycin 
and ciprofloxacin contribute the highest risk portions to the risk index (RI). 
The determined RI for fish was found to be below the threshold value of 1 
and thus no risk is expected for this species. 
KEYWORDS 
Antibiotics, sensitivity distribution, risk assessment, prescription data 
Species-related risk assessment of antibiotics
74 
INTRODUCTION 
Chemical substances which are released into the aquatic environment carry the 
potential to cause harm to a variety of organisms and compartments (Cao et al. 
2009, Guo et al. 2013). The impairment of a few established organisms in natural 
ecosystems can severely disrupt the sensitive food web which requires a proper 
characterisation and control of the according substances. In this context, the Eu-
ropean Commission offers a widely accepted guideline (Technical Guidance Do-
cument on Risk Assessment - TGD) on how to assess the environmental risk of 
chemicals in e.g. water bodies (EU 2003). This guideline is based on the identifi-
cation of Predicted No-Effect Concentration (PNEC), which is put into relation 
with a Predicted or Measured Environmental Concentration (PEC or MEC) to 
define the resulting risk (Fahd et al. 2014). According to the TGD high risk is 
defined as PEC/PNEC ratios above 1, while the Swedish Environmental Classi-
fication of Pharmaceuticals considers 10 as threshold ratio for a substance provo-
king high risk to the environment (fass.se 2014). The difference is equivocal and 
leads to a drawback of the risk rating system. There are no procedures proposed 
on how risk values above 1 (hereinafter referring to the ranking system of the 
TGD) are supposed to be dealt with. Ranking the risk-substances according to the 
species level which they actually affect is a promising adjustment of the widely 
accepted methodology of chemical risk assessment and will be proposed in this 
work.  
Considering a reliable determination of PNEC, the procedure allows a good esti-
mation of the overall risk to water bodies. The risk linearly depends on PEC which 
is a necessary assumption, but does not reflect the typical dose-effect-relationship 
(Cao et al. 2009) for organisms. Usually a logarithmic sigmoidal shaped function 
is applied to express the relationship in this context (Chevre et al. 2008). Using the 
linear instead of the sigmoidal dependency between risk and substance concentra-
tion most probably leads to a vast overestimation of risk since it is not ecologically 
justified. Hence, the present approach will evaluate the use of the species sensiti-
vity distribution (SSD), proposed by TGD (EU 2003), to approximate a sigmoidal 
shape as correction function for the calculated risk. With the aid of the Hill coef-
ficients DH and m, substances with a lack of toxicity information can be linked to 
a corresponding dose-effect relationship, or SSD, according to their mode of ac-
tion and potency. This procedure allows the trophic-level-based risk assessment 
for those substances which significantly contribute to the overall risk, in terms of 
emitted amounts, but offer little or no information on ecotoxicology. 
Antibiotics were chosen to demonstrate the concept of the proposed risk as-
sessment approach. This group of pharmaceuticals is of great scientific and envi-
ronmental interest due to their resistance-promoting potential and ecotoxic effects. 
At the present, there are some concerns, that the release and spread of antibiotic 
resistant genes affect the therapeutic potential of antibiotics against human patho-
gens (Zhang et al. 2009), which greatly decreases their operational area. The crux 
regarding these concerns is that no reliable methods exist to assess the risk of 
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antibiotic resistances at present, which complicates the evaluation of implications 
that antibiotic resistances in the environment have for public health. Many inves-
tigations have been carried out to gain knowledge on the occurrence and dissemi-
nation of antibiotic resistances. However, the current available information on re-
sistances in the environment is still very limited and more data are needed to better 
understand their development and selection processes (Rizzo et al. 2013). Investi-
gations on resistances against heavy metals and antibiotics show that both types 
often occur simultaneously (Yamina et al. 2012). Furthermore, heavy metals co-
select for antibiotic resistances and hence directly influence their development 
(Seiler and Berendonk 2012). The introduction of the minimal selection concen-
tration (MSC), which can be several orders of magnitude lower than concentra-
tions causing observable effects to organisms, gives evidence that the selective 
pressure under very low antibiotic concentrations is high enough to permanently 
maintain resistances in the ecosystem (Gullberg et al. 2014). This effect progresses 
with increasing number of compounds (e.g. heavy metals, herbicides) added to the 
system.  
On the other hand, the extensive use of antibiotics has also posed the question of 
the risk they provoke in environmental compartments from the chemical point of 
view. Considering the standard species algae, crustacean and fish, the former is 
assumed to be the most sensitive in the aquatic food chain, causing the highest 
effect if being stunt by toxic substances. Comparing toxicological investigations 
of antibiotics regarding the three species mentioned above, differences according 
to their sensitivity ranking can be observed. For instance, crustaceans are more 
susceptible to clarithromycin than algae, on the other hand fish proved to be the 
most sensible species in presence of trimethoprim (see supplementary material S1, 
annex 3). The evaluation of these differences can therefore help to prioritize subs-
tances more detailed than it is possible using the standard PNEC-approach (see 
supplementary material S2, annex 3).  
MATERIALS AND METHODS 
Concept 
The TGD suggests to perform a SSD to determine the most probabilistic PNEC 
value. The SSD includes all available long-term toxicity data5 on different taxono-
mic groups of organisms. It is assumed that they follow a theoretical distribution 
function and that each group of organisms tested in the laboratory constitutes a 
random sample of this distribution. Assuming an adequate amount of data, the 
PNEC is defined as the 5 percentile of the SSD. An assessment factor of 1 to 5 is 
applied and accounts for further uncertainties, e.g. the diversity and representa-
tiveness of the included organisms or the adequate coverage of sensible life stages 
5 NOEC (No Observable Effect Concentration), LOEC (Lowest Observable Effect Concentration), 
EC10 (Effect Concentration causing 10 % effect) and LC10 (Lethal Concentration causing a lethal effect 
of 10 %)  values were combined in this study to extend the applicable data set 
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of the organisms. Additionally, the TGD provides guidance on the minimal requi-
rements for SSD in terms of number of taxonomic groups and available NOEC 
as well as information how multiple data on species are to be considered. Those 
information state general principles on how to perform extrapolation techniques 
but are hardly applicable to antibiotics. The majority of substances neither have 
the variety of taxonomic groups nor the amount of data available to carry out a 
“proper” risk assessment, in terms of a SSD. Nevertheless, the guideline is widely 
accepted and offers valuable information on how to deal with available data sets. 
Hence, the present approach will comply with the basic principles of the guideline. 
The general idea is that the SSD specifies the probability of the PNEC to be ac-
curate, depending on the available data. This distribution is substance-specific and 
hence provides a measure on how sensitive organisms respond to concentration 
changes (mode of action). This characteristic will be used to transfer the specific 
dose-effect relationship to the three classical species algae, crustaceans and fish. 
Depending on their minimal NOEC value the SSD distribution is going to be 
adjusted in order to describe each effect probability individually. Subsequently, the 
probability is used to weight the calculated risk quotient, according to its reliability. 
A summary of the steps to species-related risk assessment is given in Figure 1. 
The SSDs will be fitted using the HILL-equation (equation 1). The parameter m 
defines the curve’s slope and is specific for the relevant mode of action. This as-
sumption was confirmed for herbicides and pharmaceuticals with similar mode of 
action (Chevre et al. 2006, Chevre et al. 2008) and hence can be transferred to the 
group of antibiotics. DH expresses the substance potency and is defined as the 
concentration where PNEC-probability amounts to 50 % (see Chèvre at al. 2006 
and supplementary material S3 for equation conversion). The PEC was calculated 
as outlined in 2.3.3. 
The determination of all SSD was not carried out for antibiotics with less than 3 
available effect concentrations, instead the SSD character of other antibiotics with 
the same mode of action was adopted. This approximation was necessary for azi-
thromycin, clindamycin, roxithromycin and doxycycline which share the same 
mode of action with clarithromycin (block of protein biosynthesis) whereas the 
former also share the same point of action. Cefuroxime was the only cephalospo-
rine with toxicity data and provides the slope characteristics for cefaclor, cefadroxil 
and cefixime. Penicilline V belongs to the same beta-lactam group as amoxicillin 
and will be described by the latter. All antibiotics investigated in this study are 
summarized in Table 1. 
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The parameter m (also referred to as slope) has significant impact on the share in 
risk an antibiotic (AB) contributes. Low data availability might lead to wrong con-
clusions of slopes, a drawback which needs to be addressed to. Therefore, the 
influence of m was evaluated by globally setting different m values from 0.1 – 3.0 
to all substances (hereinafter addressed to as SSDm), neglecting the SSD determi-
ned for each substance. The global use of m implies identical modes of action for 
every antibiotic class. This assumption can be accepted at this point since suffi-
cient data do not exist to prove the opposite for environmental organisms.  
In this approach the distribution characteristic determined from all species is as-
sumed to be valid for single species, too. Even if the use of individual values for 
m, which defines the shape of the characteristic distribution, seems to be the ap-
propriate procedure to characterize the risk on the species level, it is not practi-
cable in this case. The factor influences the curve progression and describes the 
organism’s sensitivity to the substance. The higher the chosen or approximated m 
is, the steeper the curve becomes. Comparing two dose-effect distributions, one 
with low potency and flat curve progression (high DH, low m) and the other ha-
ving the reverse characteristics, the low potency curve exhibits higher probability 
values at lower concentrations and exceeds the high potency distribution, in terms 
of calculated effect probability. This instance may be right for some antibiotics, 
but cannot be assumed in the first place without having the adequate data available. 
For this reason identical parameter m are applied to all species level under investi-
gation. 
Figure 1: Flowchart of the proposed methodology using the probability distribution of long-term tox-
icity data as weighting function for environmental risk assessment on the species level  
for single substances 
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The overall risk quotient (RQ) will be calculated using the wastewater treatment 
plant’s effluent concentration of each antibiotic (PEC), which was generated from 
prescription data (see 0). Subsequently, the RQ is weighted using the effect-pro-
bability factor (fAB,species) arising from SSD adjustment (see 2.2 and equation 2), 
according to the considered species and antibiotic (equation 4). For the calculation 
of the risk index (RI) the method of concentration addition is applied (equation 3) 
(EPA 2000). The RI will serve as standardization method to calculate the relative 
impact of single antibiotics on the overall risk of the species level. As a result, this 
procedure, complying with TGD guidelines, extends the generally accepted risk 
assessment methodology to a species-based risk ranking within the aquatic eco-
system. 
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 species,ABspecies RQRI (Equation 3) 
PNEC values applied in equation 4 were taken from literature and compared with 
the results from the SSD of each antibiotic. A brief overview regarding the se-
lection of PNEC is presented in the supplementary material S4.  
Derivation of species-based risk assessment 
Only for a few substances an adequate data set is available to reasonably carry out 
a SSD. Sulfamethoxazole is a well investigated compound for which reason thus 
it was chosen to exemplify the involved steps of species-based risk assessment.  
At first, the Hill curve is fitted to the data points of all available species to calculate 
the dose-probability as well as the potency of each substance (see Figure 2). The 
next step involves merging the minimal effect concentration of each species with 
the slope characteristics gathered from SSD (and SSDm). According to the 5 % 
percentile for PNEC-estimation, the 95 % percentile of SSDSUL is adjusted to the 
corresponding minimal NOECAB,species value of each species (= 5 %-ile of Hill 
curve, dashed grey curve in Figure 2). However, at this concentration the 
RQAB,species nearly equals the RQ determined from classical PNEC calculation. 
From this point, reduced concentrations lead to lower fAB,species and attenuated 
RQAB,species. 
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Figure 2: Example for fitting the SSD to Hill-equation using sulfamethoxazole (SUL) as an example; 
the shifted probability distribution was calculated using equation 2. Considering the individual potency 
of each species, the formula is applied to the calculated effluent concentration in order to determine 
the probabilistic factor for each RQ. 
species,AB
AB
AB
species,AB fPNEC
PEC
RQ  (Equation 4) 
It is assumed, that the probability of each species to be affected by an antibiotic 
depends on the mode of action and hence is identical within one group of anti-
biotics (for groups see Table 1. Therefore, missing species-related NOEC-values 
were replenished using the probability distribution of the antibiotic in question in 
combination with a NOEC-probability of another, better investigated antibiotic 
within the same group. For example, the NOEC probability for algae of cipro-
floxacin (3.00 µg/l) constitutes 24 % which in turn assigns an NOEC probability 
for algae of 84.96 µg/l for levofloxacin, regarding its specific probability distribu-
tion (Table 3). 
No crustacean and fish data are available for antibiotics belonging to the group of 
fluoroquinolones. Hence, the probability of crustacean and fish to be affected by 
levofloxacin and ciprofloxacin was divided into three and set to 67 and 100 %, 
respectively. This implies that fish (highest effect concentration) are more tolerant 
to fluoroquinolones than crustaceans, which in turn are more tolerant than algae 
(lowest effect concentration). Yielded effect concentrations are given in Table 3. 
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Input data and scope of the study 
Substances 
Prescription data of antibiotics from 2005 – 2011 were provided by the statutory 
health insurance company AOK PLUS which insures about 41 % of the people 
living in Dresden, Germany. The dataset covers only ambulant drug prescription. 
Additionally, data on the consumption of antibiotics were provided by the three 
major hospitals covering about 65 % of hospital beds available in the catchment 
area of the wastewater treatment plant (WWTP). In Table 1 the 15 most prescribed 
antibiotics in Dresden which were chosen for this study are listed. Ofloxacin and 
levofloxacin are racemats and considered as one substance.  
Table 1: Prescription data of investigated antibiotics 
Antibiotic Therapeutic class 
Prescription in 
WWTP catch-
ment  
(2005 – 2010) 
[kg/a] 
Share in 
group 
Total 
group 
coverage 
Cefadroxil Cephalosporine (1. generation) 10 ± 3 3 % 
91 % 
Cefuroxime Cephalosporine (2. generation) 302 ± 58 78 % 
Cefaclor Cephalosporine (2. generation) 25 ± 8 6 % 
Cefixime Cephalosporine (3. generation) 14 ± 5 4 % 
Clarithromycin Macrolide 85 ± 26 23 % 
82 % 
Azithromycin Macrolide 24 ± 9 6 % 
Roxithromycin Macrolide 24 ± 11 6 % 
Clindamycin Lincosamide 176 ± 45 47 % 
Amoxicillin Penicillin 243 ± 41 40 % 
88 % 
Penicillin V Penicillin 286 ± 39 48 % 
Ciprofloxacin Fluoroquino-lone 140 ± 9 55 % 86 % 
Levofloxacin Fluoroquino-lone 80 ± 10 31 % 
Sulfamethoxazole Sulfonamide 207 ± 27 100 % 
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Doxycyclin Tetracycline 44 ± 8 82 % 
Trimethoprim Diaminopyrimi-dine 42 ± 6 98 % 
The sewer system of the WWTP Dresden-Kaditz has a length of 1700 km and 
collects the wastewater of five cities (Dresden, Freital, Heidenau, Pirna and eastern 
Radebeul) and some bordering municipalities. Presently, the wastewater of ap-
proximately 650000 inhabitants is being treated, whereof 80 % live in Dresden. It 
is assumed that the prescription data of AOK-insured people in Dresden can be 
extrapolated to the entire catchment area of the WWTP and to all respective in-
habitants. The theory of antibiotic person equivalents was examined comparing 
the calculated amount of the total catchment area with the bordering municipali-
ties of the catchment area. The ratio of five investigated antibiotics with seasonal 
and non-seasonal influence yielded 15 to 30 % of the total input to the total cat-
chment area (see Figure 3). To cover the entire catchment area, the mean share of 
the five presented antibiotics (24 %) will be used for extrapolation purposes of 
remaining antibiotics.  
Figure 3: Bordering municipalities’ input share in the entire catchment area of the WWTP (data set: 
weekly prescription from 2005 – 2011) 
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Furthermore, it is accepted that insurants of private health companies, which hold 
a share of 10 % of the total inhabitants, receive the same type and amount of 
antibiotics as those being statutorily insured. The approximated net number of 
commuters of about 40 000 (6 % of the catchment’s population) will not be con-
sidered since antibiotic taking usually involves a sick certificate. 
Scope of the case study 
Estimating the input load of antibiotics into the aquatic environment using pres-
cription or production data is an accepted method for the environmental risk as-
sessment of chemicals (Besse and Garric 2008, Ortiz de Garcia et al. 2013). Hence, 
this methodology was applied to estimate the environmental hazard induced by 
antibiotics, including their specific human excretion information and elimination 
rate during wastewater treatment (see Table 2). 
Apart from that stated above, there is a variety of processes and factors in natural 
water bodies that have a potential influence on the assessment of antibiotics and 
can lead to different risk characteristics than determined by the general methodo-
logy. For differentiation purposes an overview of possible interaction processes 
will be briefly presented in the following in order to define the boundary condi-
tions for the case study under investigation. 
After their release into natural water bodies antibiotics are prone to a variety of 
processes which lead to a change of concentration and hence a change of toxicity. 
Depending on the actual situation the mixing of the effluent and the receiving 
stream usually results in lower antibiotic concentrations. Regarding the exem-
plifying case under investigation, the mean daily low flow of the river Elbe was 
determined to 102 m³/s (DWSO 2014) and indicates a mean dilution of the 
wastewater effluent (1.8 m³/s) of about 1/57, if complete mixing is assumed. In 
contrast, due to the slow transverse mixing between the effluent and the receiving 
river a dilution of the former is not achieved for several flow kilometers and subs-
tance concentrations remain higher than the complete mixing calculation suggests. 
The level of transverse mixing depends on the receiving stream’s characteristics 
(width, flow velocity, degree of meandering) and an estimation is difficult to carry 
out without applying appropriate mixing zone models (Jirka et al. 2004).  
Despite the fact that the main part of antibiotics with favorable adsorption cha-
racteristics are eliminated during wastewater treatment (excess sludge), sediment-
water interactions (sorption) still contribute to an alteration of antibiotic concen-
trations in natural water bodies (Zhou and Broodbank 2014). Besides, the pro-
cesses hydrolysis and photolysis are considered as further elimination pathways, 
leading to transformation or complete mineralization. Hereby, temperature, pH 
and inorganic matter in the receiving river play a crucial role concerning the in-
fluence that sorption (Gu and Karthikeyan 2008, Zhang et al. 2014), hydrolysis 
(Bialk-Bielinska et al. 2012, Kang et al. 2012, Mitchell et al. 2014) and photolysis 
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(Kümmerer 2009, Sirtori et al. 2012, Wang and Lin 2012) have regarding the ove-
rall elimination of antibiotics. In case of incomplete mineralization, transformation 
products technically become a part of the risk assessment. Nevertheless, the clas-
sical risk assessment only addresses the toxicity of the parent compounds under 
investigation, neglecting transformation products from technical (wastewater 
treatment) or natural (e.g. photolysis) elimination of antibiotics. Considering the 
fact that some transformation products can exhibit a higher toxicity compared to 
their parent substance (El Najjar et al. 2013, Iskender et al. 2007, Sirtori et al. 2012, 
Wang and Lin 2012) makes the necessity of including those substances in the risk 
assessment evident. However, the high number of possible and partly unknown 
compounds causes the inclusion of transformation products to be per se incom-
plete and hence difficult to carry out and evaluate.  
As shown above, the dilution and elimination in natural water bodies as well as 
the transformation pathways are difficult to assess in a complete manner due to 
the variety of substances, processes and changing conditions (pH, inorganic mat-
ter etc.) along the flow path. In order to demonstrate the concept of the proposed 
methodology the scope of this study focuses on the single parent substances (no 
transformation products, no synergistic effects from antibiotic mixtures) in the 
urban catchment and the respective WWTP. The manifold processes in the recei-
ving river Elbe, which cannot be adequately included without using appropriate 
hydrological and material flow models, will not be considered.  
Antibiotic’s fate within the urban catchment and the WWTP 
As described in the previous section, the case study focuses on the antibiotic flow 
starting with the consumption and ending at the outlet of the WWTP. After the 
consumption a partial elimination of the parent substance takes place during its 
passage through the human body. They are partly adsorbed by the gastric mucosa 
and/or gut and may be prone to metabolizing processes. The content that was not 
adsorbed is assumed to be excreted unchanged. The excreted ratio of the parent 
compound (EAB) can be calculated using equation 5, where fA,AB characterises an-
tibiotic-dependent the adsorption ratio in the human body. The parameter fM,AB 
determines the share of the respective antibiotic in the adsorbed fraction that is 
prone to metabolism, which in turn decreases the amount of the parent substance 
in the faeces. The necessary information are usually provided by the pharmaceu-
tical industry (see Table 2). 
. 
)1()1( ,,, ABMABAABAAB fffE   (Equation 5) 
Many anthropogenic substances pass through the sewer system and WWTP be-
fore they are released into the environment. During their passage they are prone 
to adsorption and degradation processes which differ significantly among subs-
tances (Liu et al. 2013). In case of antibiotics, most of the penicillins are easily 
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biodegradable due to cleavage of the beta-lactam ring and rarely found in the ef-
fluent of WWTP (Watkinson et al. 2007). Cephalosporines, being a sub-group of 
the latter, show higher persistence in raw wastewater and the treatment process. 
The macrolides azithromycin, clarithromycin and roxithromycin show highly va-
riable elimination rates from -45 to 55 % (Goebel et al. 2007). In order to consider 
the uncertainties regarding macrolide’s reduction in WWTP, the elimination rate 
is thus set to 0 % for this study. Tetracyclines and fluoroquinolones have strong 
adsorption capabilities. Their main removal route is expected to be excess sludge 
removal (Golet et al. 2003) which influences the fate in sewer systems as well. 
There is no evidence that tetracyclines are biodegradable (Kim et al. 2005). Sulfo-
namides are partly removed in waste water treatment whereas sorption to sludge 
is irrelevant (Watkinson et al. 2007, Yang et al. 2005). A summary of the excretion 
and elimination rates applied in this study can be seen in Table 2. 
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Table 2: Excretion and elimination rate of antibiotics under investigation 
Antibiotic Excretion rate Elimination during wastewater treatment 
Amoxicillin 
60 – 85 % (mean: 72.5 %) 
(Aktories et al. 2009, Mar-
tindale 1993) 
60 – 85 % (mean: 72.5 %) 
(Aktories et al. 2009, Mar-
tindale 1993) 
Azithromycin 99 %
6 (Watkinson et al. 
2009) 
99 % (Watkinson et al. 
2009) 
Cefaclor 67.4 % (Sandoz 2009) 67.4 % (Sandoz 2009) 
Cefadroxil 0 % (Goebel et al. 2007) 0 % (Goebel et al. 2007) 
Cefixime 53 % (Lode et al. 1979) 53 % (Lode et al. 1979) 
Cefuroxime 100 % (Watkinson et al. 2007) (used in study: 99 %) 
100 % (Watkinson et al. 
2007) (used in study: 99 %) 
Ciprofloxacin 88 % (Pfeffer et al. 1977) 88 % (Pfeffer et al. 1977) 
Clarithromycin 50 % (assumption, no data available) 
50 % (assumption, no data 
available) 
Clindamycin 18 % (Brittain et al. 1985) 18 % (Brittain et al. 1985) 
Doxycyclin 50 % (assumption, no data available) 
50 % (assumption, no data 
available) 
Levofloxacin 50 % (ODDB 2014) 50 % (ODDB 2014) 
Penicillin V 60 % (unpublished data) 60 % (unpublished data) 
Roxithromycin 
40 % (urine), 15 % (faeces) 
(sum: 55 %) (Aktories et al. 
2009, Vancebryan et al. 
1990) 
40 % (urine), 15 % (faeces) 
(sum: 55 %) (Aktories et al. 
2009, Vancebryan et al. 
1990) 
Sulfamethoxazole 66 % (Li and Zhang 2011) 66 % (Li and Zhang 2011) 
Trimethoprim 60 % (Hirsch et al. 1999) 60 % (Hirsch et al. 1999) 
Considering the elimination pathways before the substance’s discharge into the 
receiving river the PEC can be calculated using the following equation: 
6 Using equation 5 with fA,AB = 37 % and fM,AB = 88 % 
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with the ambulant prescription data of Dresden (PAOK,Dresden), the available hospital 
prescription (Phospitals,Dresden), the daily WWTP outflow of Dresden-Kaditz (QWWTP), 
the elimination during the wastewater treatment ( Elimination), the share of insured 
inhabitants (41 %), the share of bordering municipalities (24 %) and the share of 
hospital beds covered by the hospital prescription (65 %). In the region of Dres-
den agriculture plays a minor role and antibiotic inputs originating from veterinary 
use are not expected. 
RESULTS AND DISCUSSION 
Species-related toxicity thresholds 
In Table 3, toxicity threshold values related to algae, crustacean and fish are listed 
for the antibiotics under investigation. The values are either taken from literature 
(see supplementary material S1, annex 3) or estimated from the substitutes ap-
proach. The most potent antibiotics regarding toxicity towards algae are amoxicil-
lin and penicillin V with effect concentrations of 1.17 µg/l. Furthermore, cipro-
floxacin (3.00 µg/l), the macrolides azithromycin, clarithromycin and roxithromy-
cin (11.54 – 25.00 µg/l) as well as sulfamethoxazole (5.90 µg/l) are also to be 
considered to provoke effects on the algae level. The species of crustaceans show 
to be responsive to azithromycin and clarithromycin (4.40 and 4.70 µg/l) plus ci-
profloxacin, clindamycin, doxycycline, roxithromycin and sulfamethoxazole 
(30.20 – 250.00µg/l). The most effective antibiotics regarding fish toxicity are tri-
methoprim (157.00 µg/l) and levofloxacin (937.13 µg/l). Considering the results 
above macrolides and ciprofloxacin are the most potent substances regarding their 
effect on the lower trophic levels in this study.  
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Table 3: Summary of the fitting parameters and toxicity threshold for each species 
Antibiotic DH  [µg/l] 
slope 
(m) 
[-] 
species-related toxicity threshold 
Algae 
[µg/l] 
Crustacean 
[µg/l] 
Fish 
[µg/l] 
Amoxicillin 222250 0.87 1.17 2300000 182700 
Azithromycin 357 1.183 11.54 4.4 84000 
Cefaclor 2016584 1.744 760008 831004 10000004 
Cefadroxil 2016584 1.744 760004 8310004 10000004 
Cefixim 2016584 1.744 760004 8310004 10000004 
Cefuroxime 201658 1.74 76000 831000 1000000 
Ciprofloxacin 13 0.78 3 30.2 4535.06 
Clarithromycin 35 1.18 11.54 4.7 1000000 
Clindamycin 2565 1.835 81.13 42.073 329020.053 
Doxycyclin 2569 1.835 81.13 42.073 329020.053 
Levofloxacin 137 2.39 84.9611 181.17 937.13 
Penicillin V 22225010 0.876 1.176 23000006 1827006 
Roxithromycin 477 2.48 25 183.88 62383.17 
Sulfamethoxazole 1945 0.54 5.9 250 33848.57 
Trimethoprim 11394 0.87 3100 13000 157 
Antibiotics are purposefully designed to decrease the abundance of bacteria in the 
human body. Hence, it is not surprising that some toxicological investigations 
using environmental bacteria as test organisms also show considerable effects 
caused by some antimicrobial agents. Levofloxacin is being effective towards vi-
brio fisheri at 1.99 µg/l and ciprofloxacin affects pseudomonas putida at 4.90 µg/l. 
7 Adopted from clarithromycin 
8 Adopted from cefuroxime 
9 Adopted from azithromycin and clarithromycin by averaging 
10 Adopted from amoxicillin 
11 Adopted from ciprofloxacin using probability distribution 
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Hartmann et al. (1998) used a genotoxicity assay to investigate the effects of clari-
thromycin onto bacteria and determined a LOEC of 5.00 µg/l. Bacteria showed a 
similar sensitivity against toxicity like algae, however, differences in potency ran-
king can be seen. Unfortunately, the available data sets are not sufficient to carry 
out a separate bacteria-related risk assessment for the entire spectrum of antibio-
tics which are covered in this study. At this juncture, it has to be assumed that 
bacteria, which should be the most susceptible organisms, show similar effects like 
algae, even if few toxicological investigations seem to suggest otherwise. 
Evaluation of risk distribution using individual slopes 
The RIalgae nearly completely fails to fulfil the quality criteria of < 1. Only at the 
beginning of 2006, a RIalgae below 1 can be determined (see supplementary material 
S5, annex 3). Concluding from calculated values, a permanent risk on the algae 
level emanates from antibiotics in the effluent of WWTP. Taking a closer look 
onto the contributing substances, the following conclusions can be drawn. The 
antibiotics showing the highest risk potency do not significantly contribute to the 
overall risk for algae originating from the WWTPs effluent. Beta-lactams are well 
biodegradable and the expected effluent concentration of 0.02 – 0.03 µg/l is rather 
low. Their contribution to the RIalgae is about 1 to 2 %. The effluent concentra-
tion of ciprofloxacin is about 0.42 µg/l and causes the highest risk share in RIalgae 
of about 59 % (RQCIP,algae = 2.84). Azithromycin and clarithromycin have a con-
tribution to the total risk of 15 % each. Sulfamethoxazole accounts for a minor 
share of around 6 %, only. 
It is proposed to define the substances which contribute more than 80 – 90 % to 
the overall risk of the most sensitive species, in this case algae, as first-order risk 
substances. Algae play a crucial role in aquatic ecosystems and many edible species 
are being consumed by zooplankton (e.g. crustaceans), which in turn are the basis 
for fish ranking higher in the food chain. In order to prioritize measures to reduce 
the substance-induced risk on aquatic ecosystems the proposed ranking gives ad-
vice on which substances should be focused on. Accordingly, ciprofloxacin, azi-
thromycin and clarithromycin constitute first-order risk antibiotics, whereas cipro-
floxacin clearly provokes the highest risk among them. 
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Figure 4: Risk index of the species crustacean (RIcrustacean) – remaining RQAB are summed up and dis-
played as residuals 
It can be seen that risk indices for crustaceans (RIcrustacean) is nearly as high as RIalgae 
(on average 92 % of RIalgae, R2 = 0.95, p < 0.01, see Figure 5 and S5, annex 3), 
which is surprising since a significantly higher sensibility for algae was expected. 
Still, the composition of RIcrustacean is somewhat different (see Figure 4) from 
that of RIalgae. As expected from the species-related thresholds, azithromycin 
(35 %), along with ciprofloxacin (35 %) hold the highest share in RIcrustacean. The 
RQ of clarithromycin constitutes on average 1.20 and amounts 26 % of RIcrustacean. 
Additionally, sulfamethoxazole contributes an average RQSUL,crustacean of 0.12 which, 
depending on the season, corresponds to a proportion between 1 and 6 % of RI-
crustacean. The substances which induce the risk to crustaceans are the same as 
those for algae, even though their proportions are different. Crustaceans are more 
susceptible to macrolides which in turn compensates for the higher sensitivity of 
RIalgae to ciprofloxacin. The RIfish amounts up to 0.20 (see supplementary material 
S6, annex 3) and consists mainly of RQCIP and RQSUL. The index does not exceed 
the threshold value of 1 which leads to the conclusion of an acceptable risk for 
fish. 
Using the proposed sigmoidal probability distribution rather than a linear rela-
tionship between concentration and estimated risk leads to a mean attenuation of 
the classic PNEC-approach (RIclassic) of about 70 % for algae and crustaceans. The 
attenuation for RIfish is even higher and reduces the risk index below the threshold 
value of 1. The relationship between the species-related and the classical RI are 
shown in Figure 5. 
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Figure 5: Species-related RIspecies versus classical PNEC-derived RIclassic 
Evaluation of risk distribution using global slopes 
The probability distributions used in this approach are influenced by the number 
and quantity of investigated species. Owing to circumstances of randomly inves-
tigated organisms an unequal distribution of available data regarding the trophic 
levels is possible. In order to overcome, or assess, these uncertainties and evaluate 
the robustness of the present approach, the parameter m of the Hill equation was 
set constant for all antibiotics and globally diversified to estimate its influence on 
risk proportions, depending on its dimension.  
In general, a similar distribution pattern can be observed for algae and crustaceans, 
compared to the approach using individual slopes. Regarding algae, ciprofloxacin 
becomes massively dominant above a slope of 0.5 and reaches a share in total risk 
of over 90 % at a slope of 3 (see Figure 6A). Azithromycin and clarithromycin 
contribute a minor part to RIm,algae, which complies with the results of individual 
distribution curves for antibiotics. 
Azithromycin and clarithromycin show to be the most potent antibiotics for crus-
taceans (see Figure 6B). Below a slope of 1.5 the former contributes the largest 
risk proportion. Increasing m up to 3 causes the influence of clarithromycin to rise 
further, while azithromycin becomes less important. Compared with the approach 
using individual slopes, ciprofloxacin affects the risk to a lesser extent.  
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Evaluating the risk proportion of fish (see Figure 6C), it becomes apparent that 
levofloxacin and trimethoprim dominate the determined risk. Ciprofloxacin, 
which contributed between 70 and 90 % to the overall RIfish using individual slopes, 
reaches a proportion of around 30 % at m = 0.5 and is further decreasing with 
higher m-values. The reason for the observed differences are to be found in the 
comparatively low species-related toxicity thresholds of levofloxacin and tri-
methoprim. Ciprofloxacin’s potency is lower by factors 5 (levofloxacin) and 28 
(trimethoprim) which leads to minor RQCIP at identical m-values. 
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Figure 6: Risk proportions using global m-values (A – algae; B – crustacean; C – fish; D – influence on 
RIspecies) 
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The slope m also has a stake in the dimension of RIalgae, RIcrustacean and RIfish. A slope 
of zero is almost matching the average RIclassic (24.54), only reduced by a factor of 
0.95 (setting m to zero in equation 2 and Figure 6D). High slope values describe a 
faster response to concentration changes, which increases the effect probability 
considerably. But this is only the case, if calculated effluent concentrations are 
close or above the species-related toxicity thresholds. Substantially lower effluent 
concentrations lead to probability factors close to zero and, subsequently, to de-
creasing RI. RIfish hits the threshold value of 1 at a slope of around 0.6, RIalgae and 
RIcrustacean reach the threshold line at around 2.3 and 2.0, respectively (see Figure 
6D). Due to the interpretation that antibiotics do not constitute a risk to the envi-
ronment above these m-values, a further investigation of the risk proportions will 
not be necessary. Chevre et al. (2008) studied the sensitivity distribution of herbi-
cides, organophosphates and beta-blockers. The lowest slope calculated from toxi-
city data of the pharmaceutical group beta-blockers was 0.6 which is assumed to 
represent the lower limit of this investigation, too (see supplementary material S3 
for formula conversion, annex 3). Consequently, the assessed risk towards fish is 
low which corresponds well with the approach applying individual slopes. Within 
the range of reasonable m-values the risk assessed for the species algae and crus-
taceans is high and shows similar risk distributions of antibiotics, independently 
of the approach used. 
CONCLUSIONS AND SUMMARY 
The introduced approach addresses two drawbacks of the PNEC-based risk as-
sessment. Firstly, the linear relationship between concentration and effect can be 
corrected using the probability distribution as weighting function, also referred to 
as SSD. The resulting attenuated risk quotient RQ reflects the quality of the data 
set as well as the effect range which is defined through the variety of test organisms. 
Secondly, a differentiated risk assessment on the species level delivers insight into 
the real impact potential of antibiotics. It was shown, that algae are the most sen-
sitive among the investigated species, while environmental bacteria might prove 
to be even more susceptible to antibiotics. The latter need to be intensively inves-
tigated in the future in order provide a reliable data basis and to give a justified 
answer to this question. 
The combined approach of using a sigmoidal probability distribution on the 
species level leads to strongly attenuated risk indices. RIalgae and RIcrustacean are 70 % 
lower than the RI determined using the classical PNEC approach. RIfish was even 
decreased below the threshold value and thus does not indicate a risk for this 
species. 
The application of both global and individual m-values is suitable to estimate the 
contribution to the overall risk from each substance. The first-order priority subs-
tances, i.e. those that hold the highest share in the overall risk at the most sensitive 
species-level in the food chain, can be identified using either global or individual 
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slopes for the probability distribution. The knowledge of first-order priority subs-
tances is a solid step into bottom-up risk management from the chemical’s point 
of view, concentrating on the substances which are the most hazardous to the 
aquatic environment. In case of lower-tier organisms being affected by the subs-
tances under investigation a damage propagation among species-levels, which re-
sults in the weakening of higher-tier organisms, must be taken into account. He-
reby, it must be considered that standard testing procedures cover the effect 
measuring using indicators like the uptake/elimination of test chemicals, growth 
rate or mobility which result in the classical toxicologic endpoints, e.g. EC10. 
Hence, no conclusion can be drawn regarding the kind of effect that influences 
the respective organism. 
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Environmental risk assessment of antibiotics including 
synergistic and antagonistic combination effects 
Marx, C., Mühlbauer, V., Krebs, P., Kuehn, V. 
ABSTRACT 
The interaction-based hazard index (HIint) allows a prediction of mixture ef-
fects different from linear additivity by including information on binary mix-
tures between the chemicals. The aim of this study is to make a solid estimate 
on the possible synergistic potential of combined antibiotics and to quantify 
the subsequent effect for the case of the receiving river Elbe, Germany. In-
formation on binary interactions between antibiotic groups were used from 
literature and from knowledge on human antibiotic combination therapy. 
Applying a moderate and a worst-case scenario, in terms of the interaction 
magnitude, resulted in 50 to 200 % higher environmental risks, compared to 
the classical assessment approach applying simple concentration addition. A 
subsequent sensitivity analysis revealed that the data strength for some binary 
antibiotic combinations is too low to be considered for a solid estimate of 
synergistic effects. This led to the definition of certain preconditions in order 
to decide whether or not to include certain interaction information (e.g. the 
necessary number of interaction studies). The exclusion of information with 
low data strength resulted in an attenuated risk increase of 20 to 50 %, based 
on the currently available scientific information on binary antibiotic mixtures. 
In order to include antibiotics with the highest share in the overall risk (ma-
crolides, quinolones, and cephalosporins) as well as their corresponding me-
tabolites, investigations should focus on binary interactions between them. 
KEYWORDS 
Antibiotics, risk assessment, synergism, antagonism, hazard index 
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INTRODUCTION 
The assessment on whether or not a chemical substance causes a threat to the 
environment is usually carried out on the basis of toxicity tests using established 
standard organisms like fish, algae or other appropriate sensitive species. The re-
sults of these set-ups provide reliable information on the toxicity of single subs-
tances towards target and non-target organisms (Baguer et al., 2000). In order to 
understand the toxicity effects of multiple substances, each chemical has to be 
adequately described regarding its individual toxicity threshold and concentration 
within the mixture. Accordingly, this procedure of risk assessment is not appli-
cable to undefined mixtures where most of the required information is not avai-
lable. Urban wastewaters contain a vast number of chemical substances like clea-
ning agents, heavy metals, personal care products and pharmaceuticals (Trapido 
et al., 2014) and can have a significant influence on the receiving stream’s water 
quality (Eggen et al., 2014). The wide variety of substances and concentration 
ranges in wastewaters make it difficult to satisfactorily determine their actual toxi-
city to the environment. One concept which intends to transform the toxicity in-
formation of several individual substances to an overall mixture toxicity is termed 
concentration addition. It is based on the thought of a similar mode of action of 
all substances present in the mixture, irrespective of the presence of other subs-
tances (Berenbaum, 1985). Even though this assumption is rather simplistic, it 
becomes practical if only limited information on the mode of action is available. 
Nevertheless, due to the origin of the toxicity information of individually tested 
substances, no conclusion on synergism and antagonism can be drawn from this 
approach.  
Various studies have been performed to investigate mixture effects between sur-
factants (Rosal et al., 2010), organic fluorinated chemicals (Boltes et al., 2012; Ro-
dea-Palomares et al., 2012), pesticides (Laetz et al., 2009), prescription drugs (Cleu-
vers, 2003) and antibiotics in particular (Eguchi et al., 2004; Gonzalez-Pleiter et 
al., 2013; Zou et al., 2013). According to these findings, toxicity increases by a 
factor of up to 6 for surfactants and up to 29 for organic fluorinated chemicals. 
Due to the obvious potential of synergistic effects, Laetz et al. (2009) proposed 
the introduction of safety factors to ensure the protection of aquatic organisms. 
Hereby, the adequate consideration of different groups of substances calls for a 
differentiated approach that addresses the synergistic potential of each one of 
them. 
Pharmaceuticals are of special importance due to their vast application in urban 
areas and their subsequent release from wastewater treatment plants along the em-
bankment line of natural water bodies (Michael et al., 2013). The high number of 
anthropogenic organic substances requires the knowledge development for a va-
riety of new synergistic combinations. For instance, antibiotics as a sub-group of 
pharmaceuticals are known to cause toxicological impacts on the fauna of natural 
water bodies (Kümmerer, 2009). Especially primary producers like photosynthetic 
aquatic organisms (Gonzalez-Pleiter et al., 2013) and bacteria (Backhaus et al., 
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2000) which inter alia constitute the basis for the aquatic biota were shown to be 
negatively affected by antibiotic mixtures. Similar effects have been observed for 
detrivorous macroinvertebrates (Maul et al., 2006) and plants (Brain et al., 2004). 
The studies demonstrate the importance of considering antibiotic mixtures as an 
integral component of an adequate risk assessment. Hence, the study focuses on 
the application of the interaction-based hazard-index (HIint) (EPA, 2000) to make 
a solid estimate on the possible synergistic potential of antibiotic mixtures. The 
method will be used to quantify the resulting risk for the case of the receiving river 
Elbe, Germany.  
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MATERIALS AND METHODS 
Predicted environmental concentration in the river Elbe 
The calculation of the predicted environmental concentration (PECAB) is based on 
in- and outpatient prescription data covering the catchment area of the wastewater 
treatment plant (WWTP) Dresden-Kaditz, Germany. The use of information on 
nationwide productions, sales or prescriptions is an often used method to estimate 
the PECAB in WWTP effluents and receiving streams (Bendz et al., 2005; Choi et 
al., 2008; Gobel et al., 2005). Ambulant prescription data for the time period under 
investigation (2005 – 2011) were provided by the statutory health insurance com-
pany AOK PLUS. About 41 % of the people of Dresden are insured at the AOK 
PLUS. It is assumed that the prescription data of AOK-insured people can be 
extrapolated to the entire catchment area of the WWTP and to all respective in-
habitants. Furthermore, it is accepted that insurants of private health companies, 
which hold a share of about 10 % of the total inhabitants, receive the same type 
and amount of antibiotics as those being statutorily insured.  Antibiotic consump-
tion data were also provided by the three major hospitals covering about 65 % of 
hospital beds available in the catchment area of the WWTP. The 15 most pres-
cribed antibiotics in Dresden were chosen for this study and are listed in Table 1. 
The substances ofloxacin and levofloxacin are racemats and were considered as 
one substance. The total class coverage in Table 1 refers to the ratio between in-
cluded and total antibiotic loads within one therapeutic class. This means, for 
example, that all cephalosporins listed in Table 1 represent 91 % of all prescribed 
cephalosporins antibiotics, whereas the remaining cephalosporins (cefpodoxime, 
ceftibuten, loracarbef, cephalexin and ceftriaxone) hold a minor share of only 9 % 
of the total cephalosporin load.  
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Table 1: Prescription data of investigated antibiotics 
Antibiotic 
Therapeutic class Ambulant 
prescription 
in WWTP 
catchment  
(2005 – 
2011) [kg/a]1 
Share 
in 
grou
p 
Total 
class 
cover-
age 
Name Abbrev. 
Cefadroxil Cephalosporin (1. generation) CE 9.7 ± 1.6 2 % 
91 % 
Cefuroxime Cephalosporin (2. generation) CE 309.2 ± 63.9 78 % 
Cefaclor Cephalosporin (2. generation) CE 25.8 ± 3.7 7 % 
Cefixime Cephalosporin (3. generation) CE 14.1 ± 2.3 4 % 
Clarithromycin Macrolide MA 83.3 ± 6.0 22 % 
82 % 
Azithromycin Macrolide MA 24.3 ± 1.7 6 % 
Roxithromycin Macrolide MA 23.1 ± 4.0 6 % 
Clindamycin Macrolide MA 179.8 ± 40.6 48 % 
Amoxicillin Penicillin PE 251.6 ± 23.6 42 % 
88 % 
Penicillin V Penicillin PE 282.4 ± 23.3 46 % 
Ciprofloxacin Quinolone QU 141.7 ± 6.4 55 % 
86 % 
Levofloxacin Quinolone QU 81.2 ± 7.5 31 % 
Sulfamethoxazole Sulfonamide SU 202.7 ± 23.4 100 % 
Doxycycline Tetracycline TC 43.2 ± 5.7 82 % 
Trimethoprim Diaminopy-rimidine DI 41.2 ± 5.0 98 % 
Antibiotics are partly eliminated during their passage through the human body. 
The main consecutive processes are adsorption by the gastric mucosa/gut and 
metabolism. The content that is not prone to adsorption is assumed to be excreted 
unchanged. The excreted ratio of the parent compound (EAB) can be calculated 
using equation 1,  
1 Kg/a – kilogram per year 
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)1()1( ,,, ABMABAABAAB fffE   (Equation 1) 
where fA,AB characterizes the antibiotic-dependent adsorption ratio in the human 
body. The parameter fM,AB describes the metabolized part of the adsorbed fraction. 
The necessary information is usually provided by the pharmaceutical industry and 
scientific literature (see supplementary material S1, annex 4).  
This study focuses on the parent antibiotics without taking into account metabo-
lites from human metabolism or environmental degradation processes. Recent in-
vestigations on sulfonamides (Gros et al., 2013), tetracyclines (Zhang et al., 2015), 
macrolides (Rossmann et al., 2014) and quinolones (Maia et al., 2014) included a 
variety of metabolites which reflects the current effort to consider those subs-
tances in mass flow analyses of sewer systems and WWTP. However, the scarcity 
of reliable information regarding the excretion, formation and ecotoxicity of most 
antibiotic metabolites hinders a comprehensive risk assessment including combi-
nation effects. 
After human excretion, antibiotics are prone to adsorption and degradation pro-
cesses in the sewer system (length approx. 1,700 km) and the WWTP. Those cha-
racteristics significantly differ among antibiotic groups. Penicillins are easily bio-
degradable due to cleavage of the beta-lactam ring and hence rarely found in the 
effluent of WWTP operating an activated sludge system or a fixed-bed filter (Wat-
kinson et al., 2007). Cephalosporins as a sub-group of penicillins, exhibit a higher 
persistence in raw wastewater and during the treatment processes. The macrolides 
azithromycin, clarithromycin and roxithromycin show highly variable elimination 
rates from - 45 to 55 % in conventional activated sludge systems with biological 
nitrogen removal (Gao et al., 2012; Goebel et al., 2007; Yan et al., 2014). Conside-
ring the uncertainties regarding macrolide’s elimination in WWTP, no degradation 
or accumulation processes will be considered in this study. The main removal 
route of tetracyclines and fluoroquinolones during the wastewater treatment is ex-
pected to occur via excess sludge withdrawal (Golet et al., 2003). There is no evi-
dence that tetracyclines are prone to biodegradation (Kim et al., 2005). Sulfona-
mides are partly removed in activated sludge systems and a fixed-bed filters whe-
reas sorption to sludge seems to be insignificant (Watkinson et al., 2007; Yang et 
al., 2005). A summary of the excretion and elimination rates applied in this study 
is provided as supplementary material S1 (annex 4). 
The PECAB at the mixing point of WWTP discharge and river Elbe was calculated 
using equation 2: 
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with the ambulant prescription data of Dresden (PAOK,Dresden,AB), the available hos-
pital prescription (Phospitals,Dresden,AB), the excretion ratio (EAB), the daily WWTP out-
flow of Dresden-Kaditz (QWWTP), the daily flow of the receiving stream Elbe 
(QElbe), the elimination during the wastewater treatment ( AB,Elimination), the share of 
insured inhabitants (41 %) and the share of hospital beds covered by the hospital 
prescription (65 %). In the region of Dresden, agriculture plays a minor role and 
antibiotic inputs originating from veterinary use are not expected. The WWTP has 
a design capacity of 740,000 population equivalents and treats wastewater of ap-
proximately 650,000 inhabitants plus industrial wastewater. The plant is operated 
as activated sludge process with biological nitrogen removal and chemical phos-
phorus precipitation. Due to missing data the antibiotic preload of the river Elbe 
prior to the WWTP discharge of the WWTP Dresden-Kaditz could not be consi-
dered in this study. The mean daily low flow of the river Elbe constitutes about 
102 m³/s (DWSO, 2014). 
Additivity-based and interaction-based Hazard Index (HIadd and HIint) 
The risk assessment of single substances is carried out using the quotient of PECAB 
and predicted no effect concentration (PNECAB, see supplementary material S2, 
annex 4). The resulting Hazard Quotient (HQ)  is based on the approach proposed 
by the European Chemicals Bureau (EU, 2003). Exceeding the threshold value of 
1 states a risk to the environment through the substance of interest. In order to 
assess the risk of more than one substance the hazard index (HIadd) is calculated 
by summing up the respective HQAB of the mixture under investigation. For the 
calculation of the hazard index the method of concentration addition is applied 
(equation 3) (EPA, 2000) which assumes similar toxicological relevance and ne-
glects synergistic or antagonistic effects.  
 ABadd HQHI (Equation 3) 
We define “synergistic” as amplifying effect and “antagonistic” as diminishing ef-
fect, compared to the reference of linear additivity. The complex composition of 
non-synthetic waters, e.g. effluents of WWTP, makes the development of reliable 
interaction studies nearly impossible. As a result, most investigations focused on 
binary interactions to gain a rough insight into risk drivers, in terms of substances 
provoking effects greater than additive. The US EPA therefore developed a 
procedure that includes interaction data from binary mixture experiments to mo-
dify HIadd in a manner that considers synergistic and antagonistic effects. The ap-
proach was developed for human health risk assessment and is based on earlier 
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investigations by Mumtaz and Durkin (1992) reflecting the significance of avai-
lable data as well as the composition of the mixture. The HIint uses the HQAB as 
basis and considers the relative toxic hazard of each substance (Exposure Factor 
F, see equation 5), the magnitude of interaction (M), the weight-of-evidence 
(WOE) as well as the degree to which two chemicals are present in equitoxic 
amounts (Weighting factor for relative proportions , see equation 6. The calcu-
lation of the HIint is given in equation 4: 
  
 




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
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int (Equation 4) 
with the exposure factor F: 
iadd
j
ij HQHI
HQ
F

 (Equation 5) 
and ij being defined as the ratio between the geometric and arithmetic mean: 
  2/HQHQ
)HQHQ(
ji
ji
ij 

 (Equation 6) 
Interaction Magnitude 
In order to carry out the interaction-based risk assessment the knowledge of the 
actual interaction magnitude is required. In this study a symmetric interaction ma-
gnitude is assumed, which means that the interaction effect of two substances is 
identical in either direction. 
The US EPA suggests a default value of M = 5 if no information on the specific 
components is available (EPA, 2000). The factor of M = 5 arises from a study on 
the joint action of 27 chemicals and their equivolume and equitoxic combinations. 
The factor of predicted to measured effect was in the range of 0.2 to 5.0, which 
indicates a deviation factor of 5 in either direction of interaction. Due to the fact 
that even more distinct interaction effects could be observed for other chemicals 
(EPA, 2000), literature data of binary antibiotic mixtures was explored to deter-
mine a specific interaction magnitude for antibiotics. Investigated antibiotics from 
literature partially differ from the targeted substances in this study. Therefore, all 
antibiotics are referred to their corresponding superior class to achieve a general 
picture on interactions between antibiotic classes. A total of 159 binary antibiotic 
interactions were found in 21 peer-reviewed publications. The provided data of 
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82 experiments are considered sufficient to determine the magnitude of synergistic 
or antagonistic interaction. 22 tested binary mixtures did prove to act neither grea-
ter nor lesser than additivity which equals a magnitude of 1. In literature, three 
parameters were applied to decide whether additivity can be accepted or not: 
1) Toxicity Units (TU): The concentrations of both substances conjointly cau-
sing 50 % inhibition are individually related to their corresponding median
effective inhibition concentration (EC50,AB). The sum of these two fractional
terms is defined as TU (formula see supplementary material S3, annex 4).
Synergy is expected for TU < 0.8 and antagonism for TU > 1.2. Within the
range of 0.8 < TU < 1.2 simple dose additivity is assumed (Broderius et al.,
1995).
2) Combination Index (CI): The CI is very similar to TU but is not solely defi-
ned for an inhibition of 50 %. Both substance concentrations which cause
x % effect in combination are individually related to their corresponding ef-
fect concentration representing an individual effect of x % (formula see
supplementary material S3, annex 4). The threshold value of 1 indicates an
additive effect while < 1 and > 1 characterize synergism or antagonism, res-
pectively. Notwithstanding the foregoing, for reasons of conformity the de-
cision criteria on synergistic effects for CI will be adapted from the TU ap-
proach.
3) Fractional inhibitory concentration (FIC): The definition of the FIC equals
the CI in terms of calculation and decision criteria (Berenbaum, 1978) using
the minimum inhibitory concentration of single and mixed drugs (see supple-
mentary material S3, annex 4). A synergy study between aminoglycosides and
cephalosporins based on the decision criteria of Berenbaum (1978) investi-
gated the reproducibility of the FIC (Hallander et al., 1982). The investigation
states as a result that a FIC below 0.75 indicates synergism which limits the
former criteria for synergism. Nevertheless, for reasons of comparability the
decision criteria for additivity, synergism and antagonism will also be adopted
from the TU.
According to (Zhao et al., 2010) and applying the adopted decision criteria pre-
sented above, the magnitude M will be interpreted as 1/TU for synergism 
(TU ≤ 0.8), TU for antagonism (TU ≥ 1.2) and a value of 1.0 for simple additivity . 
Weight-of-evidence (WOE) 
To decide whether synergistic or antagonistic effects are significant, the number 
of studies with similar results was evaluated. If the majority of results for one 
combination of antibiotic groups found in literature was synergistic or antagonistic, 
the drug combination was classified accordingly. Simple additivity was assumed 
for a specific antibiotic combination if 
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1) No information on binary interaction studies is available from literature
2) All available interaction studies collectively indicate simple additivity
3) There is an equal amount of investigations demonstrating synergism and an-
tagonism
The weighting was chosen on the basis of the weight-of-evidence classification 
proposed by US EPA (see Table 2). The classification between -1 to 0 and 0 to 1 
indicates effects lesser (antagonistic) and greater (synergism) than additivity, res-
pectively. Each direction of the classification consists of four categories and re-
flects the strength of evidence that two chemicals influence the toxicity of each 
other. The description of each category is provided in Table 2. The WOE is not 
intended to give evidence on the magnitude of interaction nor the relative amounts 
of substances in the mixture. It just reflects the data quality regarding the interac-
tion of two chemicals in mixtures. This study is based on a composition of litera-
ture data and assuming an unequivocal evidence of interaction (category I) is not 
appropriate. Hence, the use of the second WOE category is more suitable for this 
study. Accordingly, synergism, antagonism and additivity will be accounted for as 
0.75, -0.50 and 0.00, respectively (see Table 2). The applied comparison of inte-
raction studies can be adapted if more information on toxicological interactions 
become available (EPA, 2000). 
Table 2: Weight-of-evidence categories (adopted for environmental risk assessment) 
Category Description 
Direction 
Greater 
than 
additive 
Less than 
additive 
I 
The interaction has been shown to be 
relevant to the environment and the di-
rection of the interaction is unequivocal 
1.00 -1.00
II 
The direction of the interaction has 
been demonstrated and its relevance to 
the environment is likely 
0.75 -0.50
III 
An interaction in a particular direction 
is plausible, but the evidence support-
ing the interaction is weak 
0.50 0.00 
IV The assumption of additivity has been demonstrated or must be accepted 0.00 0.00 
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A second possibility of estimating the WOE between antibiotic classes is to use 
known interactions from human combination therapy (Karow and Lang-Roth, 
2013). Antibiotics can be classified into bactericidal and bacteriostatic substances 
(see Figure 1): bactericidal antibiotics will kill bacteria, whereas bacteriostatic com-
ponents will only inhibit bacterial growth. Bactericidal antibiotics can again be 
subdivided into components that will only kill bacteria during proliferation and 
degenerative bactericidal antibiotics that will destroy them under any condition. 
The combination of antibiotics with different modes of action can therefore have 
additive, synergistic and antagonistic effects. In case of combining two bactericidal 
components (groups I and II in Figure 1) the effect is additive or synergistic, since 
the degenerative substance will destroy non-proliferating bacterial forms while the 
other component will not. The combination of degenerative bactericidal antibio-
tics with bacteriostatic ones can be additive or antagonistic – an additive effect can 
be achieved by slowing down bacterial growth through the bacteriostatic compo-
nent and destroying them through the bactericidal one. However, due to the com-
petition between both substances, the combination is less effective than additive, 
i.e. the substances cannot develop their full individual potential. The combination
of a component that destroys only proliferating bacteria with one that inhibits
bacterial growth will definitely lead to an antagonistic effect and has to be avoided
in human combination therapy.
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Figure 1: Interaction of chemotherapy agents in combination therapy (adopted from Karow and Lang-
Roth, 2013) 
The antibiotic concentrations applied for the treatment of bactericidal infections 
in humans is several orders of magnitude higher than those found in the environ-
ment. For example, clindamycin reaches a plasma concentration of several mg/l 
after its application in humans (Pharma, 2012) whereas environmental concentra-
tion can be found in the ng/l range (Gonzalez-Pleiter et al., 2013). This concen-
tration difference can lead to an interaction effect that is deviating from what was 
shown for some binary mixtures of antibiotics at much higher concentrations 
(Gonzalez-Pleiter et al., 2013). Decrease of concentrations is assumed to cause the 
interaction effect to move either towards synergisms or towards antagonism, de-
pending on the antibiotics in mixture. Ultimately, no conclusive estimation can be 
drawn on the consequences of adopting the information of antibiotic interactions 
in human therapy for environmental concentrations. Hence, for the present the 
information given by Karow and Lang-Roth (2013) will be evaluated with the same 
degree of evidence as those provided by the studies on binary mixtures of antibio-
tics (Karow and Lang-Roth, 2013). The influence of different concentration 
ranges on the interaction effect will be topic in the discussion section. 
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RESULTS 
Additive Hazard Index HIadd in the receiving stream Elbe 
The HQ of all investigated antibiotics were merged to their respective antibiotic 
classes and summed up to calculate HIadd in the river Elbe (see Figure 2). The 
mean HIadd resulted in 0.37 whereas 20 % of all weeks exceed a HIadd of 0.5. HIadd 
above 0.8 were detected during 11 weeks (3 %) of all weeks only and the threshold 
value of 1 was reached only during 1 week in the 7 years examination period. 
Quinolones (41 %), cephalosporins (31 %) and macrolides (21 %) contribute the 
highest proportion to the overall risk. Tetracyclines and penicillins are well elimi-
nated during the wastewater treatment process and do not pose a hazard to the 
environment at the present concentrations. The hazard caused by sul-
famethoxazole and trimethoprim is irrelevant due to comparatively high PNECAB 
values and resulting low HQ. The corresponding PECAB of all antibiotics under 
investigation are provided as supplementary material S4. 
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Figure 2: HIadd in the receiving stream Elbe (MA – Macrolides, QU – Quinolones, TC – Tetracyclines, 
PE – Penicillins, CE – Cephalosporins, SU – Sulfonamides, DI – Diaminopyrimidines) 
Attention should be paid to the change of hazard distribution between antibiotic 
classes over time. From 2005 to 2011 the hazard share of the group of cephalos-
porins more than doubled from 20 to 45 %. Meanwhile macrolides and quinolones 
each lost about 10 % of their share in HIadd and hence became less important in 
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terms of hazard management. This instance highlights the fact that risk is cons-
tantly changing and acquires a continually recurring assessment. Despite the signi-
ficant changes in risk distribution the HIadd did not noticeably change over time. 
A sensitivity analysis shows that the doubling of cefuroxime prescriptions was 
compensated by a close-to-equivalent decrease of roxithromycin. Both antibiotics 
have similar PNECAB values (PNECCEF = 0.15 µg/l, PNECROX = 0.10 µg/l) and 
hence mutually compensate (see supplementary material S2, annex 4). 
Interaction Magnitude 
Table 3 gives an overview on the magnitude M of all possible binary combinations 
of antibiotic classes. In this context, the direction of interaction is not considered 
in M and will be discussed in the next section regardind the weight-of-evidence. 
From Table 3 it can be seen that 15 out of 28 possible class interactions are co-
vered by literature data of which two third are consolidated with more than 3 
investigations. Quinolones (QU, 48 studies), tetracyclines (TC, 47 studies) and ma-
crolides (MA, 41 studies) and penicillins (PE, 32 studies) are well investigated re-
garding binary interactions with at least 3 other antibiotic classes. The classes of 
diaminopyrimidines (DI, 18 studies), sulfonamides (SU, 14 studies) and cephalos-
porins (CE, 0 studies) are not well supported, in terms of synergy-studies covering 
a variety of other antibiotic classes. The scarcity of synergy data for cephalosporins 
is especially alarming since this antibiotic group is responsible for almost half of 
the entire risk in 2011 (45%, see 3.1) and synergistic effects will significantly in-
crease the actual hazard to the environment. 
Table 3: Magnitude of binary antibiotic interactions (mean/max values found in literature, number of 
studies is provided in brackets) 
MA12 QU12 TC12 PE12 CE12 SU12 DI12 
MA 1.8/2.1 (2) 
1.8/6.7 
(17) 
2.2/4.3 
(10) 
1.9/4.0 
(11) 
0.0/0.0 
(0) 
1.9/1.9 
(1) 
0.0/0.0 
(0) 
QU 1.8/6.7 (17) 
2.2/4.2 
(8) 
2.4/4.8 
(16) 
1.5/2.0 
(6) 
0.0/0.0 
(0) 
2.2/2.2 
(1) 
0.0/0.0 
(0) 
TC 2.2/4.3 (10) 
2.4/4.8 
(16) 
2.0/2.0 
(1) 
3.3/7.6 
(11) 
0.0/0.0 
(0) 
1.0/1.0 
(1) 
1.8/3.8 
(8) 
PE 1.9/4.0 (11) 
1.5/2.0 
(6) 
3.3/7.6 
(11) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
CE 0.0/0.0 (0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
SU 1.9/1.9 (1) 
2.2/2.2 
(1) 
1.0/1.0 
(1) 
0/0 
(0) 
0.0/0.0 
(0) 
1.0/1.0 
(1) 
4.1/6.3 
(10) 
DI 0.0/0.0 (0) 
0.0/0.0 
(0) 
1.8/3.8 
(8) 
0.0/0.0 
(0) 
0.0/0.0 
(0) 
4.1/6.3 
(10) 
0.0/0.0 
(0) 
12MA – Macrolides, QU – Quinolones, TC – Tetracyclines, PE – Penicillins, CE – Cephalosporins, 
SU – Sulfonamides, DI – Diaminopyrimidines 
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A mean and a maximum (worst case) magnitude of interaction were determined 
to consider the range of available data (see Table 3). Tetracyclines exhibit the 
highest interaction magnitudes of all antibiotic classes. In combination with qui-
nolones and penicillins a 4.8- to 7.6-fold increase in toxicity is observed. The inte-
raction magnitudes between combinations of macrolides, quinolones and penicil-
lins can be found predominantly in a moderate range between 1.5 and 1.9, while a 
maximum of 6.7 was identified. Various studies show that sulfonamides and dia-
minopyrimidine tend to significantly influence each other by an average factor of 
4.1, exhibiting a maximum magnitude up to 6.3. Besides, information on interac-
tions between sulfonamides and other antibiotic groups like macrolides, quino-
lones or tetracyclines are scarce und unreliable. For further calculations, the sce-
narios M1 = 2.7 and M2 = 7.6 will be examined. M1 is the mean of the individual 
values of all interaction studies, excluding results indicating additivity. M2 repre-
sents the maximum interaction value from the combination between tetracyclines 
and penicillins. The so-estimated magnitudes M1 and M2 agree well with results 
from the review regarding mixture toxicity studies between metals, pesticides and 
antifoulants (Cedergreen, 2014). The collected and evaluated magnitudes rarely 
exceed 10 and support the use of M2 being above the suggestion of the US EPA. 
Weight-of-evidence WOE of interaction scenarios 
Table 4 summarizes the number of available literature results and corresponding 
WOE (in brackets). Regarding literature results on binary antibiotic mixtures, evi-
dence is given for the combinations of tetracyclines – macrolides as well as cepha-
losporins – penicillins to exhibit a synergistic effect. In case of penicillins, two 
experiments (Ampicillin in combination with Cloaxillin and Penicillin) suggest an 
interaction greater than additive within this antibiotic group. Synergistic effects are 
also plausible for the combinations of macrolides – penicillins / cephalosporins, 
quinolones – tetracyclines / cephalosporins and sulfonamides – diaminopyrimi-
dines. An antagonistic effect is evidently expected for tetracyclines in combination 
with diaminopyrimidines, as well as for the combinations macrolides – quinolones 
and tetracyclines – penicillins. A simple additive effect is assumed for the combi-
nation between quinolones – penicillins. The scarcity of synergy-studies covering 
mixtures with cephalosporins and sulfonamides (+ diaminopyrimidines) was al-
ready mentioned. There is a strong need to fill this particular knowledge gap to 
improve the toxicological assessment of these antibiotic classes.  
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Table 4: Weight-of-evidence from literature data – scenario 1 (number of investigations resulting in 
synergism/antagonism/additivity; resulting WOE is provided in brackets) 
MA12 QU12 TC12 PE12 CE12 SU12 DI12 
MA 2/0/0 (0.75) 
7/9/5 
(-0.5) 
11/0/0 
(0.75) 
5/2/6 
(0.75) 
1/0/1 
(0.75) 
0/1/0 
(-0.5) 
0/0/0 
(0) 
QU 7/9/5 (-0.5) 
5/1/2 
(0.75) 
11/3/3 
(0.75) 
5/5/17 
(0) 
1/0/2 
(0.75) 
1/0/0 
(0.75) 
0/0/0 
(0) 
TC 11/0/0 (0.75) 
11/3/3 
(0.75) 
1/0/0 
(0.75) 
10/9/2 
(0.75) 
0/0/0 
(0) 
0/0/1 
(0) 
0/6/2 
(-0.5) 
PE 5/2/6 (0.75) 
5/5/17 
(0) 
10/9/2 
(0.75) 
2/0/0 
(0.75) 
2/0/0 
(0.75) 
0/0/0 
(0) 
0/0/0 
(0) 
CE 1/0/1 (0.75) 
1/0/2 
(0.75) 
0/0/0 
(0) 
2/0/0 
(0.75) 
0/0/0 
(0) 
0/0/0 
(0) 
0/0/0 
(0) 
SU 0/1/0 (-0.5) 
1/0/0 
(0.75) 
0/0/1 
(0) 
0/0/0 
(0) 
0/0/0 
(0) 
0/0/2 
(0) 
7/3/6 
(0.75) 
DI 0/0/0 (0) 
0/0/0 
(0) 
0/6/2 
(-0.5) 
0/0/0 
(0) 
0/0/0 
(0) 
7/3/6 
(0.75) 
0/0/0 
(0) 
The instruction for the antibiotic combination therapy (Figure 1) is partially con-
trary, in terms of effect interaction between antibiotic classes. In order to cover 
the entire range of possible interactions (between groups I + II and II + III) a 
synergistic and an antagonistic scenario will be investigated. The synergistic sce-
nario (scenario 2s) will consider the synergistic effects between groups I + II and 
between groups II + III. The antagonistic scenario (scenario 2a) considers an ad-
ditive effect between groups I + II and an antagonistic effect between groups 
II + III. All antibiotic classes within one group are supposed to interact additively. 
As in the case of scenario 1 synergism, antagonism and additivity will be accounted 
for as 0.75, -0.50 and 0.00, respectively. A summary of the corresponding WOE 
is given in Table 5. 
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Table 5: Weight-of-evidence of scenarios 2s/2a 
MA12 QU12 TC12 PE12 CE12 SU12 DI12 
MA 0.00/ 0.00 
0.75/ 
-0.50
0.00/ 
0.00 
-0.50/
-0.50
-0.50/
-0.50
0.00/ 
0.00 
0.00/ 
0.00 
QU 0.75/ -0.50
0.00/ 
0.00 
0.75/ 
-0.50
0.75/ 
0.00 
0.75/ 
0.00 
0.75/ 
-0.50
0.00/ 
0.00 
TC 0.00/ 0.00 
0.75/ 
-0.50
0.00/ 
0.00 
-0.50/
-0.50
-0.50/
-0.50
0.00/ 
0.00 
0.00/ 
0.00 
PE -0.50/-0.50
0.75/ 
0.00 
-0.50/
-0.50
0.00/ 
0.00 
0.00/ 
0.00 
-0.50/
-0.50
0.00/ 
0.00 
CE -0.50/-0.50
0.75/ 
0.00 
-0.50/
-0.50
0.00/ 
0.00 
0.00/ 
0.00 
-0.50/
-0.50
0.00/ 
0.00 
SU 0.00/ 0.00 
0.75/ 
-0.50
0.00/ 
0.00 
-0.50/
-0.50
-0.50/
-0.50
0.00/ 
0.00 
0.00/ 
0.00 
DI 0.00/ 0.00 
0.00/ 
0.00 
0.00/ 
0.00 
0.00/ 
0.00 
0.00/ 
0.00 
0.00/ 
0.00 
0.00/ 
0.00 
Both scenarios 2s and 2a indicate antagonistic effects between penicillins – ma-
crolides / tetracyclines, as well as between macrolides – cephalosporins which is 
contrary to scenario 1. Except for the latter combination all WOE of binary mix-
tures between macrolides, quinolones and cephalosporins in scenario 1 are co-
vered by scenario 2s or 2a, respectively.  
Distribution pattern and magnitude of HIint 
In the previous section, it becomes obvious that only a certain fraction of the 
considered mixture is affected by effects greater or lesser than additivity. Hence, 
the distribution of hazard-inducing antibiotic groups and subsequent risk mana-
gement strategies may be subject to changes, depending on which interaction sce-
nario  
(1, 2a, 2s) is applied. In the following, the actual consequence of applying different 
WOE to the variety of binary antibiotic combinations will be determined to pro-
vide information on the robustness of the approach. 
In Figure 3 the hazard distribution of antibiotic classes is depicted for the refe-
rence condition HIadd and the three investigated scenarios of HIint. The distribu-
tion between antibiotic classes is also influenced by the interaction magnitude M. 
The influence is shown by plotting the range between 2.7 and 7.6 (M1 and M2) as 
error bars. The reference condition of HIadd was already described in 3.1. In sce-
nario 1, the contribution of macrolide antibiotics to HIint is lowered by 4 to 6 % 
for the share of cephalosporins (+ 4 to 5 %) which became nearly as important as 
quinolones. The HI of quinolones in turn remained nearly constant. Penicillins, 
sulfonamides and diaminopyrimidines did negligibly drop in terms of their in-
volvement in the environmental hazard. The two scenarios 2s and 2a show to be 
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rather similar to scenario 1. The former differs slightly due to a lower share of 
cephalosporins and the highest share of quinolones. Overall, it can be concluded 
that no major changes in hazard distribution were induced by the HIint approach, 
inasmuch as – despite the relative changes – the priority ranking remains the same. 
All changes of shares to HI were estimated to be well below 10 %.  
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Figure 3: Hazard distribution of HIadd and HIint-scenarios 1, 2s and 2a (error bars represent the varia-
bility due to applied interaction magnitudes M1 and M2) 
Between the absolute values of HIadd and HIint,n (n=1,2s,2a), a quasi-linear rela-
tionship was observed (see Figure 4). Scenario 1 (HIint,1) which is based on litera-
ture data was plotted against HIadd and results in a hazard increase of 50 % (R2 = 
0.9967) and 198 % (R2 = 0.9886), respectively, depending on whether M1 or M2 is 
applied (see dots and triangles in Figure 4). The unevenly changing amounts of 
antibiotics (see Figure 2) do not essentially lead to a pronounced scatter in linearity. 
Hence, a linear approximation passing through the origin of the diagram seems 
feasible. The use of linear factors is practical to describe the order of magnitude 
HIint differs from HIadd and will be applied for the evaluation of scenarios 2a and 
2s.  
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Figure 4: Relationship between HIadd and HIint for the scenarios 1, 2s and 2a considering the selected 
interaction magnitudes M1 and M2 
The approximated straight lines of scenarios 2s and 2a (HIint,2s and HIint,2a) were 
connectedly plotted to depict the scenario-induced span of possibilities these ap-
proaches entail (see Figure 4). In case of M1 (light grey), which states a solid esti-
mate of the average interaction magnitude of antibiotics, the antagonistic scenario 
2a falls close to the linear attenuation of the additivity-based approach HIadd. In 
case of a completely additive or antagonistic behavior between the antibiotic 
groups I + II and II + III, respectively (see Figure 3), the HIint,2a(M1) diminishes 
the risk by 16 %, compared to HIadd. The maximum interaction magnitude M2 of 
7.6 (dark grey) leads to a reduction of even 26 % (HIint,2a(M2)). Considering the 
synergistic scenario 2s the worst case constitutes an additional increase in hazard 
of 168 %, referring to M2. Applying M1, HIint,2s(M1) raises the risk by about 50 %. 
From Figure 4 it can be seen that the synergistic scenario 2s arising from human 
combination therapy is well supported by scenario 1, both suggesting an increased 
environmental hazard between 50 and 200 % as compared to the additive ap-
proach.   
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DISCUSSION 
Targeted organisms and concentration range 
Two factors are considerably influencing the results of this approach dealing with 
the inclusion of synergistic effects in risk assessment: the diversity of tested orga-
nisms and the range of applied test concentrations. Literature on antibiotic mix-
tures mainly covers bacteria as test organism, due to the fact that antimicrobials 
specifically target this group of organisms. In contrast, the classical environmental 
risk assessment is based on the sensitivity of standard organisms like fish, daphnia 
and algae. Regarding the toxic effect of antibiotic mixtures, only the latter two 
were investigated so far. A total of 47 investigations were carried out with the non-
target organisms algae (Pseudokirchneriella subcapitata, Selenastrum capricornu-
tum) and crustacean (daphnia magna). On the other hand, investigations were car-
ried out on a great variety of pathogenic bacteria (67 investigations) and two non-
pathogenic bacteria (46 investigations), which also clearly demonstrates the divi-
sion into clinical and environmental research purposes. With respect to the signi-
ficance of this approach, the high share of environmentally relevant organisms 
(58 %) justifies this data set to be valid as a basis for a general statement on binary 
mixtures causing synergistic effects in the environment. An overview of tested 
organisms and antibiotic combinations can be found as supplementary material S5 
(annex 4). 
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Figure 5: Concentration range of binary antibiotic interaction experiments among investigated groups 
of organisms 
Based on the calculated PECAB, environmental concentrations in the Elbe can be 
found up to 100 ng/l (see supplementary material S4, annex 4), which is in the 
range of previously published data (Gonzalez-Pleiter et al., 2013). The majority of 
investigations regarding binary interactions of antibiotics were carried out at con-
centrations above 100 µg/l and up to 10 g/l (see Figure 5). Some results on algae 
(Chalkley and Koornhof, 1985; Gonzalez-Pleiter et al., 2013; Yang et al., 2008) 
and pathogenic bacteria (Gradelski et al., 2001; Olajuyigbe, 2012) are found below 
100 µg/l and can be considered environmentally relevant. Nevertheless, it must 
be questioned if the number of investigations above 100 µg/l constitute a reliable 
data base.  
Concerning a projection to environmentally relevant concentrations, the ratio of 
investigations which result in synergism related to the total number of investiga-
tions per concentration range shows a decreasing tendency with increasing con-
centration (see supplementary material S6, annex 4). In this context, it must be 
concluded that lower concentrations increase the probability of synergistic inte-
ractions between antibiotics. If this thesis is correct, adjustments of the present 
approach will be necessary to display environmentally relevant results. In this con-
text, a few specific investigations cover the issue of the concentration dependency 
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of mixtures between heavy metals (Rodea-Palomares et al., 2009), pesticides (Laetz 
et al., 2009), antibiotics (Gonzalez-Pleiter et al., 2013) and surfactants (Rosal et al., 
2010). The majority of the presented results are contrary to the thesis stated above 
and dependency is either directly proportional or non-existent. Nonetheless, in 
case of antibiotics and surfactants a few results support inverse proportionality 
showing an increase of synergism with decreasing concentration. Based on the 
Combination Index CI, the presence of both antibiotics tetracycline and erythro-
mycin potentiated the effect on Pseudokirchneriella subcapitata and Anabaena 
CPB 4337 with decreasing concentration. The susceptibility of Anabena CPB 4337 
also increased at lower concentrations of tetracycline-levofloxacin and 2,4,6-tri-
chlorophenol-triclosan mixtures. The same behavior was observed for Pseudokir-
chneriella subcapitata being exposed to a mixture consisting of docusate and 2,4,6-
trichlorophenol (Rosal et al., 2010), as well as a mixture consisting of 12 antimi-
crobial agents (Yang et al., 2008). In summary, Anabaena CPB 4337 and Pseu-
dokirchneriella subcapitata showed increasing synergism inversely proportional to 
the applied concentration in 3 out of 15 and 2 out of 11 investigated mixtures, 
respectively. The results of investigations on vibrio fisheri do not give evidence 
on an indirect proportional relationship between decreasing concentration and a 
higher incident of synergism (Gonzalez-Pleiter et al., 2013; Rosal et al., 2010).  
Due to the fact that the results regarding the concentration influence on synergism 
depend on the targeted organism as well as the combination of substances, no 
general statement can be made from the available information for a mixture con-
sisting of multiple antibiotics. The results presented in 3.4 cannot be reasonably 
adapted to real environmental conditions. Hence, the findings of the literature 
research on binary mixtures and human combination therapy must be accepted to 
reflect the current state of knowledge. 
Quantity of binary mixture data 
The applied criteria to decide whether synergism or antagonism is predominating 
a certain mixture strongly depends on the total number of investigations (N) and 
the absolute difference between results indicating either one of the effect direction 
(D). If just a few studies support the occurrence of a certain effect, they only re-
flect a limited view on the concentration range and/or the variety of organisms. 
In consequence, only a minor statistical significance can be expected from these 
results (i.e. mixture between cephalosporins and macrolides). On the other hand, 
a high number of diverse investigations (i.e. mixture between penicillins and te-
tracyclines) also increases the uncertainty. In both cases the inclusion of a few new 
results can turn around the interaction direction and lead to results different from 
those presented in this study. In order to determine the robustness of the present 
data set on binary mixtures, a sensitivity analysis was performed. Therefore, the 
minimum number of investigations (N) and the required difference in number of 
investigations indicating synergism and antagonism (D) were independently varied 
from 1 to 5. In case of meeting both of the predetermined conditions, the WOE 
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was applied as presented in Table 4. If one of the conditions was not fulfilled, a 
WOE of 0 is applied due to ambiguity, indicating simple additivity.  
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Figure 6: Sensitivity analysis on the HIint/HIadd of scenario 1 (M2 = 7.6) regarding the total number of 
available investigations (N) and the minimum difference in number of investigations indicating syner-
gism and antagonism (D) 
In Figure 6 the data set’s sensitivity to preconditions (scenario 1) regarding a re-
quired minimum of data quantity N is depicted for M = 7.6. Assuming that 
D ≥ 1 is sufficient to take an adequate decision, the HIint/HIadd-ratio, as presented 
in 3.4, is significantly reduced demanding a minimum total data quantity of N = 3 
and N = 4 interaction studies per mixture. At this preconditions high-impact sy-
nergy combinations like cephalosporins – macrolides and cephalosporins – qui-
nolones do not longer have a share in determining HIint, respectively, which leads 
to the significant decrease. Demanding a minimum D of 2, 3 or 4 results in an 
attenuated HIint/HIadd ratio of around 1.5, which also leads to ignoring the above 
stated high-impact synergy combinations. Increasing D up to 5 leads to a further 
decrease down to about 1.2, due to the insignificance of the synergistic combina-
tions among quinolones and between diaminopyrimidines and sulfonamides. Ac-
cordingly, applying M = 2.7 results in HIint/HIadd-ratios between 1.1 
(N ≥ 3, D ≥ 5) and 1.2 (N ≥ 3, 2 ≤ D ≤ 4). The sensitivity analysis clearly de-
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monstrates the decision criteria’s fragility on which the quantification of this ap-
proach is based. In the present study, accepting D equal to one leads to an exagge-
rated HIint-value picturing an extreme scenario of synergistic interactions between 
antibiotics. To reduce the dependency on uncertain data, D ≥ 3 should be applied 
for a more grounded estimation of HIint. The number of interaction studies N 
does not significantly influence the results for D ≥ 3 and hence is of minor im-
portance. Nevertheless, for integrity reasons a minimum number of 5 investiga-
tions (N ≥ 5) seems to be suitable for quantifying the change in hazard due to 
synergistic and antagonistic effects in antibiotic mixtures. This proposal is based 
on the data set for antibiotics and its validity needs to be confirmed for other 
chemical mixtures. 
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CONCLUSIONS AND SUMMARY 
The interaction-based hazard index (HIint) proposed by the US EPA was applied 
for antibiotics to evaluate and quantify possible interaction effects greater or lesser 
than additivity. Scenario 1, which is based on binary antibiotic mixture experi-
ments using different organisms was confirmed by the synergistic scenario 2s 
which was derived from known synergistic and additive interactions of antibiotic 
groups from human combination therapy. Accordingly, it can be concluded that 
antibiotic mixtures tend to exhibit a synergistic overall effect. Compared to the 
classic HIadd approach an increased risk is expected. The sensitivity analysis on the 
available data quantity and its consistency provides the necessary evidence to re-
liably estimate the level of risk increase that is induced by synergism, based on the 
current state of available information. Applying a mean magnification factor of 
2.7, which stands for a consolidated risk assessment, leads to a risk increase of 
about 20 %. An increase up to 50 % was determined if carrying out a worst-case 
risk assessment using the maximum determined magnitude of 7.6. Here it must be 
noted that high-impact synergy combinations like cephalosporins – macrolides 
and cephalosporins – quinolones were not included due to data scarcity. Further-
more, limited information on the amount and ecotoxicity of antibiotic metabolites 
resulted in the exclusion of this group of possible risk inducing substances. Provi-
ding information on high-impact synergy combinations and metabolites is essen-
tial to consolidate the findings of this study and to assess the overall risk induced 
by the application and release of antibiotics.  
Applying the risk increase of 50 % to the situation of the Elbe river, it can be 
stated that the threshold value of HI ≥ 1 is exceeded during 25 weeks (rather than 
1 week applying HIadd) during the examined 7 years period. Due to this alarming 
influence more toxicologic investigations are necessary to further improve the ro-
bustness of the estimation on synergistic effects in the environment. In case of 
antibiotics, investigations should focus on binary combinations between macro-
lides, quinolones and cephalosporins in particular. The toxicologic set-up should 
definitely include varying concentrations down to the µg/l or even ng/l range, in 
order to additionally assess its influence on synergy-drifts.  
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Results and conclusions 
INDIVIDUAL RESULTS 
The first paper broaches the issue of adequacy applying a projection approach 
using prescription data to determine the influent loads of antibiotics to a WWTP 
(Marx et al. 2015d). The precise knowledge on in- and effluent loads of WWTP is 
the prerequisite to estimate predicted environmental concentration and hence to 
carry out a reliable risk assessment. The investigation focuses on uncertainties con-
cerning a variety of necessary assumptions and the accuracy of expected input 
loads. Several antibiotics with and without seasonal influence were well recovered, 
i.e. the overall mass balance lies within an acceptable range, confirming the general
suitability of the applied approach. As expected, antibiotics with low stability in
raw wastewater (e.g. beta-lactams) exhibited a poor recovery at the WWTP inflow.
The input variation of fluoroquinolones was unexpectedly high and an adequate
seasonal prediction on the basis of the available prescription data is not possible.
In this context, the assumption of an equal prescription practice in hospitals with
different structures and core areas, the non-compliance in the use of antibiotics as
well as delay and remobilization during the transport in the sewer system must be
discussed in future research. Apart from the annual input variation, the mean re-
covery of fluoroquinolones was found to be significantly lower than expected. An
insufficient analytical determination with an incomplete detection of the adsorbed
fraction was suggested to be partly responsible for this unsatisfying recovery. In
addition to the comparison between predicted and measured input loads, measu-
ring data were also used to estimate the necessary sampling quantity in case no
prescription or similar input data are available. As a result, it was proposed that a
minimum of 20 to 40 samples is necessary to capture seasonal input dynamics of
antibiotics and indicatively monitor influent (and effluent) loads of WWTPs. With
respect to the verified model and the available amount of data, the recommended
sample quantity can be considered generally valid for WWTP monitoring pro-
grams. In this context, it is advised to carry out additional experiments to prove
the suitability of the applied analytical method and to determine correction factors,
if necessary.
The second paper is based on long-term WWTP monitoring (12 months) and 
provides information on the removal efficiency of antibiotics and respective in-
fluencing factors regarding WWTP operations (Marx et al. 2015a). The applied 
evaluation of gapless time series generated robust elimination values, but no signi-
ficant dependency between the removal of most antibiotics and operation para-
meters were identified. As an exception, clindamycin influent concentrations were 
inter alia correlated to the WWTP inflow, which led to the presumption of an 
existing but unknown transformation product in the raw wastewater. The 
subsequent re-transformation to the parent substance during the wastewater 
treatment equals the previously calculated “production” of clindamycin and sup-
ports the suggested transformation model. Concerning the MFA within the urban 
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wastewater system, no net removal of excreted clindamycin can be identified. 
Furthermore, the removal of clindamycin and ciprofloxacin seems to depend on 
the sludge retention time as well as the treatment temperature. A clear differentia-
tion between both parameters was not feasible due to changing operation regimes 
of the WWTP. The subsequently performed MFA gives evidence on the fate of 
antibiotics during biological wastewater treatment, pointing out the partial fragility 
of available information. In this context, the fate of ciprofloxacin and levofloxacin 
in the solid phase cannot be reliably assessed and the influence of possible degra-
dation processes during the wastewater and sludge treatment remains unclear. The 
majority of antibiotics could be well described according to their fate during the 
treatment process of the WWTP 
How to prioritize antibiotics according to their environmental relevance is subject 
of the other two papers, which deal with risk assessment strategies at the examples 
of the WWTP effluent and the receiving stream, respectively. The third paper 
thereby addresses the species order according to their impact on the remaining 
food chain in combination with their specific susceptibility towards antibiotics 
(Marx et al. 2015c). Comparing toxicological investigations of antibiotics, diffe-
rences according to the sensitivity ranking of standard species could be observed. 
The interference of lower-tier species causes damage propagation and leads in all 
probability to a weakening of higher-tier species due to the reduction of available 
food sources. Hereby, the classification of first-order priority substances was in-
troduced to consider inconsistencies between the ranking of aquatic organisms in 
the food chain and their sensitivity towards antibiotics. The antibiotics cipro-
floxacin, azithromycin and roxithromycin are the main disruptors for algae and 
considered to be first-order priority substances, while clarithromycin is mainly res-
ponsible for the risk towards crustaceans. In addition to investigating the risk dis-
tribution among species, available toxicological data were used to replace the 
simple linear dose-effect-relationship by a sigmoidal curve, which is more appro-
priate concerning this matter. The resulting attenuated risk reflects the range of 
tested concentrations and represents the variety of all investigated organisms.   
The fourth paper deals with antibiotic mixtures and the consideration of synergis-
tic and antagonistic effects (Marx et al. 2015b). The impossibility of practically 
testing the entire existing range of antibiotic combinations, including different 
concentration ranges, calls for a substantiated estimation of their effects. The in-
teraction-based hazard index, which was proposed by the Environmental Protec-
tion Agency of the United States (EPA 2000), relies on binary interaction studies 
and considers several interaction characteristics like the magnitude of interaction 
or the weight-of-evidence. The results indicate an overall synergistic behavior of 
the considered mixture consisting of 15 antibiotics. Accepting a set of defined 
quality requirements regarding the available data, a risk increase of 20 to 50 % is 
expected, compared to the classical risk assessment applying simple concentration 
addition. Including the data of antibiotic combinations which do not yet meet 
the quality requirements (e.g. low data quantity) indicate environmental risks up to 
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300 % higher than the classical assessment approach. The results clearly highlight 
the necessity of including the synergistic potential of antibiotics to make solid 
estima-tions of the environmental risk. The increase of available binary 
interaction studies between antibiotics will be crucial to consolidate the 
determined results and pro-vide detailed information on antibiotic combinations 
causing the highest risk in-crease. 
AGGREGATION OF RESULTS 
The developed model for the comparison of predicted and measured input loads 
constitutes the basis of the environmental risk assessment based on secondary 
input data. The model verification for recalcitrant antibiotics was qualitatively car-
ried out by means of laboratory experiments, considering probable uncertainties 
of the analytical approach. The high predictive quality of antibiotics with (azithro-
mycin, clarithromycin, roxithromycin) and without (trimethoprim) seasonal varia-
tions justifies a general acceptance of the developed model. The verified model is 
hence suitable to integratively investigate the behavior of degradable and adsorb-
able antibiotics, which exhibit low recovery rates at the WWTP input, and draw 
conclusions on their fate within the urban wastewater system.  
The sensitivity of antibiotics to abiotic and biotic degradation limits the accurate 
prediction of their input loads to the WWTP, but can provide first information on 
their possible fate in the environment. The good biological availability of some 
degradable antibiotics suggests a (nearly) complete disappearance after the biolog-
ical treatment in the WWTP, resulting in further attenuated concentrations in the 
receiving water body. For example, the beta-lactam antibiotics penicillin V and 
cefotaxime exhibit a low recovery rate at the WWTP input and a predominantly 
complete elimination during the biological wastewater treatment, which complies 
well with the above interpretation. There are, however, other antibiotics with low 
recovery values at the WWTP input but significant concentrations in the WWTP 
effluent. Sulfamethoxazole, cefuroxime and piperacillin were shown to be de-
gradable in raw wastewater, but it remains unclear why the elimination process 
remains incomplete during the biological wastewater treatment. The conducted 
mass flow analysis reveals, that only a minor fraction of the total input load is 
bound to sludge. This suggests, that mainly degradation processes are responsible 
for the partial removal during the wastewater treatment, rather than sorption pro-
cesses. In addition to biodegradation, several studies also proved hydrolysis to be 
a relevant removal pathway for beta-lactams under typical pH and temperature 
conditions (Mitchell et al. 2014, Zhao et al. 2012), whereas the impact on sulfon-
amides was comparatively low (Loftin et al. 2008). These studies indicate, that 
hydrolysis as well as biodegradation must be considered as possible degradation 
processes. However, the discerning of abiotic and biotic degradation is rather 
speculative on the basis of monitoring data and hence were not carried out within 
the context of this work.  
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The mass flow analyses of ciprofloxacin and levofloxacin indicate, that about 
200 % of the measured input load was found in the two output streams effluent 
plus digested sludge. Referring to the projected input load based on prescription 
data as well as considering a low to moderate elimination during the anaerobic 
sludge treatment, the estimated input load and the sum of both output streams are 
actually well comparable. On one hand, this finding supports the assumption of 
an inadequate analytical method regarding adsorbable compounds and/or an in-
sufficient sampling strategy at the WWTP input, respectively. On the other hand, 
the constant removal rate during periods with high loads of ciprofloxacin and 
levofloxacin also indicate the simultaneous and proportionate increase of the ef-
fluent concentration, which is, compared to the influent, nearly free of particulate 
matter. Hence, an erroneous analytical method, as supposed in Marx et al. 2015a 
and Marx et al. 2015d, cannot be solely responsible for the input (and output) load 
fluctuations. It is rather likely that sampling and the projection model are the main 
sources of errors in this context, even though if it is not certain at which point.  
Concerning the environmental risk, ciprofloxacin, levofloxacin and the group of 
cephalosporins significantly affect the aquatic environment. They either have the 
highest impact on (one of) the lowest trophic level(s) or disproportionately in-
crease the ecotoxicological risk due to their synergistic characteristics. In this re-
gard, the deficiencies regarding the input prediction of these antibiotics is of par-
ticular concern. Measurements suggest significantly higher fluctuations, along with 
higher load peaks, compared to the estimated input loads using the prediction 
model. The underestimation of such critical mass flow conditions weakens the 
approach of assessing environmental risks on the basis of secondary data like pre-
scriptions. Hence, efforts must be made to further develop the projection model 
by improving the quality of secondary data, identifying additional emitters and 
understanding possible retention and degradation dynamics of antibiotics within 
the sewer system. 
FINAL CONCLUSIONS 
The prediction and projection model in combination with the conducted MFA are 
suited to estimate urban antibiotic emissions into the environment. However, the 
lack of critical information regarding the genesis of secondary data as well as the 
possibility of additional unidentified inputs partly limits their reliable estimation 
for short time periods, i.e. seasonal fluctuations Table V.1 presents a qualitative 
summary of the predictability of antibiotic emissions, covering the input recovery 
at the WWTP as well as the removal from the liquid phase during biological 
wastewater treatment. In combination with the prioritization of antibiotics accord-
ing to their ecotoxicological relevance, it becomes obvious, that 4 out of 7 identi-
fied risk drivers cannot be adequately estimated on the basis of prescription data 
(see Table V.1, highlighted in dark grey). In any case, emission dynamics of un-
predictable risk-drivers require measurements to capture load peaks and draw re-
liable conclusions on the resulting acute ecological impact. In contrast to the pro-
posed sampling quantity regarding the indicative input measurements at WWTP, 
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about 30 to 80 samples per year are necessary to solidly estimate weekly fluctua-
tions of the identified unpredictable risk-drivers. If verified in advance, antibiotic 
prescription data can be used to predict environmental loads of risk-drivers, as it 
is the case for investigated macrolides. Moreover, the identification of macrolides 
being risk-drivers is consistent with their inclusion in the European watch-list for 
substances that may pose a significant risk to or via the aquatic environment at 
Union level (EU 2015). 
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Table 1: Qualitative classification of investigated antibiotics regarding input predictability, WWTP re-
moval and ecotoxicological relevance for the aquatic environment (without highlight – not identified as 
risk-driver; highlighted in light grey – predictable risk-driver; highlighted in dark grey – unpredictable 
risk-driver; n.a. – not assessed) 
Compartment 
1 2 3 
Estimation of 
seasonal  
input  
recovery 
Estimation of 
annual  
input  
recovery13 
Estimation of 
removal from 
liquid phase 
Categoriza-
tion  
as risk- 
driving  
antibiotic 
Amoxicillin n.a. possible possible no 
Azithromycin possible possible possible yes 
Cefotaxime possible possible not possible yes 
Cefuroxime not possible possible possible yes 
Ciprofloxacin not possible possible possible yes 
Clarithromycin possible possible possible yes 
Clindamycin n.a. possible possible no 
Doxycyclin not possible not possible not possible no 
Levofloxacin not possible possible possible yes 
Penicillin V n.a. n.a. possible no 
Piperacillin n.a. possible possible no 
Roxithromycin possible possible possible yes 
Sulfamethoxazole possible possible possible no 
Trimethoprim possible possible possible no 
In the context of fate characterization during biological wastewater treatment, a 
number of aspects remain to be dealt with. Until proven otherwise, the close-to-
13 In combination with additional experiments regarding initial recovery and degradation of antibiotics in raw 
wastewater 
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constant removal rate along the year, which was determined for the majority of 
antibiotics, is still strictly limited to the investigated WWTP Dresden-Kaditz. The 
presented results must be confirmed by investigations similar in scale and process 
configuration (see Marx et al. 2015a). The integration of further plant configura-
tions (probably) allows the distinction of state-of-the-art technologies according 
to their effectiveness in removing antibiotics. Such information can be valuable 
criteria for future plant planning. Furthermore, evaluating the sludge path of anti-
biotics is still very imprecise due to highly varying outcomes. It remains unclear to 
what extent load dynamics caused by sorption and desorption processes are re-
sponsible for the observed inconsistencies. With regard to the close-to-constant 
removal from the liquid phase in combination with the comparable insignificance 
of process conditions typically influencing sorption processes (pH, temperature), 
the adsorbed amount of antibiotics is expected to be mainly influenced by the 
influent load. The interpretation of results should be verified in future investiga-
tions focusing on long-term behavior of antibiotics in WWTP sludge. 
Apart from antibiotics regularly entering the WWTP, emissions from combined 
sewer overflows must be part of future investigations regarding the assessment of 
environmental risks. About 10 % of the annual urban load of Dresden is intermit-
tently released during only a limited number of combined wastewater discharges 
(Marx and Kuehn 2015). Low wastewater dilution at the beginning of such dis-
charge events results in increased emission loads, which are expected to have the 
potential to induce acute ecotoxicological effects in the receiving water. Hence, 
future efforts should be made to develop appropriate sampling and evaluation 
techniques to quantify antibiotic loads from combined wastewater discharges and 
draw conclusions on the resulting acute impact on the aquatic environment.  
The presented risk assessment approaches provide valuable additional infor-
mation and alternative aspects to classical risk assessment methods, with the ob-
jective of prioritizing antibiotics according to their manifold impact on the envi-
ronment. Both studies reveal a significant lack of toxicity data, in connection with 
only a few types of investigated bacteria, which impairs their comprehensive eval-
uation. In addition to the testing of the activated sludge biocenosis, a total of 
2 - 5 different types of environmental bacteria were investigated, respectively, re-
garding mixture and single toxicity. The reason for the low number of tested bac-
teria can be found in the EMA-guideline, recommending standard organisms like 
algae, daphnia and fish for ecotoxicity studies of medical products for human use 
(EMA 2006). This recommendation originates from testing industrial chemicals 
and appears not fully applicable to substances with specific target organisms, like 
antibiotics (Agerstrand et al. 2015). Hence, the necessary consideration of a 
broader range of bacteria is obvious to reasonably generalize results from present 
approaches regarding the risk assessment of antibiotics. Prioritized antibiotics can 
subsequently serve as suitable indicator substances for future plant planning, with 
special regard to the advanced treatment using oxidation and adsorption pro-
cesses. This procedure would ensure the removal of risk-driving antibiotics and 
help to maximally protect the abundance and diversity of organisms in the aquatic 
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environment. In this context, choosing the apparently most susceptible (or lowest) 
tier organism influences the definition of risk-driving antibiotics and should be 
evaluated in future research. Otherwise, the identified risk-drivers must be con-
sidered questionable. 
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Figure S1: inflow generation using NH4-concentration 
Figure S2: comparison of trend prediction approaches using 2, 3 and 4 previous years 
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Figure S3: Influence of the number of repetitions on the deviation of the necessary sampling quantity 
Calculations were carried out for 100, 200, … and 1000 repetitions. The illustrated 
deviation dn (y-axis) was calculated using the following formula: 
1n
100nn
n N
NN
d

  for n=200, 300, …, 1000 
Nn … necessary number of samples using n repetitions 
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Figure S4: Relative standard deviation of different drawing ranges applying 500 repetitions by the ex-
ample of roxithromycin 
Table S1 Results derived from the monitoring program classification concerning the predicted input 
loads 
Number of 
values 
within the predicted range 
(grey area) 
mean recov-
ery 
Azithromycin 303 95 32% 110% 
Cefuroxime 379 70 18% 53% 
Clarithromycin 392 172 43% 58% 
Clindamycin 395 62 16% 7% 
Penicillin V 84 0 0% 3% 
Roxithromycin 386 207 53% 76% 
Sulfamethoxazole 387 281 85% 85% 
Trimethoprim 395 268 67% 76% 
Ciprofloxacin 381 67 18% 41% 
Levofloxacin 381 61 15% 49% 
Doxycycline 342 294 86% 155% 
Amoxicillin 158 0 0% 8% 
Piperacillin 377 0 0% 9% 
Cefotaxime 292 3 1% 22% 
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Equation S1: Determination of the excretion ratio using detailed information on adsorption and me-
tabolism 
)1()1( ,,, ABMABAABAAB fffE   
Antibiotics are partially eliminated during their passage through the human body. 
They are partly adsorbed by the gut and/or gastric mucosa and may be prone to 
metabolizing processes. If no data on faecal excretion is available, it is assumed 
that the non-adsorbed content will be excreted unchanged. Equation 3 is hence 
valid to calculate the excreted ratio of the parent compound (EAB). fA,AB characte-
rizes the adsorption ratio in the human body. The share in the adsorbed fraction 
that is prone to metabolism is determined by the parameter fM,AB, which in turn 
decreases the amount of the parent substance in the faeces. The information on 
adsorption and metabolism of the parent compound are usually provided by the 
pharmaceutical industry and research papers.  
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Table S1: Routine analysis parameters of each sampling point and applied analytical regulations 
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Total Kjeldahl nitrogen X DIN EN 25663 H11 
Ammonia nitrogen X X DIN EN ISO 11732E 23 
Nitrite nitrogen X X EN ISO 10304-1 D 20 
Nitrate nitrogen X X EN ISO 10304-1 D 20 
Total phosphorus X X X DIN EN ISO 6878 D11 DIN EN ISO 11885 E22 
Total suspended solids X X X X DIN 38414 S2 DIN 38409 H2-2 
divalent iron X X X DIN EN ISO 11885 E22 
Temperature X X WTW pH 3210 
pH X X WTW pH 3210 
Flow X X Electromagnetic flow- meter ABB DM 43 F 
Automatic sampler X X Endress + Hauser ASP Station 2000 
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Figure S2: Mass fraction of dissolved antibiotics after centrifugation at 6000 rpm for 6 min, related to 
the total mass of extracted antibiotics 
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Table S3: Identified time series of gapless in- and effluent loads 
Time series Number of values 
Removal ef-
ficiency 
Coefficient 
of determi-
nation 
Time period 
from to 
Azithromycin 
1 14 -17% 0.9969 30.09.2013 13.10.2013 
2 11 10% 0.9988 15.10.2013 25.10.2013 
3 10 2% 0.9895 20.05.2013 29.05.2013 
4 8 -5% 0.9893 17.09.2013 24.09.2013 
Cefotaxime 
1 15 100% 1.0000 04.09.2013 18.09.2013 
2 14 42% 0.9928 12.02.2013 25.02.2013 
3 13 100% 1.0000 01.05.2013 13.05.2013 
4 13 100% 1.0000 02.10.2013 14.10.2013 
Cefuroxime 
1 44 61% 0.9982 17.01.2013 01.03.2013 
2 34 69% 0.9922 22.08.2013 24.09.2013 
3 30 73% 0.9963 01.05.2013 30.05.2013 
4 29 61% 0.9938 23.07.2013 20.08.2013 
5 26 63% 0.9986 30.09.2013 25.10.2013 
6 16 65% 0.9970 03.03.2013 18.03.2013 
7 8 66% 0.9830 08.01.2013 15.01.2013 
Clarithromycin 
1 34 7% 0.9990 22.08.2013 24.09.2013 
2 29 10% 0.9975 23.07.2013 20.08.2013 
3 27 12% 0.9970 03.02.2013 01.03.2013 
4 26 14% 0.9972 30.09.2013 25.10.2013 
5 25 6% 0.9915 08.01.2013 01.02.2013 
6 23 21% 0.9864 08.05.2013 30.05.2013 
7 16 18% 0.9886 03.03.2013 18.03.2013 
8 8 -3% 0.9988 20.03.2013 27.03.2013 
9 8 16% 0.9918 03.07.2013 10.07.2013 
Clindamycin 
1 53 -155% 0.9954 08.01.2013 01.03.2013 
2 34 -288% 0.9993 22.08.2013 24.09.2013 
3 30 -241% 0.9963 01.05.2013 30.05.2013 
4 29 -227% 0.9955 23.07.2013 20.08.2013 
5 26 -304% 0.9922 30.09.2013 25.10.2013 
6 16 -183% 0.9963 03.03.2013 18.03.2013 
7 8 -174% 0.9946 20.03.2013 27.03.2013 
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Clindamycin (corrected using the re-transformation model) 
1 38 7,66% 0.9969 20.06.2013 27.07.2013 
2 34 20,70% 0.9998 22.08.2013 24.09.2013 
3 30 -3,38% 0.9994 01.05.2013 30.05.2013 
4 26 10,64% 0.9997 30.09.2013 25.10.2013 
5 13 24,77% 0.9991 08.08.2013 20.08.2013 
6 10 -16,14% 0.9969 06.03.2013 15.03.2013 
7 8 -26,08% 0.9988 20.03.2013 27.03.2013 
Clindamycin-Sulfoxid 
1 62 0,76% 0.9998 20.06.2013 20.08.2013 
2 34 -9,70% 0.9996 22.08.2013 24.09.2013 
3 30 -8,62% 0.9997 01.05.2013 30.05.2013 
4 26 -6,42% 0.9988 30.09.2013 25.10.2013 
5 10 -9,64% 0.9859 06.03.2013 15.03.2013 
6 8 7,43% 0.9988 20.03.2013 27.03.2013 
Ciprofloxacin 
1 34 64% 0.9998 22.08.2013 24.09.2013 
2 31 54% 0.9972 30.01.2013 01.03.2013 
3 30 68% 0.9938 01.05.2013 30.05.2013 
4 29 67% 0.9979 23.07.2013 20.08.2013 
5 26 65% 0.9972 30.09.2013 25.10.2013 
6 21 61% 0.9984 08.01.2013 28.01.2013 
7 12 62% 0.9958 20.06.2013 01.07.2013 
8 8 55% 0.9896 20.03.2013 27.03.2013 
Levofloxacin 
1 34 56% 0.9993 22.08.2013 24.09.2013 
2 31 47% 0.9956 30.01.2013 01.03.2013 
3 30 63% 0.9965 01.05.2013 30.05.2013 
4 29 53% 0.9966 23.07.2013 20.08.2013 
5 26 56% 0.9991 30.09.2013 25.10.2013 
6 21 56% 0.9976 08.01.2013 28.01.2013 
7 16 64% 0.9964 03.03.2013 18.03.2013 
8 12 56% 0.9964 20.06.2013 01.07.2013 
9 8 57% 0.9924 20.03.2013 27.03.2013 
10 8 46% 0.9913 03.07.2013 10.07.2013 
Piperacillin 
1 42 28% 0.9985 17.01.2013 27.02.2013 
2 34 37% 0.9939 22.08.2013 24.09.2013 
3 30 54% 0.9903 01.05.2013 30.05.2013 
4 29 57% 0.9980 23.07.2013 20.08.2013 
5 26 39% 0.9656 30.09.2013 25.10.2013 
6 16 32% 0.9784 03.03.2013 18.03.2013 
7 8 48% 0.9626 08.01.2013 15.01.2013 
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Roxithromycin 
1 37 -6% 0.9970 16.01.2013 21.02.2013 
2 34 -10% 0.9989 22.08.2013 24.09.2013 
3 29 4% 0.9988 23.07.2013 20.08.2013 
4 26 6% 0.9977 30.09.2013 25.10.2013 
5 13 15% 0.9924 18.05.2013 30.05.2013 
6 12 -3% 0.9984 01.05.2013 12.05.2013 
Sulfamethoxazole 
1 34 70% 0.9978 22.08.2013 24.09.2013 
2 30 52% 0.9945 17.01.2013 15.02.2013 
3 29 58% 0.9966 23.07.2013 20.08.2013 
4 26 65% 0.9989 30.09.2013 25.10.2013 
5 16 60% 0.9933 03.03.2013 18.03.2013 
6 16 78% 0.9822 01.05.2013 16.05.2013 
7 13 73% 0.9923 17.02.2013 01.03.2013 
8 8 59% 0.9969 08.01.2013 15.01.2013 
9 8 55% 0.9862 20.06.2013 27.06.2013 
10 8 59% 0.9969 08.01.2013 15.01.2013 
Trimethoprim 
1 43 -7% 0.9990 18.01.2013 01.03.2013 
2 34 -12% 0.9993 22.08.2013 24.09.2013 
3 30 -11% 0.9995 01.05.2013 30.05.2013 
4 29 -10% 0.9991 23.07.2013 20.08.2013 
5 26 -7% 0.9995 30.09.2013 25.10.2013 
6 15 -8% 0.9988 04.03.2013 18.03.2013 
7 12 1% 0.9964 20.06.2013 01.07.2013 
8 8 1% 0.9979 20.03.2013 27.03.2013 
9 8 5% 0.9982 03.07.2013 10.07.2013 
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S4: Calculation of normalized mass flows 
The WWTP has the wastewater influent as input stream and the effluent as well 
as the digested sludge as output streams. The overall removal from the liquid phase 
will be calculated as the mean of all removal efficiencies (RAB,liquid,i) determined 
according to the procedure presented in paragraph 2.3 in the manuscript. The 
proportion of antibiotics emitted with the effluent stream (MAB,effluent) is 
subsequently determined according to equation SE1. Within this study the 
concentration of antibiotics in primary sludge (cAB,PS), excess sludge (cAB,ES) and 
digested sludge (cAB,DS) were determined as antibiotics mass per dried sludge 
mass. The removal rate of antibiotics during the anaerobic treatment 
(RAB,digester) was determined according to equation SE2 using the associated 
daily loads of total suspended solids (TSS) LPS, LES and LDS. A value for 
RAB,digester above 0 % indicates a removal during the anaerobic treatment while 
values below 0 % theoretically account for a production/re-
transformation/desorption. The antibiotic load emitted from the WWTP via 
sludge (MAB,DS) was calculated on the basis of the digested sludge (see equation 
SE3) which was associated with the diurnal antibiotic input load to the WWTP 
(LAB,input). If the cumulative value of MAB,effluent and MAB,DS equals 100 %, the 
entire influent mass flow is described by these two process streams, i.e. there is 
neither an overall degradation nor a production of the substance. In case the 
value falls below or exceeds the value of 100 % the difference indicates the 
degradation or production of the respective antibiotic, respectively (equation 
SE4).  
, 1 , 1
∑ , ,    [%] (Equation SE1) 
, 1
, 	 	
, 	 	 	 	 , 	 	
[%] (Equation SE2) 
,
, 	 	
,
[%] (Equation SE3) 
, , 100% , ,  
[%] (Equation SE4) 
The verification of sludge streams and the determination of the SRT was carried 
out on the basis of an iron balance. The SRT based on the sludge withdrawal 
showed inconsistencies during the flood event in 2013 (see supplementary mate-
rial S6). Accordingly, for integrity reasons the SRT based on the iron balance was 
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used for the identification of relationships between SRT and the calculated remo-
val rates of antibiotics. The chemical phosphorus precipitation using iron was 
realized with a combination of iron sulphate (FeSO4) and ferrous chloride 
sulphate (FeClSO4) of which both were considered in the balance approach. 
N-removal was calculated based on the following equation: 
  1 ,
	 	 , 	 	 , 	 	 ,
,
[%] (Equation SE5) 
with concentrations of ammonia nitrogen (cNH4-N,out), nitrite nitrogen (cNO2-N,out), 
nitrate nitrogen (cNO3-N,out) and dissolved organic nitrogen compounds (cNorg,out) 
in the effluent as well as the TKN concentration in the influent (cTKN,in). 
The dissolved organic nitrogen was not measured during the monitoring and 
estimated to 4 mg/L.  
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Figure S5: Dependency between measured elimination of CLI and WWTP inflow 
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Table S6: Kd-values of antibiotics in primary (PS), excess (ES) and digested sludge (DS) in l/kg and 
the corresponding removal efficiency during the anaerobic treatment (mean ± SD; number of values in 
brackets, n.d. – not detected) 
 Antibiotic 
Primary sludge Excess sludge Digested sludge 
RAB,digester 
[l/kg] [l/kg] [l/kg] 
AMO n.d. n.d. n.d. n.d.
AZI 109 ± 63 (8) 
211 ± 127 
(8) 
473 ± 287 
(10) 
30% ± 65% 
(9) 
CEFO n.d. n.d. n.d. n.d.
CEF n.d. n.d. n.d. n.d.
CIP 4768 ± 1884 (8) 
1414 ± 539  
(6) 
5044 ± 3246 
(10) 
62% ± 29% 
(8) 
CLA 54 ± 20 (8) 
428 ± 147 
(8) 
437 ± 133 
(3) 
81% ± 16% 
(5) 
CLI 294 ± 111 (8) 
405 ± 159 
(8) 
166 ± 35 
(10) 
22% ± 75% 
(9) 
CLI-S 89 ± 57 (7) 
93 ± 31 
(7) 
183 ± 80 
(9) 
56% ± 21% 
(5) 
DOX 236 ± 102 (4) 
430 ± 285 
(7) n.d.
5% ± 42% 
(8) 
LEV 3089 ± 989 (8) 
1600 ± 777  
(8) 
4074 ± 2025 
(10) 
-21% ± 98%
(9) 
PEN n.d. n.d. n.d. n.d.
PIP n.d. n.d. n.d. n.d.
ROX 40 ± 20 (8) 
289 ± 141 
(5) 
390 
(1) 
70% ± 13% 
(5) 
SUL 526 ± 136 (6) 
403 ± 173 
(6) 1315 ± 1286 (5) 
48% ± 11% 
(4) 
TRI 176 ± 44 (8) 
346 ± 145 
(8) 
1063 ± 346  
(6) 
23% ± 72% 
(7) 
The calculation was carried out according to the following formula: 
,
,
1000 [l/kg]  (Equation SE6) 
with the sludge concentration cAB,sludge [ng/g] and the liquid concentration 
cAB,liquid [ng/l], assuming an equilibrium state. 
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Figure S7: Calculated sludge retention time based on an iron and TSS balance for the year 2013 
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Table S1: Toxicity values 
Species Group of species 
Number of 
investiga-
tions 
Geometric 
Mean [µg/l] 
Standard 
deviation 
[µg/l] 
Literature 
Amoxicillin 
1 Synechococcus leopo-liensis Algae, Moss, Fungi 2 1.17 0.39 
(Andreozzi et al. 
2004) 
2 Selenastrum capricor-nutum Algae, Moss, Fungi 1 530000.00 
(GlaxoSmithKline 
2006) 
3 
primary rainbow trout 
hepatocytes (PRTH) 
cell line 
Fish 1 182700.00 (Laville et al. 2004) 
4 PLHC-1 cell line Fish 1 182700.00 (Laville et al. 2004) 
5 Oncorhynchus mykiss Fish 1 1000000.00 (GlaxoSmithKline 2006) 
6 leopornis macrochirus Fish; U.S. Exotic/Nui-sance Species 1 930000.00 
(GlaxoSmithKline 
2006) 
7 Lemna gibba Flowers, Trees, Shrubs, Ferns 5 1000.00 0.00 (Brain et al. 2004) 
8 Daphnia magna Crustaceans 1 2300000.00 (GlaxoSmithKline 2006) 
9 bacterial short-term genotoxicity assay Bacteria 1 20000.00 
(Hartmann et al. 
1998) 
Azithromycin 
1 salmo trutta Fish 1 84000.00 (fass.se 2014) 
2 Ceriodaphnia dubia Crustaceans 1 4.40 (fass.se 2014) 
Cefuroxime 
1 Selenastrum caprocornutum Algae, Moss, Fungi 1 76000.00 (fass.se 2014) 
2 Oncorhynchus mykiss Fish 1 100000.00 (fass.se 2014) 
3 Daphnia magna Crustaceans 1 831000.00 (fass.se 2014) 
Ciprofloxacin 
1 Selenastrum capricor-nutum Algae, Moss, Fungi 1 3.00 
(Kummerer et al. 
2000) 
2 Pseudomonas putida Bacteria 2 4.90 4.38 (Golet et al. 2002, LUA 2002) 
3 Lemna gibba Flowers, Trees, Shrubs, Ferns 15 402.87 326.41 (Brain et al. 2004) 
4 Anabaena flos-aquae Algae, Moss, Fungi 2 3.43 2.23 (Ebert et al. 2011) 
Clarithromycin 
1 Pseudomonas putida Bacteria 1 12692.00 (Alexy 2003) 
2 Pseudokirchneriella subcapitata Algae, Moss, Fungi 5 11.54 16.00 
(Harada et al. 2008, 
Suzuki et al. 2007, 
Yamashita et al. 2006, 
Yang et al. 2008) 
3 Enterococcus faecalis Bacteria 1 42.00 (Alexy 2003) 
4 Daphnia magna Crustaceans 2 4.70 2.26 (Yamashita et al. 2006) 
5 Danio rerio Fish 1 1000000 (Isidori et al. 2005) 
6 Activated sludge Bacteria 1 50.00 (Ghosh et al. 2009) 
7 bacterial short-term genotoxicity assay Bacteria 1 5.00 
(Hartmann et al. 
1998) 
Doxycyclin 
1 Lemna gibba Flowers, Trees, Shrubs, Ferns 13 310.00 321.29 (Brain et al. 2004) 
Levofloxacin 
1 Xenopus laevis Amphibians 2 100000.00 0.00 (Richards and Cole 2006) 
2 Vibrio fischeri Bacteria 3 1.99 1.35 
(Backhaus and 
Grimme 1999, Back-
haus et al. 2000)  
3 Lemna gibba Flowers, Trees, Shrubs, Ferns 30 294.30 284.30 (Brain et al. 2004)  
Roxithromycin 
1 Pseudokirchneriella subcapitata Algae, Moss, Fungi 2 25 15.00 (Yang et al. 2008) 
2 Lemna gibba Flowers, Trees, Shrubs, Ferns 5 1000 0.00 (Brain et al. 2004) 
Sulfamethoxazole 
1 Xenopus laevis Amphibians 2 100000.00 0.00 (Richards and Cole 2006)  
2 stauropigiana Leo-polensis Algae, Moss, Fungi 1 5.90 (Ferrari et al. 2004)  
3 Selenastrum capricor-nutum Algae, Moss, Fungi 1 614.00 (Eguchi et al. 2004) 
4 Pseudomonas putida Bacteria 1 17393.00 (Alexy 2003) 
5 Pseudokirchneriella subcapitata Algae, Moss, Fungi 4 501.00 300.61 
(Eguchi et al. 2004, 
Ferrari et al. 2004, Liu 
et al. 2001, Yang et al. 
2008)  
6 Lemna gibba Flowers, Trees, Shrubs, Ferns 19 74.23 68.79 
(Brain et al. 2004, 
(Brain et al. 2008) 
7 Hydra attenuata Invertebrates 5 63000.00 50695.17 (Quinn et al. 2008)  
8 Escherichia faecalis bacteria 1 153592.00 (Alexy 2003) 
9 Danio rerio Fish 30 33848.57 182476.87 (Isidori et al. 2005, Madureira et al. 2011) 
10 Cyclotella meneghini-ana Algae, Moss, Fungi 1 1250.00 (Ferrari et al. 2004)  
11 Ceriodaphnia dubia Crustaceans 1 250.00 (Ferrari et al. 2004)  
12 Caenorhabditis ele-gans Worms 14 1459.31 3703.08 (Yu et al. 2011) 
13 Brachionus calyciflo-rus Invertebrates 1 25000.00 (Ferrari et al. 2004)  
14 Activated sludge Bacteria 1 50.00 (Gosh et al. 2009) 
Species-related risk management of antibiotics
166 
Figure S2: Share of antibiotics in RI using the classical PNEC-approach 
Annex 3
167 
S3: Conversion of formulas 
Hill equation 
1
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Table S4: PNEC values (applied values are printed in bold-face type) 
Own data (as-
sessment factor 
in brackets) 
[µg/l] 
Literature values 
(assessment fac-
tor in brackets) 
[µg/l] 
Literature 
Amoxicillin 
0.078 (10) - Own data 
0.1 (100) (Kummerer and Henninger 2003) 
10 (n/a) (Turkdogan and Yetilmezsoy 2009) 
Azithromycin 
0.088 (50) - Own data 
- 0.09 (n/a) (EcotoxCentre 2013) 
- 0.15 (100) (Kummerer and Henninger 2003) 
Cefaclor 
0.6 (100) (Kummerer and Henninger 2003) 
Cefadroxil 
1.1 (100) (Kummerer and Henninger 2003) 
Cefixime 
0.04 (100) (Kummerer and Henninger 2003) 
Cefuroxime 
0.15 (100) (Kummerer and Henninger 2003) 
76 (1000) (fass.se 2014) 
Ciprofloxacin 
0.12 (10) Own data 
3 (100) (Turkdogan and Yetilmezsoy 2009) 
0.02 (100) (Kummerer and Henninger 2003) 
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0.5 (100) (Halling-Sorensen et al. 2000) 
Clarithromycin 
0.94 (5) - Own data 
0.04 (100) (Kummerer and Henninger 2003) 
0.002 (1000) (Zhang et al. 2012) 
Clindamycin 
0.5 (100) (Kummerer and Henninger 2003) 
Doxycyclin 
0.054 (100) Own data 
0.3 (100) (Kummerer and Henninger 2003) 
Levofloxacin 
0.1 (100) Own data 
0.04 (100) (Kummerer and Henninger 2003) 
4.74 (1000) (Turkdogan and Yetilmezsoy 2009) 
Penicillin V 
0.1 (100) (Kummerer and Henninger 2003) 
177 (n/a) (Jones et al. 2002) 
Roxithromycin 
0.1 (100) - Own data 
0.15(100) (Kummerer and Henninger 2003) 
Sulfamethoxazole 
0.59 (10) - Own data 
0.027 (1000) (Zhang et al. 2012) 
0.6 (n/a) (EcotoxCentre 2013) 
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Trimethoprim 
15.7 (10) Own data 
16 (1000) (Turkdogan and Yetilmezsoy 2009) 
60 (n/a) (EcotoxCentre 2013) 
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Figure S5: Risk index of the species algae (RIalgae) – remaining RQAB are summed up and displayed as 
residuals 
Figure S6: Risk index of the species fish (RIfish) – remaining RQAB are summed up and displayed as 
residuals 
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Table S1: Excretion and elimination rate of antibiotics under investigation 
Antibiotic Excretion rate Elimination during wastewater treatment 
Amoxicillin 
60 – 85 % (mean: 72.5 %) 
(Aktories et al. 2009, 
Martindale 1993) 
60 – 85 % (mean: 72.5 %) 
(Aktories et al. 2009, Martin-
dale 1993) 
Azithromycin 99 %
14 (Watkinson et al. 
2009) 99 % (Watkinson et al. 2009) 
Cefaclor 67.4 % (Sandoz 2009) 67.4 % (Sandoz 2009) 
Cefadroxil 0 % (Goebel et al. 2007) 0 % (Goebel et al. 2007) 
Cefixime 53 % (Lode et al. 1979) 53 % (Lode et al. 1979) 
Cefuroxime 
100 % (Watkinson et al. 
2007) (used in study: 99 
%) 
100 % (Watkinson et al. 
2007) (used in study: 99 %) 
Ciprofloxacin 88 % (Pfeffer et al. 1977) 88 % (Pfeffer et al. 1977) 
Clarithromycin 50 % (assumption, no data available) 
50 % (assumption, no data 
available) 
Clindamycin 18 % (Brittain et al. 1985) 18 % (Brittain et al. 1985) 
Doxycyclin 50 % (assumption, no data available) 
50 % (assumption, no data 
available) 
Levofloxacin 50 % (ODDB 2014) 50 % (ODDB 2014) 
Penicillin V 60 % (unpublished data) 60 % (unpublished data) 
Roxithromycin 
40 % (urine), 15 % (fae-
ces) (sum: 55 %) 
(Aktories et al. 2009, 
Vancebryan et al. 1990) 
40 % (urine), 15 % (faeces) 
(sum: 55 %) (Aktories et al. 
2009, Vancebryan et al. 1990) 
Sulfamethoxazole 66 % (Li &Zhang 2011) 66 % (Li &Zhang 2011) 
Trimethoprim 60 % (Hirsch et al. 1999) 60 % (Hirsch et al. 1999) 
14 Using equation 5 with fA,AB = 37 % and fM,AB = 88 % 
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Table S2: PNEC values (applied values are printed in bold-face type) 
Own data (as-
sessment factor 
in brackets) 
[µg/l] 
Literature values 
(assessment fac-
tor in brackets) 
[µg/l] 
Literature 
Amoxicillin 
0.078 (10) - Own data 
0.1 (100) (Kummerer and Henninger 2003) 
10 (n/a) (Turkdogan and Yetilmezsoy 2009) 
Azithromycin 
0.088 (50) - Own data 
- 0.09 (n/a) (EcotoxCentre 2013) 
- 0.15 (100) (Kummerer and Henninger 2003) 
Cefaclor 
0.6 (100) (Kummerer and Henninger 2003) 
Cefadroxil 
1.1 (100) (Kummerer and Henninger 2003) 
Cefixime 
0.04 (100) (Kummerer and Henninger 2003) 
Cefuroxime 
0.15 (100) (Kummerer and Henninger 2003) 
76 (1000) (fass.se 2014) 
Ciprofloxacin 
0.12 (10) Own data 
3 (100) (Turkdogan and Yetilmezsoy 2009) 
0.02 (100) (Kummerer and Henninger 2003) 
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0.5 (100) (Halling-Sorensen et al. 2000) 
Clarithromycin 
0.94 (5) - Own data 
0.04 (100) (Kummerer and Henninger 2003) 
0.002 (1000) (Zhang et al. 2012) 
Clindamycin 
0.5 (100) (Kummerer and Henninger 2003) 
Doxycyclin 
0.054 (100) Own data 
0.3 (100) (Kummerer and Henninger 2003) 
Levofloxacin 
0.1 (100) Own data 
0.04 (100) (Kummerer and Henninger 2003) 
4.74 (1000) (Turkdogan and Yetilmezsoy 2009) 
Penicillin V 
0.1 (100) (Kummerer and Henninger 2003) 
177 (n/a) (Jones et al. 2002) 
Roxithromycin 
0.1 (100) - Own data 
0.15(100) (Kummerer and Henninger 2003) 
Sulfamethoxazole 
0.59 (10) - Own data 
0.027 (1000) (Zhang et al. 2012) 
0.6 (n/a) (EcotoxCentre 2013) 
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Trimethoprim 
15.7 (10) Own data 
16 (1000) (Turkdogan and Yetilmezsoy 2009) 
60 (n/a) (EcotoxCentre 2013) 
Annex 4
181 
S3: Synergy parameters 
Toxic Units 











n
1AB AB,50
50,AB
IC
C
TU (Yang et al., 2008) 
With ICx,A and ICx,B being the concentration of subtances A and B to produce 50 % 
effect and CA,x and CB,x in combination also causing 50 % effect 
Combination index 











n
1AB AB,x
x,AB
IC
C
CI (Zhao et al., 2010) 
With ICx,A and ICx,B being the concentration of subtances A and B to produce a given 
effect x (e.g. IC50) and CA,x and CB,x in combination causing the same effect x 
Fractional inhibitory concentration 











n
1AB AB,alone
AB,ncombinatio
MIC
MIC
FIC (Hallander et al., 1982) 
With MICcombination,AB being the lowest concentration of antibiotic combination per-
mitting no visible growth and MICalone,AB being the lowest concentration of the single 
antibiotic permitting no visible growth 
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Figures S4: Predicted environmental concentration of antibiotics under investigation 
Table S5: Binary interaction studies on antibiotics 
Substance 
A 
Class 
A 
Substance 
B 
Class 
B organism 
Parame-
ter 
Synergism/ 
Antagonism 
Concentra-
tion 
range A 
[mg/l] 
Concentra-
tion 
range B 
[mg/l] 
Literature 
Trime-
thoprim DI 
Sulfameth-
oxazole SU Vibrio Fisheri TU antagonistic 75.6 - 7560 
176.79 - 
17679.2 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Sulfadox-
ine SU Vibrio Fisheri TU antagonistic 75.6 - 7560 
273.67 - 
27367.2 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Sulfachlo-
ro-
pyridazine 
SU Vibrio Fisheri TU antagonistic 75.6 - 7560 134.01 - 13400.8 
(Zou et al., 
2013) 
Trime-
thoprim DI Tetracyclin TC Vibrio Fisheri TU antagonistic 75.6 - 7560 15.34 - 1383.2 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Oxytetra-
cycline TC Vibrio Fisheri TU antagonistic 75.6 - 7560 16.58 - 1657.6 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Doxycy-
clin TC Vibrio Fisheri TU antagonistic 75.6 - 7560 16.41 - 1640.8 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Chlortetra-
cyclin TC Vibrio Fisheri TU antagonistic 75.6 - 7560 17.08 - 1708 
(Zou et al., 
2013) 
Trime-
thoprim DI Tetracyclin TC Vibrio Fisheri TU antagonistic 75.6 - 7560 15.34 - 1534.4 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Oxytetra-
cycline TC Vibrio Fisheri TU antagonistic 75.6 - 7560 16.58 - 1657.6 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Chloram-
phenicol 
Feni-
cole Vibrio Fisheri TU none 75.6 - 7560 22.96 - 2296 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Chloram-
phenicol 
Feni-
cole Vibrio Fisheri TU none 75.6 - 7560 22.96 - 2296 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Doxycy-
clin TC Vibrio Fisheri TU none 75.6 - 7560 22.01 - 2200.8 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Chlortetra-
cyclin TC Vibrio Fisheri TU none 75.6 - 7560 17.08 - 1708 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Sulfameth-
oxazole SU Vibrio Fisheri TU synergistic 75.6 - 7560 
176.79 - 
17679.2 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Sulfadox-
ine SU Vibrio Fisheri TU synergistic 75.6 - 7560 
273.67 - 
27367.2 
(Zou et al., 
2013) 
Trime-
thoprim DI 
Sulfachlo-
ro-
pyridazine 
SU Vibrio Fisheri TU synergistic 75.6 - 7560 134.01 - 13400.8 
(Zou et al., 
2013) 
Amoxicil-
lin BL 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 5.9 - 13.9 4.2 - 13.6 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 5.4 - 10.0 5.4 - 10.0 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Erythro-
mycin MA 
Anabaena sp. 
CPB4337 CI antagonistic 4.2 - 13.6 4.2 - 13.6 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 
CI antagonistic 0.8 - 1.8 0.8 - 1.8 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata 
CI antagonistic 1.4 - 2.4 1.4 - 2.4 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI antagonistic 1.5 - 2.3 1.5 - 2.3 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI antagonistic 1.0 - 1.6 1.0 - 1.6 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 0.57 - 1.17 0.57 - 1.17 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 0.46 - 1.46 0.46 - 1.46 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 1.2 - 2.4 1.2 - 2.4 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI synergistic 0.7 - 1.5 0.7 - 1.5 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 0.24 - 0.44 0.24 - 0.44 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 0.25 - 0.49 0.25 - 0.49 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI synergistic 2.4 - 3.6 2.4 - 3.6 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 0.0022 - 0.007 0.0022 - 0.007 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 0.17 - 0.39 0.17 - 0.39 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 11.4 - 18.6 11.4 - 18.6 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 CI none 9.3 - 13.5 9.3 - 13.5 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Erythro-
mycin MA 
Anabaena sp. 
CPB4337 CI antagonistic 10.7 - 21.7 10.7 - 21.7 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 
CI none 1.5 - 2.5 1.5 - 2.5 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI none 2.3 - 3.1 2.3 - 3.1 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 1 - 1.6 1 - 1.6 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 
CI antagonistic 1.1 - 2.3 1.1 - 2.3 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 2.4 - 3.4 2.4 - 3.4 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 0.39 - 0.87 0.39 - 0.87 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 0.54 - 0.8 0.54 - 0.8 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI none 29.8 - 36.4 29.8 - 36.4 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 CI synergistic 20.9 - 23.9 20.9 - 23.9 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL 
Erythro-
mycin MA 
Anabaena sp. 
CPB4337 
CI none 27.5 - 44.5 27.5 - 44.5 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI synergistic 3.9 - 4.7 3.9 - 4.7 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI none 4.6 - 5.6 4.6 - 5.6 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Anabaena sp. 
CPB4337 
CI none 2.3 - 2.7 2.3 - 2.7 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Anabaena sp. 
CPB4337 CI antagonistic 3.8 - 5.2 3.8 - 5.2 
(Gonzalez-
Pleiter et al., 
2013) 
Amoxicil-
lin BL Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 6 - 7 6 - 7 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 1.3 - 1.9 1.3 - 1.9 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Anabaena sp. 
CPB4337 CI synergistic 2.7 - 3.3 2.7 - 3.3 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 3.2 - 3.8 3.2 - 3.8 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI antagonistic 22.7 - 23.3 22.7 - 23.3 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata CI synergistic 2.2 - 3.6 2.2 - 3.6 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 0.75 - 1.03 0.75 - 1.03 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI synergistic 5.1- 6.5 5.1- 6.5 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 0.014 - 0.028 0.014 - 0.028 
(Gonzalez-
Pleiter et al., 
2013) 
Norfloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 8.3 - 10.1 8.3 - 10.1 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Levofloxa-
cin QU 
Pseudokirchneri-
ella subcapitata CI synergistic 2.4 2.4 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata CI synergistic 13.7 - 16.3 13.7 - 16.3 
(Gonzalez-
Pleiter et al., 
2013) 
Levofloxa-
cin QU Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 4.1 - 5.1 4.1 - 5.1 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
CI synergistic 16.7 - 19.7 16.7 - 19.7 
(Gonzalez-
Pleiter et al., 
2013) 
Erythro-
mycin MA Tetracyclin TC 
Pseudokirchneri-
ella subcapitata CI synergistic 0.23 - 0.31 0.23 - 0.31 
(Gonzalez-
Pleiter et al., 
2013) 
Sulfadi-
methoxine SU 
Py-
rimetham-
ine 
xx Selenastrum 
capricornutum 
compari-
son EC50 none 2.17 - 2.57 2.17 - 2.57 
(Eguchi et 
al., 2004) 
Sulfameth-
oxazole SU 
Trime-
thoprim DI 
Selenastrum 
capricornutum 
compari-
son EC50 synergistic 0.239 - 0.309 0.239 - 0.309 
(Eguchi et 
al., 2004) 
Sulfadia-
zine SU 
Trime-
thoprim DI 
Selenastrum 
capricornutum 
compari-
son EC50 synergistic 0.419 - 0.517 0.419 - 0.517 
(Eguchi et 
al., 2004) 
mixture SU mixture SU Daphnia 
Magna 
compari-
son EC50 none 0.28 - 657.2 0.28 - 657.2 
(De Liguoro 
et al., 2009) 
sulfadia-
zine SU 
Trime-
thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 17.6 - 515.9 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
sulfaguani-
dine SU 
Trime-
thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 0.28 - 8.97 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
sulfamera-
zine SU 
Trime-
thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 23.1 - 675.8 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
sulfadi-
methoxine SU 
Trime-
thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 22.4 - 657.2 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
sulfame-
thazine SU 
Trime-
thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 16.2 - 486 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
sulfa-
quinoxa-
line 
SU Trime-thoprim DI 
Daphnia 
Magna 
compari-
son EC50 none 9.4 - 303.4 10.7 - 345.9 
(De Liguoro 
et al., 2009) 
Erythro-
mycin MA 
Oxolinic 
acid QU 
Pseudokirchneri-
ella subcapitata λ none 0.15 0.7 - 1.1 
(Munch 
Christensen 
et al., 2006) 
Oxytetra-
cyclin TC QU 
Pseudokirchneri-
ella subcapitata λ antagonistic 0.46 - 0.48 7.2 - 11 
(Munch 
Christensen 
et al., 2006) 
Flumequine
Erythro-
mycin MA QU 
Pseudokirchneri-
ella subcapitata 
λ antagonistic 0.23 - 0.24 8.0 - 8.1 
(Munch 
Christensen 
et al., 2006) 
Oxytetra-
cyclin TC 
Oxolinic 
acid QU 
Pseudokirchneri-
ella subcapitata λ none 1.8 - 2.2 9.9 - 31 
(Munch 
Christensen 
et al., 2006) 
Erythro-
mycin MA 
Oxolinic 
acid QU Belebtschlamm λ synergistic 33 - 44 1.1 - 2.3 
(Munch 
Christensen 
et al., 2006) 
Flumequine QU Oxolinic acid QU Belebtschlamm λ none 0.60 - 0.67 0.73 - 0.91 
(Munch 
Christensen 
et al., 2006) 
Oxytetra-
cyclin TC QU Belebtschlamm λ synergistic 2.4 - 3.6 1.1 - 1.3 
(Munch 
Christensen 
et al., 2006) 
Erythro-
mycin MA QU Belebtschlamm λ synergistic 30 - 51 0.65 - 1.80 
(Munch 
Christensen 
et al., 2006) 
Erythro-
mycin MA 
Oxytetra-
cyclin TC 
Pseudokirchneri-
ella subcapitata 
λ synergistic 0.13 1.4 
(Munch 
Christensen 
et al., 2006) 
Erythro-
mycin MA 
Oxytetra-
cyclin TC Belebtschlamm λ synergistic 33 - 49 3.1 - 4.2 
(Munch 
Christensen 
et al., 2006) 
Oxytetra-
cyclin TC 
Oxolinic 
acid QU Belebtschlamm λ synergistic 2.7 - 4.9 0.75 - 0.86 
(Munch 
Christensen 
et al., 2006) 
Flumequine
Flumequine
Flumequine
Ceftazidim CE Clarithro-mycin MA 
Pseudomonas 
aeruginosa 
Survival 
rate none 0.5 - 32 16 - 1024 
(Bui et al., 
2000) 
Ceftazidim CE Clarithro-mycin MA 
Pseudomonas 
aeruginosa 
Survival 
rate synergistic 1 16 - 128 
(Bui et al., 
2000) 
Levofloxa-
cin QU 
Clarithro-
mycin MA 
Pseudomonas 
aeruginosa 
No. Of vi-
able bacte-
ria 
synergistic - - (Yanagihara et al., 2000) 
Ciproflox-
acin QU 
Mero-
penem BL 
Staphylococcus 
aureus FIC none - - 
(Sueke et 
al., 2010) 
Carbenicil-
lin BL 
cepha-
lothin CE Escherichia coli MIC synergistic - - 
(Klasters.J 
et al., 1972) 
Carbenicil-
lin BL 
cepha-
lothin CE 
Klebsiella-En-
terobacter 
MIC synergistic - - (Klasters.J et al., 1972) 
Ciproflox-
acin QU Ampicillin BL 
Staphylococcus 
aureus FIC none 2 0.5 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU 
Ceftriax-
one BL 
Staphylococcus 
aureus FIC none 2 2 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU Cefepim BL 
Staphylococcus 
aureus 
FIC none 2 2 (Gradelski et al., 2001) 
Ciproflox-
acin QU 
Ceftriax-
one BL Escherichia coli FIC none 0.032 0.015 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU Ampicillin BL Escherichia coli FIC none 0.032 2 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU Cefepim BL Escherichia coli FIC none 0.032 0.015 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU Cefepim BL 
Pseudomonas 
aeruginosa FIC none 2 2 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU Ampicillin BL 
Enterococcus 
faecalis FIC none 8 0.25 
(Gradelski 
et al., 2001) 
Ciproflox-
acin QU 
Clarithro-
mycin MA 
Staphylococcus 
aureus 
FIC none 2 0.125 (Gradelski et al., 2001) 
Ciproflox-
acin QU 
Clarithro-
mycin MA 
Enterococcus 
faecalis 
FIC none 8 0.5 (Gradelski et al., 2001) 
Penicillin BL Chlortetra-cyclin TC 
Klebsiella pneu-
moniae 
No. Of vi-
able bacte-
ria 
antagonistic 12 1 (Jawetz et al., 1954) 
Aureomy-
cin TC Penicillin BL 
Streptococcus 
Faecalis 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Oxytetra-
cyclin TC Penicillin BL 
Streptococcus 
Faecalis 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Aureomy-
cin TC Penicillin BL 
Streptococcus 
Pyogenes 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Oxytetra-
cyclin TC Penicillin BL 
Streptococcus 
Pyogenes 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Oxytetra-
cyclin TC Penicillin BL 
Micrococcus Py-
ogenes var. au-
reus 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Aureomy-
cin TC Penicillin BL 
Klebsiella pneu-
moniae 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Oxytetra-
cyclin TC Penicillin BL 
Klebsiella pneu-
moniae 
No. Of vi-
able bacte-
ria 
antagonistic - - (Jewetz et al., 1952) 
Erythro-
mycin MA 
Amoxicil-
lin BL Escherichia coli FIC none 3.125 7.813 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Acinetobacter 
calcoaceticus  
FIC none 0.195 250 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL shigella flexneri FIC none 0.195 31.25 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Staphylococcus 
aureus 
FIC none 0.195 125 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Proteus vulgaris 
ATCC 6830 FIC none 3.125 62.5 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Proteus vulgaris 
CSIR 0030 FIC synergistic 6.25 0.12 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Salmonella 
Typhi FIC synergistic 3.906 7.813 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Erythro-
mycin MA 
Amoxicil-
lin BL 
Streptococcus 
Pyogenes 
FIC synergistic 0.781 1.953 
(Olajuyigbe 
and Ani-
mashaun, 
2012) 
Ampicillin BL Ciproflox-acin QU 
Staphylococcus 
aureus FIC antagonistic 10.4 26.1 
(Singh and 
Mishra, 
2012) 
Penicillin BL Ciproflox-acin QU 
Staphylococcus 
aureus FIC antagonistic 26.8 26.1 
(Singh and 
Mishra, 
2012) 
Azithro-
mycin MA Ofloxacin QU 
Staphylococcus 
aureus FIC antagonistic 27.4 20.7 
(Singh and 
Mishra, 
2012) 
Ampicillin BL Ofloxacin QU Staphylococcus 
aureus FIC none 10.4 20.7 
(Singh and 
Mishra, 
2012) 
Ampicillin BL Cloaxillin BL Staphylococcus 
aureus 
FIC synergistic 10.4 - 
(Singh and 
Mishra, 
2012) 
Ampicillin BL Penicillin BL Staphylococcus 
aureus FIC synergistic 10.4 26.8 
(Singh and 
Mishra, 
2012) 
Ampicillin BL Azithro-mycin MA 
Staphylococcus 
aureus 
FIC synergistic 10.4 27.4 
(Singh and 
Mishra, 
2012) 
Penicillin BL Azithro-mycin MA 
Staphylococcus 
aureus FIC synergistic 26.8 27.4 
(Singh and 
Mishra, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC Proteus vulgaris FIC antagonistic 1.953 1.953 
(Olajuyigbe, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC Bacillus cereus FIC synergistic 0.007625 0.007625 
(Olajuyigbe, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Staphylococcus 
aureus 
FIC synergistic 1.953 1.953 (Olajuyigbe, 2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Salmonella 
Typhi FIC synergistic 0.0038 0.0038 
(Olajuyigbe, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Acinetobacter 
calcoaceticus  FIC synergistic 62.5 62.5 
(Olajuyigbe, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Klebsiella pneu-
moniae 
FIC synergistic 3.9063 3.9063 (Olajuyigbe, 2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Enterococcus 
faecalis FIC synergistic 0.488 0.488 
(Olajuyigbe, 
2012) 
Amoxicil-
lin BL 
Tetracy-
cline TC 
Staphylococcus 
aureus FIC synergistic 0.488 - 1.953 0.488 - 1.953 
(Olajuyigbe, 
2012) 
Azlocillin BL Ciproflox-acin QU 
Klebsiella pneu-
moniae 
FIC none - - (Chin et al., 1986) 
Azlocillin BL Ciproflox-acin QU 
Enterobacter 
spp FIC none - - 
(Chin et al., 
1986) 
Azlocillin BL Ciproflox-acin QU Escherichia coli FIC none - - 
(Chin et al., 
1986) 
Azlocillin BL Ciproflox-acin QU 
Branhamella ca-
tarrhalis 
FIC none - - (Chin et al., 1986) 
Azlocillin BL Ciproflox-acin QU 
Pseudomonas 
aeruginosa 
FIC synergistic - - (Chin et al., 1986) 
Azlocillin BL Ciproflox-acin QU 
Pseudomonas 
aeruginosa FIC none - - 
(Bamberger 
et al., 1986) 
Ciproflox-
acin QU 
Ceftizox-
ime CE 
Serratia mar-
cescens 
FIC none - - (Bamberger et al., 1986) 
Ciproflox-
acin QU 
Ceftizox-
ime CE 
Pseudomonas 
aeruginosa FIC none - - 
(Bamberger 
et al., 1986) 
Azlocillin BL Ciproflox-acin QU 
Serratia mar-
cescens FIC synergistic - - 
(Bamberger 
et al., 1986) 
Ciproflox-
acin QU Azlocillin BL 
Pseudomonas 
aeruginosa 
No. Of vi-
able bacte-
ria 
synergistic 0.000025 0.0025 
(Chalkley 
and Koorn-
hof, 1985) 
Ciproflox-
acin QU cefotaxime CE Escherichia coli 
No. Of vi-
able bacte-
ria 
synergistic 0.00001 0.00005 
(Chalkley 
and Koorn-
hof, 1985) 
Ciproflox-
acin QU Azlocillin BL 
Pseudomonas 
aeruginosa 
No. Of vi-
able bacte-
ria 
synergistic 0.00001 0.01 
(Chalkley 
and Koorn-
hof, 1985) 
Clindamy-
cin MA Tetracyclin TC 
Staphylococcus 
epidermidis 
No. Of vi-
able bacte-
ria 
synergistic 0.25 - 2 1 - 8 (Monzon et al., 2001) 
Penicillin BL Oxytetra-cyclin TC 
Streptococcus 
faecalis 
No. of vi-
able bacte-
ria 
none - - (Gunnison et al., 1955) 
Penicillin BL Oxytetra-cyclin TC 
Staphylococcus 
aureus 
No. of vi-
able bacte-
ria 
none - - (Gunnison et al., 1955) 
Tylosin MA Roxithro-mycin MA 
Pseudokirchneri-
ella subcapitata 
TU synergistic 0.105 0.0235 (Yang et al., 2008) 
Clarithro-
mycin MA 
Roxithro-
mycin MA 
Pseudokirchneri-
ella subcapitata 
TU synergistic 0.023 0.0235 (Yang et al., 2008) 
Sulfame-
thazine SU 
Sulfameth-
oxazolee SU 
Pseudokirchneri-
ella subcapitata 
TU none 4.35 0.95 (Yang et al., 2008) 
Chlortetra-
cycline TC 
Tetracy-
cline TC 
Pseudokirchneri-
ella subcapitata TU synergistic 0.9 0.5 
(Yang et al., 
2008) 
Ciproflox-
acin QU 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata TU synergistic 3.35 90 
(Yang et al., 
2008) 
Tylosin MA Chlortetra-cycline TC 
Pseudokirchneri-
ella subcapitata 
TU synergistic 0.105 0.9 (Yang et al., 2008) 
Tylosin MA Tetracy-cline TC 
Pseudokirchneri-
ella subcapitata TU synergistic 0.105 0.5 
(Yang et al., 
2008) 
Trime-
thoprim DI 
Sulfame-
thazine SU 
Pseudokirchneri-
ella subcapitata TU synergistic 20 4.35 
(Yang et al., 
2008) 
Trime-
thoprim DI 
Sulfameth-
oxazolee SU 
Pseudokirchneri-
ella subcapitata 
TU synergistic 20 0.95 (Yang et al., 2008) 
Tylosin MA Sulfame-thazine SU 
Pseudokirchneri-
ella subcapitata TU antagonistic 0.105 0.95 
(Yang et al., 
2008) 
Tylosin MA Norfloxa-cin QU 
Pseudokirchneri-
ella subcapitata 
TU none 0.105 90 (Yang et al., 2008) 
Sulfame-
thazine SU 
Chlortetra-
cycline TC 
Pseudokirchneri-
ella subcapitata 
TU none 4.35 0.9 (Yang et al., 2008) 
Sulfame-
thazine SU 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
TU synergistic 4.35 90 (Yang et al., 2008) 
Chlortetra-
cycline TC 
Norfloxa-
cin QU 
Pseudokirchneri-
ella subcapitata 
TU synergistic 0.9 90 (Yang et al., 2008) 
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Figure S6: Tendency of synergism according to the tested concentration range of investigations 
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